Section 9

EurekaMag PDF full texts Chapter 8,251


Pereira, H.A.; Moore, P.; Grammas, P. 1996: CAP37, a neutrophil granule-derived protein stimulates protein kinase C activity in endothelial cells. Journal of Leukocyte Biology 60(3): 415-422
Pereira, H.A. 1995: CAP37, a neutrophil-derived multifunctional inflammatory mediator. Journal of Leukocyte Biology 57(6): 805-812
Heaf, J. 1995: CAPD adequacy and dialysis morbidity: detrimental effect of a high peritoneal equilibration rate. Renal Failure 17(5): 575-587
Kushihata, S.; Yorioka, N.; Ito, T.; Nishida, Y.; Amimoto, D.; Ye, X.F.; Yamakido, M. 1998: CAPD catheter rupture without deterioration. International Journal of Artificial Organs 21(2): 95-96
Heebels, A.E.; Nubé, M.J.; van Limbeek, J.; Grooteman, M.P.; van Geelen, J.A. 1995: CAPD patients exhibit a nocturnal fall in blood pressure: A single-centre study. Netherlands Journal of Medicine 46(5): 225-231
Morduchowicz, G.; Winkler, J.; Boner, G. 1992: CAPD versus haemodialysis: A comparison in the same patients. International Urology and Nephrology 24(5): 575-579
Downing, G.J.; Poisner, A.M. 1994: cAPK mediates placental renin secretion stimulated by beta-adrenoceptor activation. American Journal of Physiology 267(6 Pt 1): E954-E960
Jaffrey, S.R.; Snowman, A.M.; Eliasson, M.J.; Cohen, N.A.; Snyder, S.H. 1998: CAPON: A protein associated with neuronal nitric oxide synthase that regulates its interactions with PSD95. Neuron 20(1): 115-124
Berwin, B.; Floor, E.; Martin, T.F. 1998: CAPS (mammalian UNC-31) protein localizes to membranes involved in dense-core vesicle exocytosis. Neuron 21(1): 137-145
Den-Boeft, J.; Eerens, H.C.; Den-Tonkelaar, W.A.M.; Zandveld, P.Y.J. 1996: CAR International: A simple model to determine city street air quality. Science of the Total Environment 189-190: 321-326
Den-Tonkelaar, Wim, A.M. 1996: CAR Smog: System for on-line extrapolation from hourly measurements to concentrations along standard roads within cities. Science of the Total Environment 189-190: 423-429
Saxe, C.L.; Ginsburg, G.T.; Louis, J.M.; Johnson, R.; Devreotes, P.N.; Kimmel, A.R. 1993: CAR2, a prestalk cAMP receptor required for normal tip formation and late development of Dictyostelium discoideum. Genes and Development 7(2): 262-272
Jacobs, P. 1992: CARABAS: A programmable radiometer for the characterization of backgrounds in the thermal infrared. International Journal of Remote Sensing 13(15): 2865-2871
Warnant, P.; Francois, L.; Strivay, D.; Gerard, J.C. 1994: CARAIB: A global model of terrestrial biological productivity. Global Biogeochemical Cycles 8(3): 255-270
Winnepenninckx, B.; Van de Peer, Y.; Backeljau, T.; De Wachter, R. 1995: CARD: a drawing tool for RNA secondary structure models. Biotechniques 18(6): 1060-1063
Lichtenfels, R.; Biddison, W.E.; Schulz, H.; Vogt, A.B.; Martin, R. 1994: CARE-LASS (calcein-release-assay), an improved fluorescence-based test system to measure cytotoxic T lymphocyte activity. Journal of Immunological Methods 172(2): 227-239
Coldwell, S.E.; Getz, T.; Milgrom, P.; Prall, C.W.; Spadafora, A.; Ramsay, D.S. 1998: CARL: A LabVIEW 3 computer program for conducting exposure therapy for the treatment of dental injection fear. Behaviour Research and Therapy 36(4): 429-441
Zou, Y.; Evans, S.; Chen, J.; Kuo, H.C.; Harvey, R.P.; Chien, K.R. 1997: CARP, a cardiac ankyrin repeat protein, is downstream in the Nkx2-5 homeobox gene pathway. Development 124(4): 793-804
Lambert, P.D.; Couceyro, P.R.; McGirr, K.M.; Dall Vechia, S.E.; Smith, Y.; Kuhar, M.J. 1998: CART peptides in the central control of feeding and interactions with neuropeptide y. Synapse 29(4): 293-298
Klemke, R.L.; Leng, J.; Molander, R.; Brooks, P.C.; Vuori, K.; Cheresh, D.A. 1998: CAS/Crk coupling serves as a "molecular switch" for induction of cell migration. Journal of Cell Biology 140(4): 961-972
Goltsev, Y.V.; Kovalenko, A.V.; Arnold, E.; Varfolomeev, E.E.; Brodianskii, V.M.; Wallach, D. 1997: CASH, a novel caspase homologue with death effector domains. Journal of Biological Chemistry 272(32): 19641-19644
Hata, Y.; Butz, S.; Südhof, T.C. 1996: CASK: a novel dlg/PSD95 homolog with an N-terminal calmodulin-dependent protein kinase domain identified by interaction with neurexins. Journal of Neuroscience: the Official Journal of the Society for Neuroscience 16(8): 2488-2494
Lievens, P.M.; Tufarelli, C.; Donady, J.J.; Stagg, A.; Neufeld, E.J. 1997: CASP, a novel, highly conserved alternative-splicing product of the CDP/cut/cux gene, lacks cut-repeat and homeo DNA-binding domains, and interacts with full-length CDP in vitro. Gene 197(1-2): 73-81
Kramer, B.; Rarey, M.; Lengauer, T. 1997: CASP2 experiences with docking flexible ligands using flexX. Proteins Suppl 1: 221-225
Sobolev, V.; Moallem, T.M.; Wade, R.C.; Vriend, G.; Edelman, M. 1997: CASP2 molecular docking predictions with the LIGIN software. Proteins Suppl 1: 210-214
Lesk, A.M. 1997: CASP2: Report on Ab initio predictions. Proteins Suppl 1: 151-166
Chinese-Acute-Stroke-Trial-Collaborative-Group 1997: CAST: Randomised placebo-controlled trial of early aspirin use in 20 000 patients with acute ischaemic stroke. Lancet (North American Edition) 349(9066): 1641-1649
Vassort-Bruneau, C.; Lesage-Descauses, M.C.; Martel, J.L.; Lafont, J.P.; Chaslus-Dancla, E. 1996: CAT III chloramphenicol resistance in Pasteurella haemolytica and Pasteurella multocida isolated from calves. Journal of Antimicrobial ChemoTherapy 38(2): 205-213
Rao, D.C. 1998: CAT scans, PET scans, and genomic scans. Genetic Epidemiology 15(1): 1-18
Proft, M.; Kötter, P.; Hedges, D.; Bojunga, N.; Entian, K.D. 1995: CAT5, a new gene necessary for derepression of gluconeogenic enzymes in Saccharomyces cerevisiae. EMBO Journal 14(24): 6116-6126
Hedges, D.; Proft, M.; Entian, K.D. 1995: CAT8, a new zinc cluster-encoding gene necessary for derepression of gluconeogenic enzymes in the yeast Saccharomyces cerevisiae. Molecular and Cellular Biology 15(4): 1915-1922
Hou, J.W.; Wang, J.K.; Tsai, W.Y.; Chou, C.C.; Wang, T.R. 1997: CATCH 22: deletion of locus 22q11 in velocardiofacial syndrome, DiGeorge anomaly, and nonsyndromic conotruncal defects. Journal of the Formosan Medical Association 96(6): 419-423
Orengo, C.A.; Michie, A.D.; Jones, S.; Jones, D.T.; Swindells, M.B.; Thornton, J.M. 1997: CATH--a hierarchic classification of protein domain structures. Structure 5(8): 1093-1108
Closs, E.I. 1996: CATs, a family of three distinct mammalian cationic amino acid transporters. Amino Acids 11(2): 193-208
Lauri, G.; Bartlett, P.A. 1994: CAVEAT: A program to facilitate the design of organic molecules. Journal of Computer-Aided Molecular Design 8(1): 51-66
Berg, J.; Fayn, J.; Edenbrandt, L.; Lundh, B.; Malmström, P.; Rubel, P. 1995: CAVIAR: A tool to improve serial analysis of the 12-lead electrocardiogram. Clinical Physiology 15(5): 435-445
Bruhn, R.; Kannan, N.; Petrick, G.; Schulz-Bull, D.E.; Duinker, J.C. 1995: CB pattern in the harbour porpoise: bioaccumulation, metabolism and evidence for cytochrome P450 IIB activity. Chemosphere 31(7): 3721-3732
McIntosh, H.H.; Song, C.; Howlett, A.C. 1998: CB1 cannabinoid receptor: cellular regulation and distribution in N18TG2 neuroblastoma cells. Brain Research. Molecular Brain Research 53(1-2): 163-173
Cook, S.A.; Lowe, J.A.; Martin, B.R. 1998: CB1 receptor antagonist precipitates withdrawal in mice exposed to Delta9-tetrahydrocannabinol. Journal of Pharmacology and Experimental Therapeutics 285(3): 1150-1156
Pakkala, I.; Savli, H.; Knuutila, S.; Binderup, L.; Pakkala, S. 1997: CB1093, a novel vitamin D analog; effects on differentiation and clonal growth on HL-60 and de novo leukemia cells. Leukemia Research 21(4): 321-326
Atuma, S.S.; Linder, C.E.; Andersson, O.; Bergh, A.; Hansson, L.; Wicklund Glynn, A. 1996: CB153 as indicator for congener specific determination of PCBs in diverse fish species from Swedish waters. Chemosphere 33(8): 1459-1464
Daniel, V.; Süsal, C.; Weimer, R.; Zipperle, S.; Kröpelin, M.; Zimmermann, R.; Huth-Kühne, A.; Gerhard, I.; Maier, H.; Opelz, G. 1996: CD8+ lymphocyte decrease in HIV disease: association with anti-CD4+ but not with anti-CD8+ lymphocyte autoantibodies. Vox Sanguinis 70(2): 86-91
Champoux, M.; Kriete, M.F.; Higley, J.D.; Suomi, S.J. 1996: CBC and serum chemistry differences between Indian-derived and Chinese-Indian hybrid rhesus monkey infants. American Journal of Primatology 39(1): 79-84
Biederman, J.; Wozniak, J.; Kiely, K.; Ablon, S.; Faraone, S.; Mick, E.; Mundy, E.; Kraus, I. 1995: CBCL clinical scales discriminate prepubertal children with structured interview-derived diagnosis of mania from those with ADHD. Journal of the American Academy of Child and Adolescent Psychiatry 34(4): 464-471
Wolf, J. 1997: CBE- a universal package of PC-programs for estimating crossbreeding effects. Archiv fuer Tierzucht 40(2): 165-177
Agoff, S.N.; Wu, B. 1994: CBF mediates adenovirus Ela trans-activation by interaction at the C-terminal promoter targeting domain of conserved region 3. Oncogene 9(12): 3707-3711
Cao, W.; Britos Bray, M.; Claxton, D.F.; Kelley, C.A.; Speck, N.A.; Liu, P.P.; Friedman, A.D. 1997: CBF-beta-SMMHC, expressed M4Eo AML, reduced CBF DNA-binding and inhibited the G1 to S cell cycle transition at the restriction point in myeloid and lymphoid cells. Oncogene 15(11): 1315-1327
Teerawatanasuk, N.; Carr, L.G. 1998: CBF/NF-Y activates transcription of the human tryptophan hydroxylase gene through an inverted CCAAT box. Brain Research. Molecular Brain Research 55(1): 61-70
Roulston, D.; Espinosa, R.; Nucifora, G.; Larson, R.A.; Le Beau, M.M.; Rowley, J.D. 1998: CBFA2(AML1) translocations with novel partner chromosomes in myeloid leukemias: association with prior therapy. Blood 92(8): 2879-2885
Usuki, K.; Nakatsu, M.; Kitazume, K.; Endo, M.; Osawa, M.; Iki, S.; Arai, M.; Urabe, A. 1996: CBFB/MYH11 fusion transcripts in a case of acute myelogenous leukemia (M1) with partial deletion of the long arm of chromosome 16. Internal Medicine 35(4): 327-330
Ji, C.; Casinghino, S.; Chang, D.J.; Chen, Y.; Javed, A.; Ito, Y.; Hiebert, S.W.; Lian, J.B.; Stein, G.S.; McCarthy, T.L.; Centrella, M. 1998: CBFa(AML/PEBP2)-related elements in the TGF-beta type I receptor promoter and expression with osteoblast differentiation. Journal of Cellular Biochemistry 69(3): 353-363
Dai, P.; Akimaru, H.; Tanaka, Y.; Hou, D.X.; Yasukawa, T.; Kanei-Ishii, C.; Takahashi, T.; Ishii, S. 1996: CBP as a transcriptional coactivator of c-Myb. Genes and Development 10(5): 528-540
Ericsson, J.; Edwards, P.A. 1998: CBP is required for sterol-regulated and sterol regulatory element-binding protein-regulated transcription. Journal of Biological Chemistry 273(28): 17865-17870
Naved, A.F.; Ozawa, M.; Yu, S.; Miyauchi, T.; Muramatsu, H.; Muramatsu, T. 1995: CBP-140, a novel endoplasmic reticulum resident Ca(2+)-binding protein with a carboxy-terminal NDEL sequence showed partial homology with 70-kDa heat shock protein (hsp70). Cell Structure and Function 20(2): 133-141
Bannister, A.J.; Kouzarides, T. 1995: CBP-induced stimulation of c-Fos activity is abrogated by E1A. EMBO Journal 14(19): 4758-4762
Krämer, A.; Carstens, C.P.; Wasserman, W.W.; Fahl, W.E. 1997: CBP/cycA, a CCAAT-binding protein necessary for adhesion-dependent cyclin A transcription, consists of NF-Y and a novel Mr 115,000 subunit. Cancer Research 57(22): 5117-5121
Kobayashi, A.; Numayama-Tsuruta, K.; Sogawa, K.; Fujii-Kuriyama, Y. 1997: CBP/p300 functions as a possible transcriptional coactivator of Ah receptor nuclear translocator (Arnt). Journal of Biochemistry 122(4): 703-710
Rousseau, C.; Felin, M.; Doyennette-Moyne, M.A.; Sève, A.P. 1997: CBP70, a glycosylated nuclear lectin. Journal of Cellular Biochemistry 66(3): 370-385
Chawla, S.; Hardingham, G.E.; Quinn, D.R.; Bading, H. 1998: CBP: a signal-regulated transcriptional coactivator controlled by nuclear calcium and CaM kinase IV. Science 281(5382): 1505-1509
Ponting, C.P. 1997: CBS domains in CIC chloride channels implicated in myotonia and nephrolithiasis (kidney stones). Journal of Molecular Medicine 75(3): 160-163
Andersson, G. 1998: CBT and behavioural medicine: On definitions, applications and practical considerations. Scandinavian Journal of Behaviour Therapy 27(1): 2-9
Alkhatib, G.; Combadiere, C.; Broder, C.C.; Feng, Y.; Kennedy, P.E.; Murphy, P.M.; Berger, E.A. 1996: CC CKR5: a RANTES, MIP-1alpha, MIP-1beta receptor as a fusion cofactor for macrophage-tropic HIV-1. Science 272(5270): 1955-1958
Garred, P.; Madsen, H.O.; Petersen, J.; Marquart, H.; Hansen, T.M.; Freiesleben Sørensen, S.; Volck, B.; Svejgaard, A.; Andersen, V. 1998: CC chemokine receptor 5 polymorphism in rheumatoid arthritis. Journal of Rheumatology 25(8): 1462-1465
Alkhatib, G.; Ahuja, S.S.; Light, D.; Mummidi, S.; Berger, E.A.; Ahuja, S.K. 1997: CC chemokine receptor 5-mediated signaling and HIV-1 Co-receptor activity share common structural determinants. Critical residues in the third extracellular loop support HIV-1 fusion. Journal of Biological Chemistry 272(32): 19771-19776
Maghazachi, A.A.; Al-Aoukaty, A.; Schall, T.J. 1996: CC chemokines induce the generation of killer cells from CD56+ cells. European Journal of Immunology 26(2): 315-319
Boger, D.L.; Johnson, D.S. 1995: CC-1065 and the duocarmycins: unraveling the keys to a new class of naturally derived DNA alkylating agents. Proceedings of the National Academy of Sciences of the United States of America 92(9): 3642-3649
McHugh, M.M.; Woynarowski, J.M.; Mitchell, M.A.; Gawron, L.S.; Weiland, K.L.; Beerman, T.A. 1994: CC-1065 bonding to intracellular and purified SV40 DNA: Site specificity and functional effects. Biochemistry 33(31): 9158-9168
Wang, Y.; Gupta, R.; Huang, L.; Lown, J.W. 1993: CC-1065 functional analogues possessing different electron-withdrawing substituents and leaving groups: synthesis, kinetics, and sequence specificity of reaction with DNA and biological evaluation. Journal of Medicinal Chemistry 36(26): 4172-4182
Shi, P.Y.; Maizels, N.; Weiner, A.M. 1998: CCA addition by tRNA nucleotidyltransferase: polymerization without translocation?. EMBO Journal 17(11): 3197-3206
Yue, D.; Maizels, N.; Weiner, A.M. 1996: CCA-adding enzymes and poly(A) polymerases are all members of the same nucleotidyltransferase superfamily: characterization of the CCA-adding enzyme from the archaeal hyperthermophile Sulfolobus shibatae. Rna 2(9): 895-908
Bellorini, M.; Lee, D.K.; Dantonel, J.C.; Zemzoumi, K.; Roeder, R.G.; Tora, L.; Mantovani, R. 1997: CCAAT binding NF-Y-TBP interactions: NF-YB and NF-YC require short domains adjacent to their histone fold motifs for association with TBP basic residues. Nucleic Acids Research 25(11): 2174-2181
Wright, K.L.; Vilen, B.J.; Itoh-Lindstrom, Y.; Moore, T.L.; Li, G.; Criscitiello, M.; Cogswell, P.; Clarke, J.B.; Ting, J.P. 1994: CCAAT box binding protein NF-Y facilitates in vivo recruitment of upstream DNA binding transcription factors. EMBO Journal 13(17): 4042-4053
Vietor, I.; Oliveira, I.C.; Vilcek, J. 1996: CCAAT box enhancer binding protein alpha (C/EBP-alpha) stimulates kappaB element-mediated transcription in transfected cells. Journal of Biological Chemistry 271(10): 5595-5602
Khanna-Gupta, A.; Zibello, T.; Kolla, S.; Neufeld, E.J.; Berliner, N. 1997: CCAAT displacement protein (CDP/cut) recognizes a silencer element within the lactoferrin gene promoter. Blood 90(7): 2784-2795
Luo, W.; Skalnik, D.G. 1996: CCAAT displacement protein competes with multiple transcriptional activators for binding to four sites in the proximal gp91phox promoter. Journal of Biological Chemistry 271(30): 18203-18210
Pattison, S.; Skalnik, D.G.; Roman, A. 1997: CCAAT displacement protein, a regulator of differentiation-specific gene expression, binds a negative regulatory element within the 5' end of the human papillomavirus type 6 long control region. Journal of Virology 71(3): 2013-2022
Mao, X.; Xia, L.; Liang, G.; Gai, X.; Huang, D.Y.; Prystowsky, M.B.; Lipson, K.E. 1995: CCAAT-box contributions to human thymidine kinase mRNA expression. Journal of Cellular Biochemistry 57(4): 701-710
Linhoff, M.W.; Wright, K.L.; Ting, J.P. 1997: CCAAT-binding factor NF-Y and RFX are required for in vivo assembly of a nucleoprotein complex that spans 250 base pairs: the invariant chain promoter as a model. Molecular and Cellular Biology 17(8): 4589-4596
Ronchi, A.; Bellorini, M.; Mongelli, N.; Mantovani, R. 1995: CCAAT-box binding protein NF-Y (CBF, CP1) recognizes the minor groove and distorts DNA. Nucleic Acids Research 23(22): 4565-4572
López-Rodríguez, C.; Botella, L.; Corbí, A.L. 1997: CCAAT-enhancer-binding proteins (C/EBP) regulate the tissue specific activity of the CD11c integrin gene promoter through functional interactions with Sp1 proteins. Journal of Biological Chemistry 272(46): 29120-29126
Wedel, A.; Sulski, G.; Ziegler-Heitbrock, H.W. 1996: CCAAT/Enhancer binding protein is involved in the expression of the tumour necrosis factor gene in human monocytes. Cytokine 8(5): 335-341
Doppler, W.; Welte, T.; Philipp, S. 1995: CCAAT/enhancer-binding protein isoforms beta and delta are expressed in mammary epithelial cells and bind to multiple sites in the beta-casein gene promoter. Journal of Biological Chemistry 270(30): 17962-17969
Radomska, H.S.; Huettner, C.S.; Zhang, P.; Cheng, T.; Scadden, D.T.; Tenen, D.G. 1998: CCAAT/enhancer binding protein alpha is a regulatory switch sufficient for induction of granulocytic development from bipotential myeloid progenitors. Molecular and Cellular Biology 18(7): 4301-4314
Lin, F.T.; Lane, M.D. 1994: CCAAT/enhancer binding protein alpha is sufficient to initiate the 3T3-L1 adipocyte differentiation program. Proceedings of the National Academy of Sciences of the United States of America 91(19): 8757-8761
Timchenko, N.A.; Harris, T.E.; Wilde, M.; Bilyeu, T.A.; Burgess-Beusse, B.L.; Finegold, M.J.; Darlington, G.J. 1997: CCAAT/enhancer binding protein alpha regulates p21 protein and hepatocyte proliferation in newborn mice. Molecular and Cellular Biology 17(12): 7353-7361
Sterneck, E.; Johnson, P.F. 1998: CCAAT/enhancer binding protein beta is a neuronal transcriptional regulator activated by nerve growth factor receptor signaling. Journal of Neurochemistry 70(6): 2424-2433
Yamanaka, R.; Kim, G.D.; Radomska, H.S.; Lekstrom-Himes, J.; Smith, L.T.; Antonson, P.; Tenen, D.G.; Xanthopoulos, K.G. 1997: CCAAT/enhancer binding protein epsilon is preferentially up-regulated during granulocytic differentiation and its functional versatility is determined by alternative use of promoters and differential splicing. Proceedings of the National Academy of Sciences of the United States of America 94(12): 6462-6467
Blais, S.; Boudreau, F.; Beaulieu, J.F.; Asselin, C. 1995: CCAAT/enhancer binding protein isoforms expression in the colon of neonatal mice. Developmental Dynamics: An Official Publication of the American Association of Anatomists 204(1): 66-76
Nerlov, C.; Ziff, E.B. 1995: CCAAT/enhancer binding protein-alpha amino acid motifs with dual TBP and TFIIB binding ability co-operate to activate transcription in both yeast and mammalian cells. EMBO Journal 14(17): 4318-4328
Yubero, P.; Manchado, C.; Cassard-Doulcier, A.M.; Mampel, T.; Viñas, O.; Iglesias, R.; Giralt, M.; Villarroya, F. 1994: CCAAT/enhancer binding proteins alpha and beta are transcriptional activators of the brown fat uncoupling protein gene promoter. Biochemical and Biophysical Research Communications 198(2): 653-659
Boudreau, F.; Yu, S.J.; Asselin, C. 1998: CCAAT/enhancer binding proteins beta and delta regulate alpha1-acid glycoprotein gene expression in rat intestinal epithelial cells. Dna and Cell Biology 17(8): 669-677
Skarpen, E.; Lindeman, B.; Thoresen, G.H.; Låg, M.; Christoffersen, T.; Huitfeldt, H.S. 1995: CCAAT/enhancer-binding protein (C/EBP) immunoreactivity during rat liver carcinogenesis. Histochemistry and Cell Biology 104(4): 287-294
Yamada, T.; Tobita, K.; Osada, S.; Nishihara, T.; Imagawa, M. 1997: CCAAT/enhancer-binding protein delta gene expression is mediated by APRF/STAT3. Journal of Biochemistry 121(4): 731-738
Yamada, T.; Tsuchiya, T.; Osada, S.; Nishihara, T.; Imagawa, M. 1998: CCAAT/enhancer-binding protein delta gene expression is mediated by autoregulation through downstream binding sites. Biochemical and Biophysical Research Communications 242(1): 88-92
Ossipow, V.; Descombes, P.; Schibler, U. 1993: CCAAT/enhancer-binding protein mRNA is translated into multiple proteins with different transcription activation potentials. Proceedings of the National Academy of Sciences of the United States of America 90(17): 8219-8223
Tollet, P.; Lahuna, O.; Ahlgren, R.; Mode, A.; Gustafsson, J.A. 1995: CCAAT/enhancer-binding protein-alpha-dependent transactivation of CYP2C12 in rat hepatocytes. Molecular Endocrinology 9(12): 1771-1781
Manchado, C.; Yubero, P.; Viñas, O.; Iglesias, R.; Villarroya, F.; Mampel, T.; Giralt, M. 1994: CCAAT/enhancer-binding proteins alpha and beta in brown adipose tissue: evidence for a tissue-specific pattern of expression during development. Biochemical Journal 302: 695-700
Osada, S.; Takano, K.; Nishihara, T.; Suzuki, T.; Muramatsu, M.; Imagawa, M. 1995: CCAAT/enhancer-binding proteins alpha and beta interact with the silencer element in the promoter of glutathione S-transferase P gene during hepatocarcinogenesis. Journal of Biological Chemistry 270(52): 31288-31293
Eleouet, J.F.; Roméo, P.H. 1993: CCACC-binding or simian-virus-40-protein-1-binding proteins cooperate with human GATA-1 to direct erythroid-specific transcription and to mediate 5' hypersensitive site 2 sensitivity of a TATA-less promoter. European Journal of Biochemistry 212(3): 763-770
de Smit, M.H.; van Duin, J.; van Knippenberg, P.H.; van Eijk, H.G. 1994: CCC.UGA: A new site of ribosomal frameshifting in Escherichia coli. Gene 143(1): 43-47
Akhavan-Tafti, H.; Schaap, A.P.; Arghavani, Z.; DeSilva, R.; Eickholt, R.A.; Handley, R.S.; Schoenfelner, B.A.; Sugioka, K.; Sugioka, Y. 1994: CCD camera imaging for the chemiluminescent detection of enzymes using new ultrasensitive reagents. Journal of Bioluminescence and Chemiluminescence 9(3): 155-164
Canepari, M.; Campani, M.; Spadavecchia, L.; Torre, V. 1996: CCD imaging of the electrical activity in the leech nervous system. European Biophysics Journal: Ebj 24(6): 359-370
Tanke, H.J.; Florijn, R.J.; Wiegant, J.; Raap, A.K.; Vrolijk, J. 1995: CCD microscopy and image analysis of cells and chromosomes stained by fluorescence in situ hybridization. Histochemical Journal 27(1): 4-14
Snell, E.H.; Boggon, T.J.; Helliwell, J.R.; Moskowitz, M.E.; Nadarajah, A. 1997: CCD video observation of microgravity crystallization of lysozyme and correlation with accelerometer data. Acta Crystallographica Section D Biological Crystallography 53(6): 747-755,. 1
Edgar, D.M.; Seidel, W.F.; Gee, K.W.; Lan, N.C.; Field, G.; Xia, H.; Hawkinson, J.E.; Wieland, S.; Carter, R.B.; Wood, P.L. 1997: CCD-3693: an orally bioavailable analog of the endogenous neuroactive steroid, pregnanolone, demonstrates potent sedative hypnotic actions in the rat. Journal of Pharmacology and Experimental Therapeutics 282(1): 420-429
Vargas, G.A.; Isas, J.M.; Fantino, E.; Gargus, J.J.; Haigler, H.T. 1998: CCG1/TAF(II)250 regulates epidermal growth factor receptor gene transcription in cell cycle mutant ts13. Journal of Cellular Physiology 176(3): 642-647
Tanaka, J.; Kariya, K.; Ushigome, A.; Matsuda, M.; Nomura, M. 1994: CCK activates excitatory ventral tegmental pathways to the posterior nucleus accumbens. Neuroreport 5(18): 2558-2560
Bragado, M.J.; Dabrowski, A.; Groblewski, G.E.; Williams, J.A. 1997: CCK activates p90rsk in rat pancreatic acini through protein kinase C. American Journal of Physiology 272(3 Part 1): G401-G407
Nakano, S.; Kihara, Y.; Otsuki, M. 1998: CCK administration after CCK receptor blockade accelerates recovery from cerulein-induced acute pancreatitis in rats. Pancreas 16(2): 169-175
Miles, C.; Dickson, P.; Rana, K.; Lippert, C.; Fleisher, D. 1997: CCK antagonist pre-treatment inhibits meal-enhanced drug absorption in dogs. Regulatory Peptides 68(1): 9-14
Yule, D.I.; Williams, J.A. 1994: CCK antagonists reveal that CCK-8 and JMV-180 interact with different sites on the rat pancreatic acinar cell CCKA receptor. Peptides 15(6): 1045-1051
Beinfeld, M.C. 1997: CCK biosynthesis and processing: Recent progress and future challenges. Life Sciences 61(24): 2359-2366
Garcia, L.J.; Rosado, J.A.; Tsuda, T.; Jensen, R.T. 1997: CCK causes rapid tyrosine phosphorylation of p125FAK focal adhesion kinase and paxillin in rat pancreatic acini. Biochimica Et Biophysica Acta 1358(2): 189-199
Branchereau, P.; Champagnat, J.; Roques, B.P.; Denavit-Saubie, M. 1992: CCK modulates inhibitory synaptic transmission in the solitary complex through CCKB sites. Neuroreport 3(10): 909-912
Rezayat, M.; Nikfar, S.; Zarrindast, M.R. 1994: CCK receptor activation may prevent tolerance to morphine in mice. European Journal of Pharmacology 254(1-2): 21-26
Wang, B.; Sims, S.M. 1998: CCK regulates nonselective cation channels in guinea pig gastric smooth muscle cells. American Journal of Physiology 274(4): G709-G717
Lu, L.; Logsdon, C.D. 1992: CCK, bombesin, and carbachol stimulate c-fos, c-jun, and c-myc oncogene expression in rat pancreatic acini. American Journal of Physiology 263(3 Part 1): G327-G332
Piiper, A.; Stryjek-Kaminska, D.; Klengel, R.; Zeuzem, S. 1997: CCK, carbachol, and bombesin activate distinct PLC-beta isoenzymes via Gq/11 in rat pancreatic acinar membranes. American Journal of Physiology 272(1 Part 1): G135-G140
Yamamoto, M.; Shirohara, H.; Otsuki, M. 1998: CCK-, secretin-, and cholinergic-independent pancreatic fluid hypersecretion in protease inhibitor-treated rats. American Journal of Physiology 274(2): G406-G412
Gonzalez Muniz, R.; Dominguez, J.; Martin Martinez, M.; Herranz, R.; Garcia Lopez, M.T.; Barer, A.; Ballaz, S.; Del Rio, J. 1996: CCK-4 restricted analogues containing a 3-oxoindolizidine skeleton. Bioorganic and Medicinal Chemistry Letters 6(8): 967-972
Akiyoshi, J.; Moriyama, T.; Isogawa, K.; Miyamoto, M.; Sasaki, I.; Kuga, K.; Yamamoto, H.; Yamada, K.; Fujii, I. 1996: CCK-4-induced calcium mobilization in T cells is enhanced in panic disorder. Journal of Neurochemistry 66(4): 1610-1616
Raybould, H.E.; Reeve, J.R. 1996: CCK-58: A novel reagent for studying the regulation of cholecystokinin bioactivity. Peptides 17(8): 1307-1311
Cox, J.E.; Randich, A. 1997: CCK-8 activates hepatic vagal C-fiber afferents. Brain Research 776(1-2): 189-194,. 21
Rogy, M.A.; Kovats, E.; Koss, G.; Müller, M.; Függer, R.; Steininger, R.; Pilz, E.; Rauhs, R.; Fritsch, A. 1993: CCK-8 and gastrin plasma levels in cholecystectomized and colorectal cancer patients. International Journal of Colorectal Disease 8(3): 154-157
Wu, T.; Wang, H.L. 1994: CCK-8 excites substantia nigra dopaminergic neurons by increasing a cationic conductance. Neuroscience Letters 170(2): 229-232
Solter, P.F.; Hoffmann, W.E.; Chambers, M.D.; Schaeffer, D.J. 1997: CCK-8 infusion increases plasma LMW alkaline phosphatase coincident with enterohepatic circulation of bile acids. American Journal of Physiology 273(2 Pt 1): G381-G388
Qian, M.; Johnson, A.E.; Södersten, P. 1998: CCK-8 inhibits ingestive behavior in rats with lateral hypothalamic 6-OHDA lesions. Neuroreport 9(12): 2763-2767
Wu, T.; Wang, H.L. 1994: CCK-8-evoked cationic currents in substantia nigra dopaminergic neurons are mediated by InsP3-induced Ca2+ release. Neuroscience Letters 175(1-2): 95-98
Voigt, J.P.; Sohr, R.; Fink, H. 1998: CCK-8S facilitates 5-HT release in the rat hypothalamus. Pharmacology Biochemistry and Behavior 59(1): 179-182
Sethi, T.; Herget, T.; Wu, S.V.; Walsh, J.H.; Rozengurt, E. 1993: CCKA and CCKB receptors are expressed in small cell lung cancer lines and mediate Ca2+ mobilization and clonal growth. Cancer Research 53(21): 5208-5213
Lemaire, M.; Böhme, G.A.; Piot, O.; Roques, B.P.; Blanchard, J.C. 1994: CCK-A and CCK-B selective receptor agonists and antagonists modulate olfactory recognition in male rats. Psychopharmacology 115(4): 435-440
Sugg, E.E.; Kimery, M.J.; Ding, J.M.; Kenakin, D.C.; Miller, L.J.; Queen, K.L.; Rimele, T.J. 1995: CCK-A receptor selective antagonists derived from the CCK-A receptor selective tetrapeptide agonist Boc-Trp-Lys(Tac)-Asp-MePhe-NH2 (A-71623). Journal of Medicinal Chemistry 38(1): 207-211
Knoper, S.R.; Meehan, A.G.; Purnyn, S.; Coggan, J.S.; Anthony, T.L.; Kreulen, D.L. 1993: CCKA receptors mediate slow depolarizations in cultured mammalian sympathetic neurons. European Journal of Pharmacology 232(1): 65-69
Dauge, V.; Corringer, P.J.; Roques, B.P. 1995: CCKA, but not CCKB, agonists suppress the hyperlocomotion induced by endogenous enkephalins, protected from enzymatic degradation by systemic RB 101. Pharmacology Biochemistry and Behavior 50(2): 133-139
Bennett, M.J.; Nikkel, A.L.; Bianchi, B.R.; Miller, T.R.; Bednarz, L.; Witte, D.G.; Stashko, M.; Wang, S.S.; Gore, P.A.; Asin, K.E. 1994: CCK-A-selective tetrapeptides containing lys(N epsilon)-amide residues: favorable in vivo and in vitro effects of N-methylation at the aspartyl residue. Journal of Medicinal Chemistry 37(11): 1569-1571
Kaufmann, R.; Lindschau, C.; Schöneberg, T.; Henklein, P.; Boomgaarden, M.; Haller, H.; Ott, T. 1994: CCKB receptor signaling in rat pituitary GH3 cells. CCK-8S-induced intracellular calcium mobilization by Ca2+ release and Ca2+ influx. Neuropeptides 27(4): 211-216
Corringer, P.J.; Weng, J.H.; Ducos, B.; Durieux, C.; Boudeau, P.; Bohme, A.; Roques, B.P. 1993: CCK-B agonist or antagonist activities of structurally hindered and peptidase-resistant Boc-CCK4 derivatives. Journal of Medicinal Chemistry 36(1): 166-172
Yasui, M.; Kawasaki, K. 1995: CCKB receptor activation protects CA1 neurons from ischemia-induced dysfunction in stroke-prone spontaneously hypertensive rats hippocampal slices. Neuroscience Letters 191(1-2): 99-102
Harro, J.; Westerling, P.; Oreland, L. 1993: CCKB receptor activation reduces glutamate-induced depolarization in slices of rat cerebral cortex. Journal of Neural Transmission. General Section 93(1): 61-66
Smith, A.J.; Freedman, S.B. 1996: CCK-B receptor-mediated stimulation of polyphosphoinositide turnover in GH3 pituitary cells in response to cholecystokinin and pentagastrin. Life Sciences 58(11): 883-895
Smadja, C.; Ruiz, F.; Coric, P.; Fournié-Zaluski, M.C.; Roques, B.P.; Maldonado, R. 1997: CCK-B receptors in the limbic system modulate the antidepressant-like effects induced by endogenous enkephalins. Psychopharmacology 132(3): 227-236
Gronier, B.; Debonnel, G. 1995: CCKB receptors mediate CCK-8S-induced activation of dorsal hippocampus CA3 pyramidal neurons: an in vivo electrophysiological study in the rat. Synapse 21(2): 158-168
Detjen, K.; Yule, D.; Tseng, M.J.; Williams, J.A.; Logsdon, C.D. 1997: CCK-B receptors produce similar signals but have opposite growth effects in CHO and Swiss 3T3 cells. American Journal of Physiology 273(5): C1449-C1457
Van-Niel, M., B.; Freedman, S., B.; Matassa, V., G.; Patel, S.; Pengilley, R., R.; Smith, A., J. 1995: CCK-B selective receptor ligands: Novel 1,3,5-trisubstituted benzazepin-2-ones. Bioorganic and Medicinal Chemistry Letters 5(13): 1421-1426
Yasui, M.; Kawasaki, K. 1995: CCKB-receptor activation augments the long-term potentiation in guinea pig hippocampal slices. Japanese Journal of Pharmacology 68(4): 441-447
Schaeffer, P.; Prabonnaud, V.; Roux, M.; Gully, D.; Herbert, J.M. 1994: CCK-JMV-180 acts as an antagonist of the CCKA receptor in the human IMR-32 neuroblastoma cell line. Febs Letters 354(2): 203-206
Cecio, A.; Cocca, T.; Masotti, M.T.; La Mura, E.; Vittoria, A. 1993: CCK-containing paraneurons in human adenomatous prostate. Bioscience Reports 13(5): 251-258
Heinemann, A.; Jocic, M.; Peskar, B.M.; Holzer, P. 1996: CCK-evoked hyperemia in rat gastric mucosa involves neural mechanisms and nitric oxide. American Journal of Physiology 270(2 Pt 1): G253-G258
Himick, B.A.; Golosinski, A.A.; Jonsson, A.C.; Peter, R.E. 1993: CCK/gastrin-like immunoreactivity in the goldfish pituitary: regulation of pituitary hormone secretion by CCK-like peptides in vitro. General and Comparative Endocrinology 92(1): 88-103
Sztefko, K.; Li, P.; Ballatori, N.; Chey, W.Y. 1994: CCK-receptor antagonists proglumide and loxiglumide stimulate bile flow and biliary glutathione excretion. Digestive Diseases and Sciences 39(9): 1974-1980
Niederau, C.; Meereis-Schwanke, K.; Klonowski-Stumpe, H.; Herberg, L. 1997: CCK-resistance in Zucker obese versus lean rats. Regulatory Peptides 70(2-3): 97-104
Himick, B.A.; Peter, R.E. 1994: CCK/gastrin-like immunoreactivity in brain and gut, and CCK suppression of feeding in goldfish. American Journal of Physiology 267(3 Pt 2): R841-R851
Schutte, I.W.M.; Akkermans, L.M.A.; Kroese, A.B.A. 1997: CCKA and CCKB receptor subtypes both mediate the effects of CCK-8 on myenteric neurons in the guinea-pig ileum. Journal of the Autonomic Nervous System 67(1-2): 51-59,. 3
Wilson, J.; Little, H.J. 1998: CCK(B) antagonists protect against some aspects of the ethanol withdrawal syndrome. Pharmacology Biochemistry and Behavior 59(4): 967-973
Wilson, J.; Watson, W.P.; Little, H.J. 1998: CCK(B) antagonists protect against anxiety-related behaviour produced by ethanol withdrawal, measured using the elevated plus maze. Psychopharmacology 137(2): 120-131
Chen, X.H.; Geller, E.B.; Adler, M.W. 1998: CCK(B) receptors in the periaqueductal grey are involved in electroacupuncture antinociception in the rat cold water tail-flick test. Neuropharmacology 37(6): 751-757
Frezza, E.E.; Gerunda, G.E.; Farinati, F.; DeMaria, N.; Galligioni, A.; Plebani, F.; Giacomin, A.; Van Thiel, D.H. 1994: CCL4-induced liver cirrhosis and hepatocellular carcinoma in rats: relationship to plasma zinc, copper and estradiol levels. Hepato-Gastroenterology 41(4): 367-369
Bautista, S.; Theillet, C. 1998: CCND1 and FGFR1 coamplification results in the colocalization of 11q13 and 8p12 sequences in breast tumor nuclei. Genes Chromosomes and Cancer 22(4): 268-277
Xiao, L.; Owen, S.M.; Goldman, I.; Lal, A.A.; deJong, J.J.; Goudsmit, J.; Lal, R.B. 1998: CCR5 coreceptor usage of non-syncytium-inducing primary HIV-1 is independent of phylogenetically distinct global HIV-1 isolates: delineation of consensus motif in the V3 domain that predicts CCR-5 usage. Virology 240(1): 83-92
Greaves, D.R.; Wang, W.; Dairaghi, D.J.; Dieu, M.C.; Saint-Vis, B.; Franz-Bacon, K.; Rossi, D.; Caux, C.; McClanahan, T.; Gordon, S.; Zlotnik, A.; Schall, T.J. 1997: CCR6, a CC chemokine receptor that interacts with macrophage inflammatory protein 3alpha and is highly expressed in human dendritic cells. Journal of Experimental Medicine 186(6): 837-844
Bi, W.; Stambrook, P.J. 1997: CCR: a rapid and simple approach for mutation detection. Nucleic Acids Research 25(14): 2949-2951
Oertel, J.; Oertel, B.; Beyer, J.; Huhn, D. 1994: CD 34 immunotyping of blasts in myelodysplasia. Annals of Hematology 68(2): 77-80
Biesold, C.; Köhler, U.; Horn, L.C.; Bilek, K.; Kade, R.; Emmert, C. 1995: CD 44 exon v6 as a predictor of lymphatic metastases in cervical carcinoma--an immunocytochemical study of 94 cases. Archives of Gynecology and Obstetrics 256(3): 147-153
Rainer, R.O.; Hodges, L.; Seltzer, G.T. 1995: CD 45 gating correlates with bone marrow differential. Cytometry 22(2): 139-145
Ochsendorf, F.R.; Beschmann, H.A.; Neuhauser, S.; Milbradt, R. 1997: CD 45/67 immunobead preparation of human semen activates granulocytes. Andrologia 29(4): 193-199
Heil, G.; Krauter, J.; Beyer-Johannböke, E.; Bunjes, D.; Kurrle, E.; Westphal-Frösch, C.; Heimpel, H. 1994: CD 54 expression and its role in homotypic aggregation of the blasts of acute myeloblastic leukemias (AML). International Journal of Hematology 60(1): 39-49
Bezouska, K.; Nepovím, A.; Horváth, O.; Pospísil, M.; Hamann, J.; Feizi, T. 1995: CD 69 antigen of human lymphocytes is a calcium-dependent carbohydrate-binding protein. Biochemical and Biophysical Research Communications 208(1): 68-74
Nedved, M.L.; Gottlieb, P.A.; Moe, G.R. 1994: CD and DNA binding studies of a proline repeat-containing segment of the replication arrest protein Tus. Nucleic Acids Research 22(23): 5024-5030
Lamthanh, H.; Léonetti, M.; Nabedryk, E.; Ménez, A. 1993: CD and FTIR studies of an immunogenic disulphide cyclized octadecapeptide, a fragment of a snake curaremimetic toxin. Biochimica Et Biophysica Acta 1203(2): 191-198
Najbar, L.V.; Craik, D.J.; Wade, J.D.; Lin, F.; Mcleish, M.J. 1995: CD and NMR determination of the solution structure of a peptide corresponding to T4 lysozyme residues 38-51. Biochimica Et Biophysica Acta 1250(2): 163-170
Ragona, L.; Molinari, H.; Zetta, L.; Longhi, R.; Marchini, D.; Dallai, R.; Bernini, L.F.; Lozzi, L.; Scarselli, M.; Niccolai, N. 1996: CD and NMR structural characterization of ceratotoxins, natural peptides with antimicrobial activity. Biopolymers 39(5): 653-664
Casté, L.; Zandomeneghi, M.; Houben, J.L.; Rovero, P.; Pegoraro, S.; Revoltella, P.R.; Brochon, J.C. 1995: CD and fluorescence studies of the human granulocyte-macrophage colony-stimulating factor and related peptide conformations in aqueous solution. Biopolymers 36(1): 1-8
Hollósi, M.; Majer, Z.; Rónai, A.Z.; Magyar, A.; Medzihradszky, K.; Holly, S.; Perczel, A.; Fasman, G.D. 1994: CD and Fourier transform ir spectroscopic studies of peptides. II. Detection of beta-turns in linear peptides. Biopolymers 34(2): 177-185
Cai, G.; Bozhkova, N.; Odingo, J.; Berova, N.; Nakanishi, K. 1993: CD exciton chirality method: New red-shifted chromophores for hydroxyl groups. Journal of the American Chemical Society 115(16): 7192-7198
Yu, Z.B.; Li, C.C.; Tang, C.Q.; Kuang, T.Y.; Lu, R.H.; Tang, P.S. 1994: CD spectra of D1/D2/Cyt B559 complex in photo-damaged photosystem II reaction center. Acta Botanica Sinica 36(8): 603-606
Andersen, N.H.; Palmer, R.B. 1994: CD studies of a peptide mimetic of L-type calcium channels. Bioorganic and Medicinal Chemistry Letters 4(6): 817-822
Nicolas, E.; Bacardit, J.; Ferrer, T.; Giralt, E. 1996: CD studies of peptides that mimic the four helicoidal sequences of the uteroglobin monomer. Letters in Peptide Science 2(6): 353-362
Flint, A.; Weiss, S.W. 1995: CD-34 and keratin expression distinguishes solitary fibrous tumor (fibrous mesothelioma) of pleura from desmoplastic mesothelioma. Human Pathology 26(4): 428-431
Saenghirunvattana, S. 1996: CD4 + T counts with a course of antituberculous therapy in healthy and HIV-infected patients. Journal of the Medical Association of Thailand 79(4): 246-248
Bourguignon, L.Y.; Zhu, D.; Zhu, H. 1998: CD44 isoform-cytoskeleton interaction in oncogenic signaling and tumor progression. Frontiers in Bioscience: a Journal and Virtual Library 3: D637-D649
Lesley, J.; Hyman, R. 1998: CD44 structure and function. Frontiers in Bioscience: a Journal and Virtual Library 3: D616-D630
Korabiowska, M.; Brinck, U.; Hönig, J.; Mora, O.; Bartkowski, S.; Schauer, A. 1995: CD-44: a marker of metastases of head and neck melanomas. In Vivo 9(3): 253-256
Miyata, N.; Yamaura, H.; Tanaka, M.; Takahashi, K.; Tsuchida, K.; Otomo, S. 1993: CD-832, a new dihydropyridine derivative with both nitrate-like and Ca2+ channel antagonist vasodilator activities. European Journal of Pharmacology 249(2): 141-149
Takala, J. 1993: CD-ROMs and databases as vehicles for chemical safety information. American Industrial Hygiene Association Journal 54(11): 683-696
Jarvik, J.W.; Adler, S.A.; Telmer, C.A.; Subramaniam, V.; Lopez, A.J. 1996: CD-tagging: a new approach to gene and protein discovery and analysis. Biotechniques 20(5): 896-904
Bendelac, A.; Lantz, O.; Quimby, M.E.; Yewdell, J.W.; Bennink, J.R.; Brutkiewicz, R.R. 1995: CD1 Recognition by Mouse NK1+ T Lymphocytes. Science 268(5212): 863-865
Hanau, D.; Fricker, D.; Bieber, T.; Esposito-Farese, M.E.; Bausinger, H.; Cazenave, J.P.; Donato, L.; Tongio, M.M.; de la Salle, H. 1994: CD1 expression is not affected by human peptide transporter deficiency. Human Immunology 41(1): 61-68
Elder, J.T.; Reynolds, N.J.; Cooper, K.D.; Griffiths, C.E.; Hardas, B.D.; Bleicher, P.A. 1993: CD1 gene expression in human skin. Journal of Dermatological Science 6(3): 206-213
Le Calvez, S.; Avan, P.; Gilain, L.; Romand, R. 1998: CD1 hearing-impaired mice. I: Distortion product otoacoustic emission levels, cochlear function and morphology. Hearing Research 120(1-2): 37-50
Le Calvez, S.; Guilhaume, A.; Romand, R.; Aran, J.M.; Avan, P. 1998: CD1 hearing-impaired mice. II. Group latencies and optimal f2/f1 ratios of distortion product otoacoustic emissions, and scanning electron microscopy. Hearing Research 120(1-2): 51-61
Kasinrerk, W.; Baumruker, T.; Majdic, O.; Knapp, W.; Stockinger, H. 1993: CD1 molecule expression on human monocytes induced by granulocyte-macrophage colony-stimulating factor. Journal of Immunology 150(2): 579-584
Jullien, D.; Stenger, S.; Ernst, W.A.; Modlin, R.L. 1997: CD1 presentation of microbial nonpeptide antigens to T cells. Journal of Clinical Investigation 99(9): 2071-2074
Fairhurst, R.M.; Wang, C.X.; Sieling, P.A.; Modlin, R.L.; Braun, J. 1998: CD1 presents antigens from a gram-negative bacterium, Haemophilus influenzae type B. Infection and Immunity 66(8): 3523-3526
Todd, S.C.; Baccala, R.; Hedrick, J.A.; Theofilopoulos, A.N.; Tsoukas, C.D. 1994: CD1+ human thymocytes proliferate in response to superantigen staphylococcal enterotoxin B1. Journal of Immunology 153(5): 2038-2045
Sugita, M.; Moody, D.B.; Jackman, R.M.; Grant, E.P.; Rosat, J.P.; Behar, S.M.; Peters, P.J.; Porcelli, S.A.; Brenner, M.B. 1998: CD1--a new paradigm for antigen presentation and T cell activation. Clinical Immunology and Immunopathology 87(1): 8-14
Cardell, S.; Tangri, S.; Chan, S.; Kronenberg, M.; Benoist, C.; Mathis, D. 1995: CD1-restricted CD4+ T cells in major histocompatibility complex class II-deficient mice. Journal of Experimental Medicine 182(4): 993-1004
Sieling, P.A.; Chatterjee, D.; Porcelli, S.A.; Prigozy, T.I.; Mazzaccaro, R.J.; Soriano, T.; Bloom, B.R.; Brenner, M.B.; Kronenberg, M.; Brennan, P.J. 1995: CD1-restricted T cell recognition of microbial lipoglycan antigens. Science 269(5221): 227-230
Fujieda, S.; Sieling, P.A.; Modlin, R.L.; Saxon, A. 1998: CD1-restricted T-cells influence IgG subclass and IgE production. Journal of Allergy and Clinical Immunology 101(4 Pt 1): 545-551
Guerin, S.; Mari, B.; Belhacene, N.; Rossi, B.; Peyron, J.F.; Auberger, P. 1997: CD10 (endopeptidase 24.11) is a thymic peptide-degrading enzyme possibly involved in the regulation of thymocyte functions. Cellular Immunology 175(1): 85-91
Hofman, P.; Selva, E.; Le Negrate, G.; d'Andrea, L.; Guérin, S.; Rossi, B.; Auberger, P. 1998: CD10 inhibitors increase f-Met-Leu-Phe-induced neutrophil transmigration. Journal of Leukocyte Biology 63(3): 312-320
Guérin, S.; Mari, B.; Fernandez, E.; Belhacene, N.; Toribio, M.L.; Auberger, P. 1997: CD10 is expressed on human thymic epithelial cell lines and modulates thymopentin-induced cell proliferation. FASEB Journal 11(12): 1003-1011
Guérin, S.; Mari, B.; Maulon, L.; Belhacène, N.; Marguet, D.; Auberger, P. 1997: CD10 plays a specific role in early thymic development. FASEB Journal 11(5): 376-381
Mandel, M.; Rechavi, G.; Neumann, Y.; Biniaminov, M.; Rosenthal, E.; Toren, A.; Brok-Simoni, F.; Ben-Bassat, I.; Ramot, B. 1994: CD10+ cell population in the bone marrow of patients with advanced neuroblastoma. Medical and Pediatric Oncology 22(2): 115-118
Sunday, M.E.; Hua, J.; Torday, J.S.; Reyes, B.; Shipp, M.A. 1992: CD10/neutral endopeptidase 24.11 in developing human fetal lung. Patterns of expression and modulation of peptide-mediated proliferation. Journal of Clinical Investigation 90(6): 2517-2525
Ganju, R.K.; Shpektor, R.G.; Brenner, D.G.; Shipp, M.A. 1996: CD10/neutral endopeptidase 24.11 is phosphorylated by casein kinase Ii and coassociates with other phosphoproteins including the lyn src-related kinase. Blood 88(11): 4159-4165
King, K.A.; Hua, J.; Torday, J.S.; Drazen, J.M.; Graham, S.A.; Shipp, M.A.; Sunday, M.E. 1993: CD10/neutral endopeptidase 24.11 regulates fetal lung growth and maturation in utero by potentiating endogenous bombesin-like peptides. Journal of Clinical Investigation 91(5): 1969-1973
Bagot, M.; Martinel, I.; Charue, D.; Weill, F.; Boulland, M.L.; Wechsler, J.; Freeman, G.J.; Bensussan, A.; Boumsell, L. 1997: CD101 is expressed by skin dendritic cells. Role in T-lymphocyte activation. Tissue Antigens 50(5): 439-448
Power, C.; Kobayashi, K.; Nishimura, T.; Yoshida, T. 1994: CD11/CD18 and ICAM-1 expression in a murine foreign body granulomatous lung model. Clinical Immunology and Immunopathology 73(3): 321-329
Flaherty, S.F.; Golenbock, D.T.; Milham, F.H.; Ingalls, R.R. 1997: CD11/CD18 leukocyte integrins: new signaling receptors for bacterial endotoxin. Journal of Surgical Research 73(1): 85-89
Issekutz, A.C.; Chuluyan, H.E.; Lopes, N. 1995: CD11/CD18-independent transendothelial migration of human polymorphonuclear leukocytes and monocytes: involvement of distinct and unique mechanisms. Journal of Leukocyte Biology 57(4): 553-561
Cascavilla, N.; Musto, P.; D'Arena, G.; Melillo, L.; Carella, A.M.; Petrilli, M.P.; Sanpaolo, G.; Carotenuto, M. 1998: CD117 (c-kit) is a restricted antigen of acute myeloid leukemia and characterizes early differentiative levels of M5 FAB subtype. Haematologica 83(5): 392-397
Wells, S.J.; Bray, R.A.; Stempora, L.L.; Farhi, D.C. 1996: CD117/CD34 expression in leukemic blasts. American Journal of Clinical Pathology 106(2): 192-195
Sarlomo-Rikala, M.; Kovatich, A.J.; Barusevicius, A.; Miettinen, M. 1998: CD117: a sensitive marker for gastrointestinal stromal tumors that is more specific than CD34. Modern Pathology: An Official Journal of the United States and Canadian Academy of Pathology Inc 11(8): 728-734
Antonaci, S.; Polignano, A.; Garofalo, A.R.; Pugliese, P.; Tortorella, C.; Jirillo, E. 1993: CD11a and CD54 adhesion molecules are not involved in the impaired T helper cell-B lymphocyte relationship in the elderly. EOS-Rivista di Immunologia ed Immunofarmacologia 13(2): 137-141
Pellat-Deceunynck, C.; Amiot, M.; Robillard, N.; Wijdenes, J.; Bataille, R. 1996: CD11a-CD18 and CD102 interactions mediate human myeloma cell growth arrest induced by CD40 stimulation. Cancer Research 56(8): 1909-1916
Fan, S.T.; Brian, A.A.; Lollo, B.A.; Mackman, N.; Shen, N.L.; Edgington, T.S. 1993: CD11a/CD18 (LFA-1) integrin engagement enhances biosynthesis of early cytokines by activated T cells. Cellular Immunology 148(1): 48-59
Carratelli, C.R.; Nuzzo, I.; Bentivoglio, C.; Galdiero, M. 1996: CD11a/CD18 and CD11b/18 modulation by lipoteichoic acid, N-acetyl-muramyl-alpha-alanyl-D-isoglutamine, muramic acid and protein A from Staphylococcus aureus. FEMS Immunology and Medical Microbiology 16(3-4): 309-315
Koike, K.; Moore, E.E.; Moore, F.A.; Franciose, R.J.; Fontes, B.; Kim, F.J. 1995: CD11b blockade prevents lung injury despite neutrophil priming after gut ischemia/reperfusion. Journal of Trauma 39(1): 23-7; Discussion 27-8
in 't Veen, J.C.; Grootendorst, D.C.; Bel, E.H.; Smits, H.H.; Van Der Keur, M.; Sterk, P.J.; Hiemstra, P.S. 1998: CD11b and L-selectin expression on eosinophils and neutrophils in blood and induced sputum of patients with asthma compared with normal subjects. Clinical and Experimental Allergy: Journal of the British Society for Allergy and Clinical Immunology 28(5): 606-615
Kang, K.; Hammerberg, C.; Meunier, L.; Cooper, K.D. 1994: CD11b+ macrophages that infiltrate human epidermis after in vivo ultraviolet exposure potently produce IL-10 and represent the major secretory source of epidermal IL-10 protein. Journal of Immunology 153(11): 5256-5264
Elstad, M.R.; Parker, C.J.; Cowley, F.S.; Wilcox, L.A.; McIntyre, T.M.; Prescott, S.M.; Zimmerman, G.A. 1994: CD11b/CD18 integrin and a beta-glucan receptor act in concert to induce the synthesis of platelet-activating factor by monocytes. Journal of Immunology 152(1): 220-230
Gross, T.J.; Leavell, K.J.; Peterson, M.W. 1997: CD11b/CD18 mediates the neutrophil chemotactic activity of fibrin degradation product D domain. Thrombosis and Haemostasis 77(5): 894-900
Lundgren-Akerlund, E.; Olofsson, A.M.; Berger, E.; Arfors, K.E. 1993: CD11b/CD18-dependent polymorphonuclear leucocyte interaction with matrix proteins in adhesion and migration. Scandinavian Journal of Immunology 37(5): 569-574
Steadman, R.; Petersen, M.M.; Williams, J.D. 1996: CD11b/CD18-dependent stimulation of leukotriene B4 synthesis by human neutrophils (PMN) is synergistically enhanced by tumour necrosis factor alpha and low dose diacylglycerol. International Journal of Biochemistry and Cell Biology 28(7): 771-776
Molica, S.; Dattilo, A.; Mannella, A.; Levato, D. 1994: CD11c expression in B-cell chronic lymphocytic leukemia. a comparison of results obtained with different monoclonal antibodies. Haematologica 79(5): 452-455
Ingalls, R.R.; Golenbock, D.T. 1995: CD11c/CD18, a transmembrane signaling receptor for lipopolysaccharide. Journal of Experimental Medicine 181(4): 1473-1479
Söderberg, C.; Giugni, T.D.; Zaia, J.A.; Larsson, S.; Wahlberg, J.M.; Möller, E. 1993: CD13 (human aminopeptidase N) mediates human cytomegalovirus infection. Journal of Virology 67(11): 6576-6585
Soderberg, C.; Sumitran-Karuppan, S.; Ljungman, P.; Moller, E. 1996: CD13-specific autoimmunity in cytomegalovirus-infected immunocompromised patients. Transplantation 61(4): 594-600
Schwarz, H.; Arden, K.; Lotz, M. 1997: CD137, a member of the tumor necrosis factor receptor family, is located on chromosome 1p36, in a cluster of related genes, and colocalizes with several malignancies. Biochemical and Biophysical Research Communications 235(3): 699-703
Hmama, Z.; Mey, A.; Normier, G.; Binz, H.; Revillard, J.P. 1994: CD14 and CD11b mediate serum-independent binding to human monocytes of an acylpolygalactoside isolated from Klebsiella pneumoniae. Infection and Immunity 62(5): 1520-1527
Su, G.L.; Rahemtulla, A.; Thomas, P.; Klein, R.D.; Wang, S.C.; Nanji, A.A. 1998: CD14 and lipopolysaccharide binding protein expression in a rat model of alcoholic liver disease. American Journal of Pathology 152(3): 841-849
Kielian, T.L.; Blecha, F. 1995: CD14 and other recognition molecules for lipopolysaccharide: A review. Immunopharmacology 29(3): 187-205
Yang, Z.; Carter, C.D.; Miller, M.S.; Bochsler, P.N. 1995: CD14 and tissue factor expression by bacterial lipopolysaccharide-stimulated bovine alveolar macrophages in vitro. Infection and Immunity 63(1): 51-56
Labeta, M.O.; Durieux, J.J.; Spagnoli, G.; Fernandez, N.; Wijdenes, J.; Herrmann, R. 1993: CD14 and tolerance to lipopolysaccharide: biochemical and functional analysis. Immunology 80(3): 415-423
Delude, R.L.; Savedra, R.; Zhao, H.; Thieringer, R.; Yamamoto, S.; Fenton, M.J.; Golenbock, D.T. 1995: CD14 enhances cellular responses to endotoxin without imparting ligand-specific recognition. Proceedings of the National Academy of Sciences of the United States of America 92(20): 9288-9292
Haugen, T.S.; Nakstad, B.; Skjønsberg, O.H.; Lyberg, T. 1998: CD14 expression and binding of lipopolysaccharide to alveolar macrophages and monocytes. Inflammation 22(5): 521-532
Virchow, J.C.; Julius, P.; Matthys, H.; Kroegel, C.; Luttmann, W. 1998: CD14 expression and soluble CD14 after segmental allergen provocation in atopic asthma. European Respiratory Journal 11(2): 317-323
Gupta, D.; Kirkland, T.N.; Viriyakosol, S.; Dziarski, R. 1996: CD14 is a cell-activating receptor for bacterial peptidoglycan. Journal of Biological Chemistry 271(38): 23310-23316
Ziegler-Heitbrock, H.W.; Pechumer, H.; Petersmann, I.; Durieux, J.J.; Vita, N.; Labeta, M.O.; Ströbel, M. 1994: CD14 is expressed and functional in human B cells. European Journal of Immunology 24(8): 1937-1940
Kirikae, F.; Kirikae, T.; Qureshi, N.; Takayama, K.; Morrison, D.C.; Nakano, M. 1995: CD14 is not involved in Rhodobacter sphaeroides diphosphoryl lipid A inhibition of tumor necrosis factor alpha and nitric oxide induction by taxol in murine macrophages. Infection and Immunity 63(2): 486-497
Treon, S.P.; Anand, B.; Ulevitch, R.; Broitman, S.A. 1994: CD14 mediated endogenous TNF-alpha release in HL60 AML cells: A potential model for CD14 mediated endogenous cytokine release in the treatment of AML. Leukemia Research 18(1): 17-21
Galea, E.; Reis, D.J.; Fox, E.S.; Xu, H.; Feinstein, D.L. 1996: CD14 mediate endotoxin induction of nitric oxide synthase in cultured brain glial cells. Journal of Neuroimmunology 64(1): 19-28
Peterson, P.K.; Gekker, G.; Hu, S.; Sheng, W.S.; Anderson, W.R.; Ulevitch, R.J.; Tobias, P.S.; Gustafson, K.V.; Molitor, T.W.; Chao, C.C. 1995: CD14 receptor-mediated uptake of nonopsonized Mycobacterium tuberculosis by human microglia. Infection and Immunity 63(4): 1598-1602
Zhou, L.J.; Tedder, T.F. 1996: CD14+ blood monocytes can differentiate into functionally mature CD83+ dendritic cells. Proceedings of the National Academy of Sciences of the United States of America 93(6): 2588-2592
Mielcarek, M.; Roecklein, B.A.; Torok-Storb, B. 1996: CD14+ cells in granulocyte colony-stimulating factor (G-CSF)-mobilized peripheral blood mononuclear cells induce secretion of interleukin-6 and G-CSF by marrow stroma. Blood 87(2): 574-580
Sato, T.T.; Kovacich, J.C.; Boyle, E.M.; Haddix, T.L.; Weintraub, A.; Pohlman, T.H. 1998: CD14-dependent activation of human endothelial cells by Bacteroides fragilis outer membrane. Journal of Surgical Research 74(2): 103-111
Liu, M.K.; Herrera-Velit, P.; Brownsey, R.W.; Reiner, N.E. 1994: CD14-dependent activation of protein kinase C and mitogen-activated protein kinases (p42 and p44) in human monocytes treated with bacterial lipopolysaccharide. Journal of Immunology 153(6): 2642-2652
Poussin, C.; Foti, M.; Carpentier, J.L.; Pugin, J. 1998: CD14-dependent endotoxin internalization via a macropinocytic pathway. Journal of Biological Chemistry 273(32): 20285-20291
Legrand, C.B.; Thieringer, R. 1994: CD14-dependent induction of protein tyrosine phosphorylation by lipopolysaccharide in murine B-lymphoma cells. Biochimica Et Biophysica Acta 1223(1): 36-46
Schroeder, R.A.; delaTorre, A.; Kuo, P.C. 1997: CD14-dependent mechanism for endotoxin-mediated nitric oxide synthesis in murine macrophages. American Journal of Physiology 273(3 Pt 1): C1030-C1039
Cohen, L.; Haziot, A.; Shen, D.R.; Lin, X.Y.; Sia, C.; Harper, R.; Silver, J.; Goyert, S.M. 1995: CD14-independent responses to LPS require a serum factor that is absent from neonates. Journal of Immunology 155(11): 5337-5342
Tracy, T.F.; Fox, E.S. 1995: CD14-lipopolysaccharide receptor activity in hepatic macrophages after cholestatic liver injury. Surgery 118(2): 371-377
Thieblemont, N.; Weiss, L.; Sadeghi, H.M.; Estcourt, C.; Haeffner-Cavaillon, N. 1995: CD14lowCD16high: a cytokine-producing monocyte subset which expands during human immunodeficiency virus infection. European Journal of Immunology 25(12): 3418-3424
Watanabe, A.; Takeshita, A.; Kitano, S.; Hanazawa, S. 1996: CD14-mediated signal pathway of Porphyromonas gingivalis lipopolysaccharide in human gingival fibroblasts. Infection and Immunity 64(11): 4488-4494
Bardin, N.; Francès, V.; Combes, V.; Sampol, J.; Dignat-George, F. 1998: CD146: Biosynthesis and production of a soluble form in human cultured endothelial cells. FEBS Letters 421(1): 12-14
de la Fuente-García, M.A.; Nicolás, J.M.; Freed, J.H.; Palou, E.; Thomas, A.P.; Vilella, R.; Vives, J.; Gayá, A. 1998: CD148 is a membrane protein tyrosine phosphatase present in all hematopoietic lineages and is involved in signal transduction on lymphocytes. Blood 91(8): 2800-2809
Palou, E.; de la Fuente-García, M.A.; Nicolás, J.M.; Vilardell, C.; Vives, J.; Gayá, A. 1997: CD148, a membrane protein tyrosine phosphatase, is able to induce tyrosine phosphorylation on human lymphocytes. Immunology Letters 57(1-3): 101-103
McGinley, M.D.; Narhi, L.O.; Kelley, M.J.; Davy, E.; Robinson, J.; Rohde, M.F.; Wright, S.D.; Lichenstein, H.S. 1995: CD14: physical properties and identification of an exposed site that is protected by lipopolysaccharide. Journal of Biological Chemistry 270(10): 5213-5218
Mai, J.K.; Bartsch, D.; Marani, E. 1995: CD15 and HKN-1 reveal cerebellar compartments with a complex overlap. European Journal of Morphology 33(2): 101-107
Yoshiyama, K.; Higuchi, Y.; Kataoka, M.; Matsuura, K.; Yamamoto, S. 1997: CD156 (human ADAM8): expression, primary amino acid sequence, and gene location. Genomics 41(1): 56-62
Kabutomori, O.; Iwatani, Y.; Koh, T.; Yanagihara, T. 1997: CD16 antigen density on neutrophils in chronic myeloproliferative disorders. American Journal of Clinical Pathology 107(6): 661-664
Saleh, M.N.; Goldman, S.J.; LoBuglio, A.F.; Beall, A.C.; Sabio, H.; McCord, M.C.; Minasian, L.; Alpaugh, R.K.; Weiner, L.M.; Munn, D.H. 1995: CD16+ monocytes in patients with cancer: spontaneous elevation and pharmacologic induction by recombinant human macrophage colony-stimulating factor. Blood 85(10): 2910-2917
Galandrini, R.; Palmieri, G.; Piccoli, M.; Frati, L.; Santoni, A. 1996: CD16-mediated p21ras activation is associated with Shc and p36 tyrosine phosphorylation and their binding with Grb2 in human natural killer cells. Journal of Experimental Medicine 183(1): 179-186
Watt, S.M.; Bühring, H.J.; Rappold, I.; Chan, J.Y.; Lee-Prudhoe, J.; Jones, T.; Zannettino, A.C.; Simmons, P.J.; Doyonnas, R.; Sheer, D.; Butler, L.H. 1998: CD164, a novel sialomucin on CD34(+) and erythroid subsets, is located on human chromosome 6q21. Blood 92(3): 849-866
Ramamoorthy, C.; Sasaki, S.S.; Su, D.L.; Sharar, S.R.; Harlan, J.M.; Winn, R.K. 1997: CD18 adhesion blockade decreases bacterial clearance and neutrophil recruitment after intrapulmonary E. coli, but not after S. aureus. Journal of Leukocyte Biology 61(2): 167-172
McDonagh, P.F.; Wilson, D.S.; Iwamura, H.; Smith, C.W.; Williams, S.K.; Copeland, J.G. 1996: CD18 antibody treatment limits early myocardial reperfusion injury after initial leukocyte deposition. Journal of Surgical Research 64(2): 139-149
Nagendra, A.R.; Mickelson, J.K.; Smith, C.W. 1997: CD18 integrin and CD54-dependent neutrophil adhesion to cytokine-stimulated human hepatocytes. American Journal of Physiology 272(3 Pt 1): G408-G416
Lum, H.; Gibbs, L.; Lai, L.; Malik, A.B. 1994: CD18 integrin-dependent endothelial injury: effects of opsonized zymosan and phorbol ester activation. Journal of Leukocyte Biology 55(1): 58-63
Jerome, S.N.; Smith, C.W.; Korthuis, R.J. 1993: CD18-dependent adherence reactions play an important role in the development of the no-reflow phenomenon. American Journal of Physiology 264(2 Part 2): H479-H483
Fortenberry, J.D.; Marolda, J.R.; Anderson, D.C.; Smith, C.W.; Mariscalco, M.M. 1994: CD18-dependent and L-selectin-dependent neutrophil emigration is diminished in neonatal rabbits. Blood 84(3): 889-897
Gidday, J.M.; Park, T.S.; Gonzales, E.R.; Beetsch, J.W. 1997: CD18-dependent leukocyte adherence and vascular injury in pig cerebral circulation after ischemia. American Journal of Physiology 272(6 Pt 2): H2622-H2629
Thomas, D.D.; Sharar, S.R.; Winn, R.K.; Chi, E.Y.; Verrier, E.D.; Allen, M.D.; Bishop, M.J. 1995: CD18-independent mechanism of neutrophil emigration in the rabbit lung after ischemia-reperfusion. Annals of Thoracic Surgery 60(5): 1360-1366
Winn, R.K.; Harlan, J.M. 1993: CD18-independent neutrophil and mononuclear leukocyte emigration into the peritoneum of rabbits. Journal of Clinical Investigation 92(3): 1168-1173
Kurose, I.; Higuchi, H.; Watanabe, N.; Miura, S.; Tomita, K.; Yonei, Y.; Takaishi, M.; Zeki, S.; Nakamura, T.; Saito, H.; Kato, S.; Ishii, H. 1997: CD18/ICAM-1-dependent nitric oxide production of Kupffer cells as a cause of mitochondrial dysfunction in hepatoma cells: influence of chronic alcohol feeding. Free Radical Biology and Medicine 22(1-2): 229-239
Kurose, I.; Saito, H.; Miura, S.; Ebinuma, H.; Higuchi, H.; Watanabe, N.; Zeki, S.; Nakamura, T.; Takaishi, M.; Ishii, H. 1997: CD18/ICAM-1-dependent oxidative NF-kappaB activation leading to nitric oxide production in rat Kupffer cells cocultured with syngeneic hepatoma cells. Journal of Clinical Investigation 99(5): 867-878
Sato, S.; Jansen, P.J.; Tedder, T.F. 1997: CD19 and CD22 expression reciprocally regulates tyrosine phosphorylation of Vav protein during B lymphocyte signaling. Proceedings of the National Academy of Sciences of the United States of America 94(24): 13158-13162
Zandecki, M.; Facon, T.; Bernardi, F.; Izydorczyk, V.; Dupond, L.; François, M.; Reade, R.; Iaru, T.; Bauters, F.; Cosson, A. 1995: CD19 and immunophenotype of bone marrow plasma cells in monoclonal gammopathy of undetermined significance. Journal of Clinical Pathology 48(6): 548-552
O'Rourke, L.M.; Tooze, R.; Turner, M.; Sandoval, D.M.; Carter, R.H.; Tybulewicz, V.L.; Fearon, D.T. 1998: CD19 as a membrane-anchored adaptor protein of B lymphocytes: Costimulation of lipid and protein kinases by recruitment of Vav. Immunity 8(5): 635-645
Maloney, M.D.; Lingwood, C.A. 1994: CD19 has a potential CD77 (globotriaosyl ceramide)-binding site with sequence similarity to verotoxin B-subunits: implications of molecular mimicry for B cell adhesion and enterohemorrhagic Escherichia coli pathogenesis. Journal of Experimental Medicine 180(1): 191-201
Roifman, C.M.; Ke, S. 1993: CD19 is a substrate of the antigen receptor-associated protein tyrosine kinase in human B cells. Biochemical and Biophysical Research Communications 194(1): 222-225
Tuveson, D.A.; Carter, R.H.; Soltoff, S.P.; Fearon, D.T. 1993: CD19 of B cells as a surrogate kinase insert region to bind phosphatidylinositol 3-kinase. Science 260(5110): 986-989
Battistini, L.; Fischer, F.R.; Raine, C.S.; Brosnan, C.F. 1996: CD1b is expressed in multiple sclerosis lesions. Journal of Neuroimmunology 67(2): 145-151
Porcelli, S.; Morita, C.T.; Brenner, M.B. 1992: CD1b restricts the response of human CD4-negative 8-negative T lymphocytes to a microbial antigen. Nature (London) 360(6404): 593-597
Panja, A.; Blumberg, R.S.; Balk, S.P.; Mayer, L. 1993: CD1d is involved in T cell-intestinal epithelial cell interactions. Journal of Experimental Medicine 178(3): 1115-1119
Mendiratta, S.K.; Martin, W.D.; Hong, S.; Boesteanu, A.; Joyce, S.; Van Kaer, L. 1997: CD1d1 mutant mice are deficient in natural T cells that promptly produce IL-4. Immunity 6(4): 469-477
Uckun, F.M.; Steinherz, P.G.; Sather, H.; Trigg, M.; Arthur, D.; Tubergen, D.; Gaynon, P.; Reaman, G. 1996: CD2 antigen expression on leukemic cells as a predictor of event-free survival after chemotherapy for T-lineage acute lymphoblastic leukemia: a Children's Cancer Group study. Blood 88(11): 4288-4295
Kapur, S.; Khanna, A.; Sharma, V.K.; Li, B.; Suthanthiran, M. 1996: CD2 antigen targeting reduces intragraft expression of mRNA-encoding granzyme B and IL-10 and induces tolerance. Transplantation 62(2): 249-255
Biondi, A.; Luciano, A.; Bassan, R.; Mininni, D.; Specchia, G.; Lanzi, E.; Castagna, S.; Cantù-Rajnoldi, A.; Liso, V.; Masera, G. 1995: CD2 expression in acute promyelocytic leukemia is associated with microgranular morphology (FAB M3v) but not with any PML gene breakpoint. Leukemia 9(9): 1461-1466
Van Houten, N.; Mixter, P.F.; Wolfe, J.; Budd, R.C. 1993: CD2 expression on murine intestinal intraepithelial lymphocytes is bimodal and defines proliferative capacity. International Immunology 5(6): 665-672
Boussiotis, V.A.; Freeman, G.J.; Griffin, J.D.; Gray, G.S.; Gribben, J.G.; Nadler, L.M. 1994: CD2 is involved in maintenance and reversal of human alloantigen-specific clonal anergy. Journal of Experimental Medicine 180(5): 1665-1673
Baixeras, E.; Moreno, M.C.; Martinez-A, C. 1996: CD2 ligation abrogates antigen-independent apoptosis in B cells. Cellular Immunology 171(1): 55-61
Gollob, J.A.; Li, J.; Reinherz, E.L.; Ritz, J. 1995: CD2 regulates responsiveness of activated T cells to interleukin 12. Journal of Experimental Medicine 182(3): 721-731
Ayroldi, E.; Migliorati, G.; Cannarile, L.; Moraca, R.; Delfino, D.V.; Riccardi, C. 1997: CD2 rescues T cells from T-cell receptor/CD3 apoptosis: a role for the Fas/Fas-L system. Blood 89(10): 3717-3726
King, P.D.; Sadra, A.; Han, A.; Liu, X.R.; Sunder-Plassmann, R.; Reinherz, E.L.; Dupont, B. 1996: CD2 signaling in T cells involves tyrosine phosphorylation and activation of the Tec family kinase, EMT/ITK/TSK. International Immunology 8(11): 1707-1714
Genaro, A.M.; Gonzalo, J.A.; Bosca, L.; Martinez, C. 1994: CD2-CD48 interaction prevents apoptosis in murine B lymphocytes by up-regulating bcl-2 expression. European Journal of Immunology 24(10): 2515-2521
Evans, C.F.; Rall, G.F.; Killeen, N.; Littman, D.; Oldstone, M.B. 1993: CD2-deficient mice generate virus-specific cytotoxic T lymphocytes upon infection with lymphocytic choriomeningitis virus. Journal of Immunology 151(11): 6259-6264
Mollereau, B.; Deckert, M.; Déas, O.; Rieux-Laucat, F.; Hirsch, F.; Bernard, A.; Fischer, A.; Lynch, D.H.; Charpentier, B.; Le Deist, F.; Senik, A. 1996: CD2-induced apoptosis in activated human peripheral T cells: a Fas-independent pathway that requires early protein tyrosine phosphorylation. Journal of Immunology 156(9): 3184-3190
King, P.D.; Sadra, A.; Teng, J.M.; Bell, G.M.; Dupont, B. 1998: CD2-mediated activation of the Tec-family tyrosine kinase ITK is controlled by proline-rich stretch-4 of the CD2 cytoplasmic tail. International Immunology 10(7): 1009-1016
Steeg, C.; von Bonin, A.; Mittrücker, H.W.; Malissen, B.; Fleischer, B. 1997: CD2-mediated signaling in T cells lacking the zeta-chain-specific immune receptor tyrosine-based activation (ITAM) motif. European Journal of Immunology 27(9): 2233-2238
Liu, L.; Foer, A.; Sesterhenn, J.; Reinhold, U. 1996: CD2-mediated stimulation of the naive CD4+ T-cell subset promotes the development of skin-associated cutaneous lymphocyte antigen-positive memory cells. Immunology 88(2): 207-213
Algino, K.M.; Thomason, R.W.; King, D.E.; Montiel, M.M.; Craig, F.E. 1996: CD20 (pan-B cell antigen) expression on bone marrow-derived T cells. American Journal of Clinical Pathology 106(1): 78-81
Hultin, L.E.; Hausner, M.A.; Hultin, P.M.; Giorgi, J.V. 1993: CD20 (pan-B cell) antigen is expressed at a low level on a subpopulation of human T lymphocytes. Cytometry 14(2): 196-204
Smiers, F.J.; van Paassen, M.; Hählen, K.; Löwenberg, B.; Touw, I.P. 1996: CD20 and CD40 mediated mitogenic responses in B-lineage acute lymphoblastic leukaemia. British Journal of Haematology 93(1): 125-130
Bourget, I.; Breittmayer, J.P.; Grenier-Brossette, N.; Cousin, J.L. 1993: CD20 monoclonal antibodies down-regulate IgM at the surface of B cells. European Journal of Immunology 23(3): 768-771
Takami, A.; Saito, M.; Nakao, S.; Asakura, H.; Nozue, T.; Onoe, Y.; Yachie, A.; Shiobara, S.; Matsuda, T. 1998: CD20-positive T-cell chronic lymphocytic leukaemia. British Journal of Haematology 102(5): 1327-1329
Tatsumi, E.; Yoneda, N.; Kawano, S.; Yamaguchi, N. 1994: CD21 antigen in T-lineage neoplastic lymphoid cells: Characteristic expression at thymic stage. American Journal of Hematology 45(2): 150-155
Bacon, K.; Gauchat, J.F.; Aubry, J.P.; Pochon, S.; Graber, P.; Henchoz, S.; Bonnefoy, J.Y. 1993: CD21 expressed on basophilic cells is involved in histamine release triggered by CD23 and anti-CD21 antibodies. European Journal of Immunology 23(10): 2721-2724
Rabatić, S.; Gagro, A.; Medar-Lasić, M. 1993: CD21-CD23 ligand pair expression in children with allergic asthma. Clinical and Experimental Immunology 94(2): 337-340
Law, C.L.; Sidorenko, S.P.; Chandran, K.A.; Zhao, Z.; Shen, S.H.; Fischer, E.H.; Clark, E.A. 1996: CD22 associates with protein tyrosine phosphatase 1C, Syk, and phospholipase C-gamma(1) upon B cell activation. Journal of Experimental Medicine 183(2): 547-560
Leprince, C.; Draves, K.E.; Geahlen, R.L.; Ledbetter, J.A.; Clark, E.A. 1993: CD22 associates with the human surface IgM-B-cell antigen receptor complex. Proceedings of the National Academy of Sciences of the United States of America 90(8): 3236-3240
Nitschke, L.; Carsetti, R.; Ocker, B.; Köhler, G.; Lamers, M.C. 1997: CD22 is a negative regulator of B-cell receptor signalling. Current Biology: Cb 7(2): 133-143
Sgroi, D.; Varki, A.; Braesch-Andersen, S.; Stamenkovic, I. 1993: CD22, a B cell-specific immunoglobulin superfamily member, is a sialic acid-binding lectin. Journal of Biological Chemistry 268(10): 7011-7018
Aruffo, A.; Kanner, S.B.; Sgroi, D.; Ledbetter, J.A.; Stamenkovic, I. 1992: CD22-mediated stimulation of T cells regulates T-cell receptor/CD3-induced signaling. Proceedings of the National Academy of Sciences of the United States of America 89(21): 10242-10246
Marolewski, A.E.; Buckle, D.R.; Christie, G.; Earnshaw, D.L.; Flamberg, P.L.; Marshall, L.A.; Smith, D.G.; Mayer, R.J. 1998: CD23 (FcepsilonRII) release from cell membranes is mediated by a membrane-bound metalloprotease. Biochemical Journal 333: 573-579
Fernández-Gutiérrez, B.; Hernández-García, C.; Bañares, A.A.; Jover, J.A. 1994: CD23 Hyperexpression in rheumatoid arthritis: Evidence for a B cell hyperresponsiveness to cognate and noncognate T-cell signals. Clinical Immunology and Immunopathology 72(3): 321-327
Björck, P.; Elenström-Magnusson, C.; Rosén, A.; Severinson, E.; Paulie, S. 1993: CD23 and CD21 function as adhesion molecules in homotypic aggregation of human B lymphocytes. European Journal of Immunology 23(8): 1771-1775
Sarfati, M. 1993: CD23 and chronic lymphocytic leukemia. Blood Cells 19(3): 591-6; Discussion 597-9
Vouldoukis, I.; Issaly, F.; Fourcade, C.; Paul-Eugène, N.; Arock, M.; Kolb, J.P.; da Silva, O.A.; Monjour, L.; Poinsot, H.; Tselentis, Y. 1994: CD23 and IgE expression during the human immune response to cutaneous leishmaniasis: possible role in monocyte activation. Research in Immunology 145(1): 17-27
Haczku, A.; Takeda, K.; Hamelmann, E.; Oshiba, A.; Loader, J.; Joetham, A.; Irvin, C.; Kikutani, H.; Gelfand, E.W. 1997: CD23 deficient mice develop allergic airway hyperresponsiveness following sensitization with ovalbumin. American Journal of Respiratory and Critical Care Medicine 156(6): 1945-1955
Carini, C.; Fratazzi, C. 1996: CD23 expression in activated human T cells is enhanced by interleukin-7. International Archives of Allergy and Immunology 110(1): 23-30
Dunphy, C.H.; Wheaton, S.E.; Perkins, S.L. 1997: CD23 expression in transformed small lymphocytic lymphomas/chronic lymphocytic leukemias and blastic transformations of mantle cell lymphoma. Modern Pathology: An Official Journal of the United States and Canadian Academy of Pathology Inc 10(8): 818-822
Corominas, M.; Mestre, M.; Bas, J.; Verdaguer, J.; Valls, A.; Romeu, A.; Buendia, E. 1993: CD23 expression on B-lymphocytes and its modulation by cytokines in allergic patients. Clinical and Experimental Allergy: Journal of the British Society for Allergy and Clinical Immunology 23(7): 612-617
Aubry, J.P.; Pochon, S.; Gauchat, J.F.; Nueda-Marin, A.; Holers, V.M.; Graber, P.; Siegfried, C.; Bonnefoy, J.Y. 1994: CD23 interacts with a new functional extracytoplasmic domain involving N-linked oligosaccharides on CD21. Journal of Immunology 152(12): 5806-5813
Nunez, R.; Lynch, R.G. 1993: CD23 isoforms in murine T and B lymphocytes. Pathobiology: Journal of Immunopathology Molecular and Cellular Biology 61(3-4): 128-137
Xiang, Shu Lin; Zhang; Xin; Xu; De Sheng 1994: CD23 molecular expression on activated human tonsil lymphocytes. Zhonghua Weishengquxue He Mianyixue Zazhi 14(4): 264-266
Kijimoto-Ochiai, S.; Uede, T. 1995: CD23 molecule acts as a galactose-binding lectin in the cell aggregation of EBV-transformed human B-cell lines. Glycobiology 5(4): 443-448
Kolb, J.P.; Abadie, A.; Proschnicka-Chalufour, A.; de Gramont, A.; Poggioli, J. 1994: CD23-mediated cell signalling. Journal of Lipid Mediators and Cell Signalling 9(1): 27-35
Moulder, K.; Barton, A.; Weston, B. 1993: CD23-mediated homotypic cell adhesion: the role of proteolysis. European Journal of Immunology 23(9): 2066-2071
Bécherel, P.A.; Le Goff, L.; Ktorza, S.; Chosidow, O.; Francès, C.; Issaly, F.; Mencia-Huerta, J.M.; Debré, P.; Mossalayi, M.D.; Arock, M. 1996: CD23-mediated nitric oxide synthase pathway induction in human keratinocytes is inhibited by retinoic acid derivatives. Journal of Investigative Dermatology 106(6): 1182-1186
Grosjean, I.; Lachaux, A.; Bella, C.; Aubry, J.P.; Bonnefoy, J.Y.; Kaiserlian, D. 1994: CD23/CD21 interaction is required for presentation of soluble protein antigen by lymphoblastoid B cell lines to specific CD4+ T cell clones. European Journal of Immunology 24(12): 2982-2986
Carini, C.; Pini, C.; Difelice, G.; Fattorossi, A.; Fratazzi, C. 1993: CD23/Fc-epsilon-RII expression on phytohemagglutinin A- or phorbol-12myristate-13acetate-calcium-activated human tonsil T cells. International Archives of Allergy and Immunology 101(1): 30-38
Gustavsson, S.; Hjulström, S.; Liu, T.; Heyman, B. 1994: CD23/IgE-mediated regulation of the specific antibody response in vivo. Journal of Immunology 152(10): 4793-4800
Aigner, S.; Ramos, C.L.; Hafezi-Moghadam, A.; Lawrence, M.B.; Friederichs, J.; Altevogt, P.; Ley, K. 1998: CD24 mediates rolling of breast carcinoma cells on P-selectin. FASEB Journal 12(12): 1241-1251
Poncet, C.; Frances, V.; Gristina, R.; Scheiner, C.; Pellissier, J.F.; Figarella-Branger, D. 1996: CD24, a glycosylphosphatidylinositol-anchored molecules is transiently expressed during the development of human central nervous system and is a marker of human neural cell lineage tumors. Acta Neuropathologica 91(4): 400-408
Aigner, S.; Sthoeger, Z.M.; Fogel, M.; Weber, E.; Zarn, J.; Ruppert, M.; Zeller, Y.; Vestweber, D.; Stahel, R.; Sammar, M.; Altevogt, P. 1997: CD24, a mucin-type glycoprotein, is a ligand for P-selectin on human tumor cells. Blood 89(9): 3385-3395
Figarella-Branger, D.; Moreau, H.; Pellissier, J.F.; Bianco, N.; Rougon, G. 1993: CD24, a signal-transducing molecule expressed on human B lymphocytes, is a marker for human regenerating muscle. Acta Neuropathologica 86(3): 275-284
Horiguchi, S.; Hisamatsu, K.; Tasaka, K. 1995: CD25 T-lymphocytes induce CD11b on eosinophils in allergic nasal mucosa. Mediators of Inflammation 4(2): 144-148
Tison, T.; Dazzi, F.; Giacon, C.; Vianello, F.; Valente, M.L.; Radossi, P.; Sgarabotto, D.; Girolami, A.; Pennelli, N.; Poletti, A. 1995: CD25-negative hairy cell leukaemia: intracytoplasmic detection of Tac antigen and interferon-induced surface expression. Journal of Pathology 177(1): 41-47
Mattern, T.; Reich, C.; Schönbeck, U.; Ansorge, S.; Demuth, H.U.; Loppnow, H.; Ulmer, A.J.; Flad, H.D. 1998: CD26 (dipeptidyl peptidase I.v.) on human T lymphocytes does not mediate adhesion of these cells to endothelial cells or fibroblasts. Immunobiology 198(4): 465-475
Tanaka, T.; Umeki, K.; Yamamoto, I.; Sakamoto, F.; Noguchi, S.; Ohtaki, S. 1995: CD26 (Dipeptidyl peptidase IV/DPP IV) as a novel molecular marker for differentiated thyroid carcinoma. International Journal of Cancer 64(5): 326-331
Ruiz, P.; Mailhot, S.; Delgado, P.; Amador, A.; Viciana, A.L.; Ferrer, L.; Zacharievich, N. 1998: CD26 expression and dipeptidyl peptidase IV activity in an aggressive hepatosplenic T-cell lymphoma. Cytometry 34(1): 30-35
Scheel-Toellner, D.; Richter, E.; Toellner, K.M.; Reiling, N.; Wacker, H.H.; Flad, H.D.; Gerdes, J. 1995: CD26 expression in leprosy and other granulomatous diseases correlates with the production of interferon-gamma. Laboratory Investigation; A Journal of Technical Methods and Pathology 73(5): 685-690
Reinhold, D.; Wrenger, S.; Bank, U.; Bühling, F.; Hoffmann, T.; Neubert, K.; Kraft, M.; Frank, R.; Ansorge, S. 1996: CD26 mediates the action of HIV-1 Tat protein on DNA synthesis and cytokine production in U937 cells. Immunobiology 195(1): 119-128
Gerli, R.; Muscat, C.; Bertotto, A.; Bistoni, O.; Agea, E.; Tognellini, R.; Fiorucci, G.; Cesarotti, M.; Bombardieri, S. 1996: CD26 surface molecule involvement in T cell activation and lymphokine synthesis in rheumatoid and other inflammatory synovitis. Clinical Immunology and Immunopathology 80(1): 31-37
Iwaki-Egawa, S.; Watanabe, Y.; Fujimoto, Y. 1997: CD26/dipeptidyl peptidase IV does not work as an adenosine deaminase-binding protein in rat cells. Cellular Immunology 178(2): 180-186
Carbone, A.; Cozzi, M.; Gloghini, A.; Pinto, A. 1994: CD26/dipeptidyl peptidase IV expression in human lymphomas is restricted to CD30-positive anaplastic large cell and a subset of T-cell non-Hodgkin's lymphomas. Human Pathology 25(12): 1360-1365
Popescu, A.; Cernescu, C. 1994: CD 26--to be or not to be a cofactor for CD 4 receptor of human immunodeficiency viruses. Revue Roumaine de Virologie 45(3-4): 203-209
Gravestein, L.A.; van Ewijk, W.; Ossendorp, F.; Borst, J. 1996: CD27 cooperates with the pre-T cell receptor in the regulation of murine T cell development. Journal of Experimental Medicine 184(2): 675-685
Molica, S.; Vitelli, G.; Levato, D.; Crispino, G.; Dell'Olio, M.; Dattilo, A.; Matera, R.; Gandolfo, G.M.; Musto, P. 1998: CD27 in B-cell chronic lymphocytic leukemia. Cellular expression, serum release and correlation with other soluble molecules belonging to nerve growth factor receptors (NGFr) superfamily. Haematologica 83(5): 398-402
Kobata, T.; Agematsu, K.; Kameoka, J.; Schlossman, S.F.; Morimoto, C. 1994: CD27 is a signal-transducing molecule involved in CD45RA+ naive T cell costimulation. Journal of Immunology 153(12): 5422-5432
Prasad, K.V.; Ao, Z.; Yoon, Y.; Wu, M.X.; Rizk, M.; Jacquot, S.; Schlossman, S.F. 1997: CD27, a member of the tumor necrosis factor receptor family, induces apoptosis and binds to Siva, a proapoptotic protein. Proceedings of the National Academy of Sciences of the United States of America 94(12): 6346-6351
Akiba, H.; Nakano, H.; Nishinaka, S.; Shindo, M.; Kobata, T.; Atsuta, M.; Morimoto, C.; Ware, C.F.; Malinin, N.L.; Wallach, D.; Yagita, H.; Okumura, K. 1998: CD27, a member of the tumor necrosis factor receptor superfamily, activates NF-kappaB and stress-activated protein kinase/c-Jun N-terminal kinase via TRAF2, TRAF5, and NF-kappaB-inducing kinase. Journal of Biological Chemistry 273(21): 13353-13358
Kobata, T.; Jacquot, S.; Kozlowski, S.; Agematsu, K.; Schlossman, S.F.; Morimoto, C. 1995: CD27-CD70 interactions regulate B-cell activation by T cells. Proceedings of the National Academy of Sciences of the United States of America 92(24): 11249-11253
Jacquot, S.; Kobata, T.; Iwata, S.; Schlossman, S.F.; Morimoto, C. 1997: CD27/CD70 interaction contributes to the activation and the function of human autoreactive CD27+ regulatory T cells. Cellular Immunology 179(1): 48-54
Agematsu, K.; Kobata, T.; Yang, F.C.; Nakazawa, T.; Fukushima, K.; Kitahara, M.; Mori, T.; Sugita, K.; Morimoto, C.; Komiyama, A. 1995: CD27/CD70 interaction directly drives B cell IgG and IgM synthesis. European Journal of Immunology 25(10): 2825-2829
Yang, F.C.; Agematsu, K.; Nakazawa, T.; Mori, T.; Ito, S.; Kobata, T.; Morimoto, C.; Komiyama, A. 1996: CD27/CD70 interaction directly induces natural killer cell killing activity. Immunology 88(2): 289-293
Nunes, J.A.; Battifora, M.; Woodgett, J.R.; Truneh, A.; Olive, D.; Cantrell, D.A. 1996: CD28 Signal transduction pathways. A comparison of B7-1 and B7-2 regulation of the MAP kinases: ERK2 and Jun kinases. Molecular Immunology 33(1): 63-70
Boucher, L.M.; Wiegmann, K.; Fütterer, A.; Pfeffer, K.; Machleidt, T.; Schütze, S.; Mak, T.W.; Krönke, M. 1995: CD28 signals through acidic sphingomyelinase. Journal of Experimental Medicine 181(6): 2059-2068
King, C.L.; Stupi, R.J.; Craighead, N.; June, C.H.; Thyphronitis, G. 1995: CD28 activation promotes Th2 subset differentiation by human CD4+ cells. European Journal of Immunology 25(2): 587-595
Tuosto, L.; Acuto, O. 1998: CD28 affects the earliest signaling events generated by TCR engagement. European Journal of Immunology 28(7): 2131-2142
Krummel, M.F.; Allison, J.P. 1995: CD28 and CTLA-4 have opposing effects on the response of T cells to stimulation. Journal of Experimental Medicine 182(2): 459-465
Green, J.M.; Turka, L.A.; June, C.H.; Thompson, C.B. 1992: CD28 and staphylococcal enterotoxins synergize to induce MHC-independent T-cell proliferation. Cellular Immunology 145(1): 11-20
Horenstein, A.L.; Stockinger, H.; Imhof, B.A.; Malavasi, F. 1998: CD38 binding to human myeloid cells is mediated by mouse and human CD31. Biochemical Journal 330: 1129-1135
Lin, H.; Wei, R.Q.; Goodman, R.E.; Bolling, S.F. 1997: CD28 blockade alters cytokine mRNA profiles in cardiac transplantation. Surgery 122(2): 129-137
Collette, Y.; Razanajaona, D.; Ghiotto, M.; Olive, D. 1997: CD28 can promote T cell survival through a phosphatidylinositol 3-kinase-independent mechanism. European Journal of Immunology 27(12): 3283-3289
Maurice, M.M.; van der Voort, E.A.; Leow, A.; Levarht, N.; Breedveld, F.C.; Verweij, C.L. 1998: CD28 co-stimulation is intact and contributes to prolonged ex vivo survival of hyporesponsive synovial fluid T cells in rheumatoid arthritis. European Journal of Immunology 28(5): 1554-1562
Johnson-Léger, C.; Christensen, J.; Klaus, G.G. 1998: CD28 co-stimulation stabilizes the expression of the CD40 ligand on T cells. International Immunology 10(8): 1083-1091
Cefai, D.; Cai, Y.C.; Hu, H.; Rudd, C. 1996: CD28 co-stimulatory regimes differ in their dependence on phosphatidylinositol 3-kinase: common co-signals induced by CD80 and CD86. International Immunology 8(10): 1609-1616
Toyooka, K.; Maruo, S.; Iwahori, T.; Yamamoto, N.; Tai, X.G.; Abe, R.; Takahama, Y.; Murakami, M.; Uede, T.; Hamaoka, T.; Fujiwara, H. 1996: CD28 co-stimulatory signals induce IL-2 receptor expression on antigen-stimulated virgin T cells by an IL-2-independent mechanism. International Immunology 8(2): 159-169
Carlesimo, M.; Pontesilli, O.; Varani, A.R.; Bernardi, M.L.; Mazzone, A.M.; Rosso, R.; Guerra, E.C.; Cassone, A.; Paganelli, R.; Aiuti, F. 1997: CD28 costimulation and T lymphocyte proliferative responses in HIV-1 infection. Clinical and Experimental Immunology 109(3): 406-411
Radvanyi, L.G.; Shi, Y.; Vaziri, H.; Sharma, A.; Dhala, R.; Mills, G.B.; Miller, R.G. 1996: CD28 costimulation inhibits TCR-induced apoptosis during a primary T cell response. Journal of Immunology 156(5): 1788-1798
Noel, P.J.; Boise, L.H.; Green, J.M.; Thompson, C.B. 1996: CD28 costimulation prevents cell death during primary T cell activation. Journal of Immunology 157(2): 636-642
Ohnishi, H.; Ledbetter, J.A.; Kanner, S.B.; Linsley, P.S.; Tanaka, T.; Geller, A.M.; Kotb, M. 1995: CD28 cross-linking augments TCR-mediated signals and costimulates superantigen responses. Journal of Immunology 154(7): 3180-3193
Ohnishi, H.; Tanaka, T.; Takahara, J.; Kotb, M. 1993: CD28 delivers costimulatory signals for superantigen-induced activation of antigen-presenting cell-depleted human T lymphocytes. Journal of Immunology 150(8 Pt 1): 3207-3214
Truitt, K.E.; Shi, J.; Gibson, S.; Segal, L.G.; Mills, G.B.; Imboden, J.B. 1995: CD28 delivers costimulatory signals independently of its association with phosphatidylinositol 3-kinase. Journal of Immunology 155(10): 4702-4710
Linsley, P.S.; Bradshaw, J.; Urnes, M.; Grosmaire, L.; Ledbetter, J.A. 1993: CD28 engagement by B7/BB-1 induces transient down-regulation of CD28 synthesis and prolonged unresponsiveness to CD28 signaling. Journal of Immunology 150(8 Pt 1): 3161-3169
Boucher, N.; Dufeu-Duchesne, T.; Vicaut, E.; Farge, D.; Effros, R.B.; Schächter, F. 1998: CD28 expression in T cell aging and human longevity. Experimental Gerontology 33(3): 267-282
Niehues, T.; Ndagijimana, J.; Horneff, G.; Wahn, V. 1998: CD28 expression in pediatric human immunodeficiency virus infection. Pediatric Research 44(2): 265-268
Walunas, T.L.; Sperling, A.I.; Khattri, R.; Thompson, C.B.; Bluestone, J.A. 1996: CD28 expression is not essential for positive and negative selection of thymocytes or peripheral T cell tolerance. Journal of Immunology 156(3): 1006-1013
Sfikakis, P.P.; Zografou, A.; Viglis, V.; Iniotaki-Theodoraki, A.; Piskontaki, I.; Tsokos, G.C.; Sfikakis, P.; Choremi-Papadopoulou, H. 1995: CD28 expression on T cell subsets in vivo and CD28-mediated T cell response in vitro in patients with rheumatoid arthritis. Arthritis and Rheumatism 38(5): 649-654
García-Alonso, A.M.; Minguela, A.; Muro, M.; Ontañón, J.; Torío, A.; Marín, L.; López-Segura, P.; Miras, M.; Alvarez-López, M.R. 1997: CD28 expression on peripheral blood T lymphocytes after orthotopic liver transplant: upregulation in acute rejection. Human Immunology 53(1): 64-72
Life, P.; Aubry, J.P.; Estoppey, S.; Schnuriger, V.; Bonnefoy, J.Y. 1995: CD28 functions as an adhesion molecule and is involved in the regulation of human IgE synthesis. European Journal of Immunology 25(2): 333-339
August, A.; Gibson, S.; Kawakami, Y.; Kawakami, T.; Mills, G.B.; Dupont, B. 1994: CD28 is associated with and induces the immediate tyrosine phosphorylation and activation of the Tec family kinase ITK/EMT in the human Jurkat leukemic T-cell line. Proceedings of the National Academy of Sciences of the United States of America 91(20): 9347-9351
Wen, T.; Kono, K.; Shahinian, A.; Kiessling, R.; Mak, T.W.; Klein, G. 1997: CD28 is not required for rejection of unmanipulated syngeneic and autologous tumors. European Journal of Immunology 27(8): 1988-1993
Ferguson, S.E.; Han, S.; Kelsoe, G.; Thompson, C.B. 1996: CD28 is required for germinal center formation. Journal of Immunology 156(12): 4576-4581
Van Gool, S.W.; de Boer, M.; Ceuppens, J.L. 1993: CD28 ligation by monoclonal antibodies or B7/BB1 provides an accessory signal for the cyclosporin A-resistant generation of cytotoxic T cell activity. Journal of Immunology 150(8 Pt 1): 3254-3263
Nunès, J.; Klasen, S.; Ragueneau, M.; Pavon, C.; Couez, D.; Mawas, C.; Bagnasco, M.; Olive, D. 1993: CD28 mAbs with distinct binding properties differ in their ability to induce T cell activation: analysis of early and late activation events. International Immunology 5(3): 311-315
Harhaj, E.W.; Maggirwar, S.B.; Good, L.; Sun, S.C. 1996: CD28 mediates a potent costimulatory signal for rapid degradation of IkappaBbeta which is associated with accelerated activation of various NF-kappaB/Rel heterodimers. Molecular and Cellular Biology 16(12): 6736-6743
Shapiro, V.S.; Truitt, K.E.; Imboden, J.B.; Weiss, A. 1997: CD28 mediates transcriptional upregulation of the interleukin-2 (IL-2) promoter through a composite element containing the CD28RE and NF-IL-2B AP-1 sites. Molecular and Cellular Biology 17(7): 4051-4058
August, A.; Dupont, B. 1994: CD28 of T lymphocytes associates with phosphatidylinositol 3-kinase. International Immunology 6(5): 769-774
Lu, Y.; Phillips, C.A.; Bjorndahl, J.M.; Trevillyan, J.M. 1994: CD28 signal transduction: tyrosine phosphorylation and receptor association of phosphoinositide-3 kinase correlate with Ca(2+)-independent costimulatory activity. European Journal of Immunology 24(11): 2732-2739
Akalin, E.; Chandraker, A.; Russell, M.E.; Turka, L.A.; Hancock, W.W.; Sayegh, M.H. 1996: CD28-B7 T cell costimulatory blockade by CTLA4Ig in the rat renal allograft model: inhibition of cell-mediated and humoral immune responses in vivo. Transplantation 62(12): 1942-1945
Sayegh, M.H.; Akalin, E.; Hancock, W.W.; Russell, M.E.; Carpenter, C.B.; Linsley, P.S.; Turka, L.A. 1995: CD28-B7 blockade after alloantigenic challenge in vivo inhibits Th1 cytokines but spares Th2. Journal of Experimental Medicine 181(5): 1869-1874
Khoury, S.J.; Akalin, E.; Chandraker, A.; Turka, L.A.; Linsley, P.S.; Sayegh, M.H.; Hancock, W.W. 1995: CD28-B7 costimulatory blockade by CTLA4Ig prevents actively induced experimental autoimmune encephalomyelitis and inhibits Th1 but spares Th2 cytokines in the central nervous system. Journal of Immunology 155(10): 4521-4524
Jones, L.A.; Izon, D.J.; Nieland, J.D.; Linsley, P.S.; Kruisbeek, A.M. 1993: CD28-B7 interactions are not required for intrathymic clonal deletion. International Immunology 5(5): 503-512
Amsen, D.; Kruisbeek, A.M. 1996: CD28-B7 interactions function to co-stimulate clonal deletion of double-positive thymocytes. International Immunology 8(12): 1927-1936
Sainio-Pöllänen, S.; Saari, T.; Simell, O.; Pöllänen, P. 1996: CD28-CD80/CD86 interactions in testicular immunoregulation. Journal of Reproductive Immunology 31(3): 145-163
Crooks, M.E.; Littman, D.R.; Carter, R.H.; Fearon, D.T.; Weiss, A.; Stein, P.H. 1995: CD28-mediated costimulation in the absence of phosphatidylinositol 3-kinase association and activation. Molecular and Cellular Biology 15(12): 6820-6828
Shi, Y.; Radvanyi, L.G.; Sharma, A.; Shaw, P.; Green, D.R.; Miller, R.G.; Mills, G.B. 1995: CD28-mediated signaling in vivo prevents activation-induced apoptosis in the thymus and alters peripheral lymphocyte homeostasis. Journal of Immunology 155(4): 1829-1837
King, C.L.; Xianli, J.; June, C.H.; Abe, R.; Lee, K.P. 1996: CD28-deficient mice generate an impaired Th2 response to Schistosoma mansoni infection. European Journal of Immunology 26(10): 2448-2455
Lu, Y.; Rodriguez, R.; Bjorndahl, J.; Phillips, C.A.; Trevillyan, J.M. 1996: CD28-dependent killing by human YT cells requires phosphatidylinositol 3-kinase activation. European Journal of Immunology 26(6): 1278-1284
Wu, Y.; Zhou, Q.; Zheng, P.; Liu, Y. 1998: CD28-independent induction of T helper cells and immunoglobulin class switches requires costimulation by the heat-stable antigen. Journal of Experimental Medicine 187(7): 1151-1156
Saoulli, K.; Lee, S.Y.; Cannons, J.L.; Yeh, W.C.; Santana, A.; Goldstein, M.D.; Bangia, N.; DeBenedette, M.A.; Mak, T.W.; Choi, Y.; Watts, T.H. 1998: CD28-independent, TRAF2-dependent costimulation of resting T cells by 4-1BB ligand. Journal of Experimental Medicine 187(11): 1849-1862
McArthur, J.G.; Raulet, D.H. 1993: CD28-induced costimulation of T helper type 2 cells mediated by induction of responsiveness to interleukin 4. Journal of Experimental Medicine 178(5): 1645-1653
Lahdenpohja, N.; Hurme, M. 1998: CD28-mediated activation in CD45RA+ and CD45RO+ T cells: enhanced levels of reactive oxygen intermediates and c-Rel nuclear translocation in CD45RA+ cells. Journal of Leukocyte Biology 63(6): 775-780
Siefken, R.; Kurrle, R.; Schwinzer, R. 1997: CD28-mediated activation of resting human T cells without costimulation of the CD3/TCR complex. Cellular Immunology 176(1): 59-65
Nandi, D.; Gross, J.A.; Allison, J.P. 1994: CD28-mediated costimulation is necessary for optimal proliferation of murine NK cells. Journal of Immunology 152(7): 3361-3369
Seder, R.A.; Germain, R.N.; Linsley, P.S.; Paul, W.E. 1994: CD28-mediated costimulation of interleukin 2 (IL-2) production plays a critical role in T cell priming for IL-4 and interferon gamma production. Journal of Experimental Medicine 179(1): 299-304
Teng, J.M.; Liu, X.R.; Mills, G.B.; Dupont, B. 1996: CD28-mediated cytotoxicity by the human leukemic NK cell line YT involves tyrosine phosphorylation, activation of phosphatidylinositol 3-kinase, and protein kinase C. Journal of Immunology 156(9): 3222-3232
Roger, R.; Bréard, J.; Comisso, M.; Bohuon, C.; Pallardy, M.; Bertoglio, J. 1996: CD28-mediated cytotoxicity of YT natural killer cells on B7-positive targets induces rapid necrotic death independent of granule exocytosis. Cellular Immunology 168(1): 24-32
Tacke, M.; Hanke, G.; Hanke, T.; Hünig, T. 1997: CD28-mediated induction of proliferation in resting T cells in vitro and in vivo without engagement of the T cell receptor: evidence for functionally distinct forms of CD28. European Journal of Immunology 27(1): 239-247
Herold, K.G.; Lenschow, D.J.; Bluestone, J.A. 1997: CD28/B7 regulation of autoimmune diabetes. Immunologic Research 16(1): 71-84
Fernández-Ruiz, E.; Somoza, C.; Sánchez-Madrid, F.; Lanier, L.L. 1995: CD28/CTLA-4 ligands: the gene encoding CD86 (B70/B7.2) maps to the same region as CD80 (B7/B7.1) gene in human chromosome 3q13-q23. European Journal of Immunology 25(5): 1453-1456
Champagne, E.; Scarpellino, L.; Lane, P.; Acha-Orbea, H. 1996: CD28/CTLA4-B7 interaction is dispensable for T cell stimulation by mouse mammary tumor virus superantigen but not for B cell differentiation and virus dissemination. European Journal of Immunology 26(7): 1595-1602
Witas, H., W.; Mylnarska, A.; Mlynarski, W.; Bodalski, J. 1998: CD28/CTLA4: Co-stimulatory signal of T cells activation. Postepy Biologii Komorki 25(1): 111-123
Ward, S.G. 1996: CD28: a signalling perspective. Biochemical Journal 318: 361-377
Turcovski-Corrales, S.M.; Fenton, R.G.; Peltz, G.; Taub, D.D. 1995: CD28:B7 interactions promote T cell adhesion. European Journal of Immunology 25(11): 3087-3093
Seymour, G.J.; Taubman, M.A.; Eastcott, J.W.; Gemmell, E.; Smith, D.J. 1997: CD29 expression on CD4+ gingival lymphocytes supports migration of activated memory T lymphocytes to diseased periodontal tissue. Oral Microbiology and Immunology 12(3): 129-134
Elenström-Magnusson, C.; Altevogt, P.; Severinson, E. 1993: CD2: a functional adhesion molecule on murine B cells, involved in interleukin-4-induced aggregation. European Journal of Immunology 23(4): 888-892
Alexander, D.R.; Brown, M.H.; Tutt, A.L.; Crumpton, M.J.; Shivnan, E. 1992: CD3 and CD2 antigen-mediated CD3 gamma-chain phosphorylation in permeabilized human T cells. Regulation by cytosolic phosphatases. Biochemical Journal 288: 69-77
Lin, J.; Qin, L.; Chavin, K.D.; Ding, Y.; Punch, J.D.; Yang, Q.; Burkly, L.C.; Bromberg, J.S. 1995: CD3 and CD2 ligation alters CD49d epitope expression. Pathobiology: Journal of Immunopathology Molecular and Cellular Biology 63(3): 119-132
Sevcíková, Z. 1997: CD3 cells in the intestine of broilers inoculated with intestinal homogenate. British Poultry Science 38(1): 55-58
Jacobs, H.; Vandeputte, D.; Tolkamp, L.; de Vries, E.; Borst, J.; Berns, A. 1994: CD3 components at the surface of pro-T cells can mediate pre-T cell development in vivo. European Journal of Immunology 24(4): 934-939
DeNofrio, D.; Radcliff, G.; Weinhold, K.J.; Denning, S.M. 1995: CD3 delta and epsilon gene expression in CD3-CD16+ natural killer cell clones derived from thymic precursors. Human Immunology 43(4): 283-294
Matsuda, M.; Maeda, Y.; Shirakawa, C.; Masaki, H.; Koyama, A.; Horiuchi, F.; Hamazaki, H.; Fujimoto, T.; Irimajiri, K.; Horiuchi, A. 1993: CD3 down-regulating factor in sera and culture supernatants of leukaemic cells from patients with adult T cell leukaemia. British Journal of Haematology 83(2): 212-217
Basson, M.A.; Bommhardt, U.; Cole, M.S.; Tso, J.Y.; Zamoyska, R. 1998: CD3 ligation on immature thymocytes generates antagonist-like signals appropriate for CD8 lineage commitment, independently of T cell receptor specificity. Journal of Experimental Medicine 187(8): 1249-1260
Breittmayer, J.P.; Berthe, P.; Cousin, J.L.; Bernard, A.; Aussel, C. 1993: CD3 monoclonal antibodies evoke the same cytochrome P450-regulated capacitative entry of calcium as thapsigargin in Jurkat T cells. Cellular Immunology 152(1): 143-151
Pulik, M.; Lionnet, F.; Genet, P.; Petitdidier, C.; Jary, L.; Fourcade, C. 1997: CD3+ CD8+ CD56- clonal large granular lymphocyte leukaemia and HIV infection. British Journal of Haematology 98(2): 444-445
Warzynski, M.J.; Barbour, S.D.; Winkler-Pickett, R.T.; Ortaldo, J.R. 1994: CD3+, CD56+ non-MHC restricted cytotoxic T lymphocytes in two fraternal AIDS patients: a case report. Cytometry 18(4): 231-236
Gentile, T.C.; Uner, A.H.; Hutchison, R.E.; Wright, J.; Ben-Ezra, J.; Russell, E.C.; Loughran, T.P. 1994: CD3+, CD56+ aggressive variant of large granular lymphocyte leukemia. Blood 84(7): 2315-2321
Husch, B.; Eibl, M.M.; Mannhalter, J.W. 1993: CD3, CD8 double-positive cells from HIV-1-infected chimpanzees show group-specific inhibition of HIV-1 replication. Aids Research and Human Retroviruses 9(5): 405-413
Corado, J.A.; Toro, F.I.; Baroja, M.L.; Bianco, N.E.; Machado, I.V. 1994: CD3- and CD28-activating pathways in HCV infection. Viral Immunology 7(1): 37-40
Multhoff, G.; Botzler, C.; Wiesnet, M.; Eissner, G.; Issels, R. 1995: CD3- large granular lymphocytes recognize a heat-inducible immunogenic determinant associated with the 72-kD heat shock protein on human sarcoma cells. Blood 86(4): 1374-1382
Wilczyński, J.; Sułowska, Z.; Malinowski, A.; Zeman, K.; Szpakowski, M.; Tchórzewski, H.; Podciechowski, L. 1997: CD3-/HLA-DR+, CD3+/HLA-DR+ cell levels and PHA stimulation of lymphocytes obtained from women with recurrent spontaneous abortions and subjected to partner's lymphocyte immunization. Archivum Immunologiae et Therapiae Experimentalis 45(4): 289-294
Small, M.; Weissman, I.L. 1996: CD3-4-8- thymocyte precursors with interleukin-2 receptors differentiate phenotypically in coculture with thymic stromal cells. Scandinavian Journal of Immunology 44(2): 115-121
Mazzoni, A.; Mezzanzanica, D.; Jung, G.; Wolf, H.; Colnaghi, M.I.; Canevari, S. 1996: CD3-CD28 costimulation as a means to avoiding T cell preactivation in bispecific monoclonal antibody-based treatment of ovarian carcinoma. Cancer Research 56(23): 5443-5449
Honda, J.; Okubo, Y.; Tanaka, K.; Kusaba, M.; Kumagai, M.; Saruwatari, N.; Oizumi, K. 1998: CD3-CD4-CD8-CD56-CD19-CD14- cells and CD3+CD8 dull-positive cells produce IL-4 in AIDS patients. British Journal of Haematology 101(1): 74-77
Lin, T.; Matsuzaki, G.; Yoshida, H.; Kobayashi, N.; Kenai, H.; Omoto, K.; Nomoto, K. 1994: CD3-CD8+ intestinal intraepithelial lymphocytes (IEL) and the extrathymic development of IEL. European Journal of Immunology 24(5): 1080-1087
Wang, B.; She, J.; Salio, M.; Allen, D.; Lacy, E.; Lonberg, N.; Terhorst, C. 1997: CD3-epsilon overexpressed in prothymocytes acts as an oncogene. Molecular Medicine 3(1): 72-81
Bianchi, A.; Montacchini, L.; Barral, P.; Borrione, P.; Attisano, C.; Orsini, E.; Boccadoro, M.; Pileri, A.; Massaia, M. 1995: CD3-induced T-cell activation in the bone marrow of myeloma patients: Major role of CD4+ cells. British Journal of Haematology 90(3): 625-632
Tokoro, Y.; Tsuda, S.; Tanaka, S.; Nakauchi, H.; Takahama, Y. 1996: CD3-induced apoptosis of CD4+CD8+ thymocytes in the absence of clonotypic T cell antigen receptor. European Journal of Immunology 26(5): 1012-1017
Conti, A.; Brando, C.; DeBell, K.E.; Alava, M.A.; Hoffman, T.; Bonvini, E. 1993: CD3-induced preferential hydrolysis of polyphosphoinositides and calcium regulation of inositol phosphate metabolism in a permeabilized murine T cell clone. Journal of Biological Chemistry 268(2): 783-791
Groux, H.; Monte, D.; Plouvier, B.; Capron, A.; Ameisen, J.C. 1993: CD3-mediated apoptosis of human medullary thymocytes and activated peripheral T cells: respective roles of interleukin-1, interleukin-2, interferon-gamma and accessory cells. European Journal of Immunology 23(7): 1623-1629
Fukunaga, Y.; Asano, T.; Takehana, J.; Ambo, K.; Matsuoka, K.; Yamamoto, M. 1994: CD3-negative lymphoproliferative disease of granular lymphocytes in a girl with an unusual pattern of anti-Epstein-Barr virus antibodies. European Journal of Pediatrics 153(12): 894-897
Manié, S.; Kubar, J.; Limouse, M.; Ferrua, B.; Ticchioni, M.; Breittmayer, J.P.; Peyron, J.F.; Schaffar, L.; Rossi, B. 1993: CD3-stimulated Jurkat T cells mediate IL-1 beta production in monocytic THP-1 cells. Role of LFA-1 molecule and participation of CD69 T cell antigen. European Cytokine Network 4(1): 7-13
Millward, C.; Weidner, N. 1998: CD30 (Ber-H2) expression in nonhematopoietic tumors. Applied Immunohistochemistry 6(3): 164-168
Takeshita, M.; Akamatsu, M.; Ohshima, K.; Kobari, S.; Kikuchi, M.; Suzumiya, J.; Uike, N.; Okamura, T. 1995: CD30 (Ki-1) expression in adult T-cell leukaemia/lymphoma is associated with distinctive immunohistological and clinical characteristics. Histopathology 26(6): 539-546
Falini, B.; Pileri, S.; Pizzolo, G.; Dürkop, H.; Flenghi, L.; Stirpe, F.; Martelli, M.F.; Stein, H. 1995: CD30 (Ki-1) molecule: a new cytokine receptor of the tumor necrosis factor receptor superfamily as a tool for diagnosis and immunotherapy. Blood 85(1): 1-14
Chadburn, A.; Cesarman, E.; Jagirdar, J.; Subar, M.; Mir, R.N.; Knowles, D.M. 1993: CD30 (Ki-1) positive anaplastic large cell lymphomas in individuals infected with the human immunodeficiency virus. Cancer 72(10): 3078-3090
Tirelli, U.; Vaccher, E.; Zagonel, V.; Talamini, R.; Bernardi, D.; Tavio, M.; Gloghini, A.; Merola, M.C.; Monfardini, S.; Carbone, A. 1995: CD30 (Ki-1)-positive anaplastic large-cell lymphomas in 13 patients with and 27 patients without human immunodeficiency virus infection: the first comparative clinicopathologic study from a single institution that also includes 80 patients with other human immunodeficiency virus-related systemic lymphomas. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 13(2): 373-380
Filippa, D.A.; Ladanyi, M.; Wollner, N.; Straus, D.J.; O'Brien, J.P.; Portlock, C.; Gangi, M.; Sun, M. 1996: CD30 (Ki-1)-positive malignant lymphomas: clinical, immunophenotypic, histologic, and genetic characteristics and differences with Hodgkin's disease. Blood 87(7): 2905-2917
Ross, C.W.; Hanson, C.A.; Schnitzer, B. 1992: CD30 (Ki-1)-positive, anaplastic large cell lymphoma mimicking gastrointestinal carcinoma. Cancer 70(10): 2517-2523
Pera, M.F.; Bennett, W.; Cerretti, D.P. 1998: CD30 and its ligands teratoma: Possible role in regulation of teratoma stem cells. APMIS 106(1): 169-173
Romagnani, S.; Del Prete, G.; Maggi, E.; Chilosi, M.; Caligaris-Cappio, F.; Pizzolo, G. 1995: CD30 and type 2 T helper (Th2) responses. Journal of Leukocyte Biology 57(5): 726-730
Segal, G.H.; Kjeldsberg, C.R.; Smith, G.P.; Perkins, S.L. 1994: CD30 antigen expression in florid immunoblastic proliferations. a clinicopathologic study of 14 cases. American Journal of Clinical Pathology 102(3): 292-298
Latza, U.; Foss, H.D.; Dürkop, H.; Eitelbach, F.; Dieckmann, K.P.; Loy, V.; Unger, M.; Pizzolo, G.; Stein, H. 1995: CD30 antigen in embryonal carcinoma and embryogenesis and release of the soluble molecule. American Journal of Pathology 146(2): 463-471
Smith, C.A.; Gruss, H.J.; Davis, T.; Anderson, D.; Farrah, T.; Baker, E.; Sutherland, G.R.; Brannan, C.I.; Copeland, N.G.; Jenkins, N.A. 1993: CD30 antigen, a marker for Hodgkin's lymphoma, is a receptor whose ligand defines an emerging family of cytokines with homology to TNF. Cell 73(7): 1349-1360
Chilosi, M.; Facchetti, F.; Notarangelo, L.D.; Romagnani, S.; Del Prete, G.; Almerigogna, F.; De Carli, M.; Pizzolo, G. 1996: CD30 cell expression and abnormal soluble CD30 serum accumulation in Omenn's syndrome: evidence for a T helper 2-mediated condition. European Journal of Immunology 26(2): 329-334
Gedrich, R.W.; Gilfillan, M.C.; Duckett, C.S.; Van Dongen, J.L.; Thompson, C.B. 1996: CD30 contains two binding sites with different specificities for members of the tumor necrosis factor receptor-associated factor family of signal transducing proteins. Journal of Biological Chemistry 271(22): 12852-12858
Alzona, M.; Jäck, H.M.; Fisher, R.I.; Ellis, T.M. 1994: CD30 defines a subset of activated human T cells that produce IFN-gamma and IL-5 and exhibit enhanced B cell helper activity. Journal of Immunology 153(7): 2861-2867
Miettinen, M. 1992: CD30 distribution. Immunohistochemical study on formaldehyde-fixed, paraffin-embedded Hodgkin's and non-Hodgkin's lymphomas. Archives of Pathology and Laboratory Medicine 116(11): 1197-1201
Manetti, R.; Annunziato, F.; Biagiotti, R.; Giudizi, M.G.; Piccinni, M.P.; Giannarini, L.; Sampognaro, S.; Parronchi, P.; Vinante, F.; Pizzolo, G.; Maggi, E.; Romagnani, S. 1994: CD30 expression by CD8+ T cells producing type 2 helper cytokines. Evidence for large numbers of CD8+CD30+ T cell clones in human immunodeficiency virus infection. Journal of Experimental Medicine 180(6): 2407-2411
Hamann, D.; Hilkens, C.M.; Grogan, J.L.; Lens, S.M.; Kapsenberg, M.L.; Yazdanbakhsh, M.; van Lier, R.A. 1996: CD30 expression does not discriminate between human Th1- and Th2-type T cells. Journal of Immunology 156(4): 1387-1391
Martinez, O.M.; Villanueva, J.; Abtahi, S.; Beatty, P.R.; Esquivel, C.O.; Krams, S.M. 1998: CD30 expression identifies a functional alloreactive human T-lymphocyte subset. Transplantation 65(9): 1240-1247
de Bruin, P.C.; Gruss, H.J.; van der Valk, P.; Willemze, R.; Meijer, C.J. 1995: CD30 expression in normal and neoplastic lymphoid tissue: biological aspects and clinical implications. Leukemia 9(10): 1620-1627
Hittmair, A.; Rogatsch, H.; Hobisch, A.; Mikuz, G.; Feichtinger, H. 1996: CD30 expression in seminoma. Human Pathology 27(11): 1166-1171
Cerutti, A.; Schaffer, A.; Shah, S.; Zan, H.; Liou, H.C.; Goodwin, R.G.; Casali, P. 1998: CD30 is a CD40-inducible molecule that negatively regulates CD40-mediated immunoglobulin class switching in non-antigen-selected human B cells. Immunity 9(2): 247-256
Gruss, H.J.; Pinto, A.; Gloghini, A.; Wehnes, E.; Wright, B.; Boiani, N.; Aldinucci, D.; Gattei, V.; Zagonel, V.; Smith, C.A.; Kadin, M.E.; von Schilling, C.; Goodwin, R.G.; Herrmann, F.; Carbone, A. 1996: CD30 ligand expression in nonmalignant and Hodgkin's disease-involved lymphoid tissues. American Journal of Pathology 149(2): 469-481
Younes, A.; Consoli, U.; Snell, V.; Clodi, K.; Kliche, K.O.; Palmer, J.L.; Gruss, H.J.; Armitage, R.; Thomas, E.K.; Cabanillas, F.; Andreeff, M. 1997: CD30 ligand in lymphoma patients with CD30+ tumors. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 15(11): 3355-3362
Younes, A.; Consoli, U.; Zhao, S.; Snell, V.; Thomas, E.; Gruss, H.J.; Cabanillas, F.; Andreeff, M. 1996: CD30 ligand is expressed on resting normal and malignant human B lymphocytes. British Journal of Haematology 93(3): 569-571
Gattei, V.; Degan, M.; Gloghini, A.; De Iuliis, A.; Improta, S.; Rossi, F.M.; Aldinucci, D.; Perin, V.; Serraino, D.; Babare, R.; Zagonel, V.; Gruss, H.J.; Carbone, A.; Pinto, A. 1997: CD30 ligand is frequently expressed in human hematopoietic malignancies of myeloid and lymphoid origin. Blood 89(6): 2048-2059
Wendtner, C.M.; Schmitt, B.; Gruss, H.J.; Druker, B.J.; Emmerich, B.; Goodwin, R.G.; Hallek, M. 1995: CD30 ligand signal transduction involves activation of a tyrosine kinase and of mitogen-activated protein kinase in a Hodgkin's lymphoma cell line. Cancer Research 55(18): 4157-4161
Gomez, R.S.; de Souza, P.E.; da Costa, J.E.; Araújo, N.S. 1997: CD30+ lymphocytes in chronic gingivitis from HIV-positive patients: a pilot study. Journal of Periodontology 68(9): 881-883
Pohl, C.; Denfeld, R.; Renner, C.; Jung, W.; Bohlen, H.; Sahin, U.; Hombach, A.; van Lier, R.; Schwonzen, M.; Diehl, V. 1993: CD30-antigen-specific targeting and activation of T cells via murine bispecific monoclonal antibodies against CD3 and CD28: Potential use for the treatment of Hodgkin's lymphoma. International Journal of Cancer 54(5): 820-827
Duckett, C.S.; Thompson, C.B. 1997: CD30-dependent degradation of TRAF2: implications for negative regulation of TRAF signaling and the control of cell survival. Genes and Development 11(21): 2810-2821
Del Prete, G.; De Carli, M.; D'Elios, M.M.; Daniel, K.C.; Almerigogna, F.; Alderson, M.; Smith, C.A.; Thomas, E.; Romagnani, S. 1995: CD30-mediated signaling promotes the development of human T helper type 2-like T cells. Journal of Experimental Medicine 182(6): 1655-1661
Tsutsuml, Y.; Nakamura, M.; Machimura, T. 1996: CD30-positive T cell lymphoma of the intestine, complicating ulcerative colitis. Pathology International 46(5): 384-388
Takeshita, M.; Ohshima, K.; Akamatsu, M.; Ohgami, A.; Kikuchi, M.; Suzumiya, J.; Uike, N.; Okamura, T.; Nakayama, J. 1995: CD30-positive anaplastic large cell lymphoma in a human T-cell lymphotropic virus-I endemic area. Human Pathology 26(6): 614-619
Nakagawa, A.; Nakamura, S.; Ito, M.; Shiota, M.; Mori, S.; Suchi, T. 1997: CD30-positive anaplastic large cell lymphoma in childhood: expression of p80npm/alk and absence of Epstein-Barr virus. Modern Pathology: An Official Journal of the United States and Canadian Academy of Pathology Inc 10(3): 210-215
Macgrogan, G.; Vergier, B.; Dubus, P.; Beylot-Barry, M.; Belleannee, G.; Delaunay, M.M.; Eghbali, H.; Beylot, C.; Rivel, J.; Trojani, M.; Vital, C.; De Mascarel, A.; Bloch, B.; Merlio, J.P. 1996: CD30-positive cutaneous large cell lymphomas. A comparative study of clinicopathologic and molecular features of 16 cases. American Journal of Clinical Pathology 105(4): 440-450
Hori, M.; Mitsuhashi, S.; Kobayashi, T.; Nagasawa, T.; Mori, N.; Miwa, M.; Abe, T. 1994: CD30-positive lymphoma in human T-cell leukaemia virus type 1 carrier without monoclonal integration of HTLV-1. British Journal of Haematology 88(2): 419-420
Perkins, P.L.; Ross, C.W.; Schnitzer, B. 1992: CD30-positive, anaplastic large-cell lymphomas that express CD15 but lack CD45. a possible diagnostic pitfall. Archives of Pathology and Laboratory Medicine 116(11): 1192-1196
Telford, W.G.; Nam, S.Y.; Podack, E.R.; Miller, R.A. 1997: CD30-regulated apoptosis in murine CD8 T cells after cessation of TCR signals. Cellular Immunology 182(2): 125-136
Pohl, C.; Renner, C.; Schwonzen, M.; Schobert, I.; Liebenberg, V.; Jung, W.; Wolf, J.; Pfreundschuh, M.; Diehl, V. 1993: CD30-specific AB1-AB2-AB3 internal image antibody network: Potential use as anti-idiotype vaccine against Hodgkin's lymphoma. International Journal of Cancer 54(3): 418-425
Govender, D.; Harilal, P.; Dada, M.; Chetty, R. 1997: CD31 (JC70) expression in plasma cells: an immunohistochemical analysis of reactive and neoplastic plasma cells. Journal of Clinical Pathology 50(6): 490-493
Demeure, C.E.; Byun, D.G.; Yang, L.P.; Vezzio, N.; Delespesse, G. 1996: CD31 (PECAM-1) is a differentiation antigen lost during human CD4 T-cell maturation into Th1 or Th2 effector cells. Immunology 88(1): 110-115
Charpin, C.; Devictor, B.; Bergeret, D.; Andrac, L.; Boulat, J.; Horschowski, N.; Lavaut, M.N.; Piana, L. 1995: CD31 quantitative immunocytochemical assays in breast carcinomas. Correlation with current prognostic factors. American Journal of Clinical Pathology 103(4): 443-448
De Young, B.R.; Frierson, H.F.; Ly, M.N.; Smith, D.; Swanson, P.E. 1998: CD31 immunoreactivity in carcinomas and mesotheliomas. American Journal of Clinical Pathology 110(3): 374-377
DeYoung, B.R.; Swanson, P.E.; Argenyi, Z.B.; Ritter, J.H.; Fitzgibbon, J.F.; Stahl, D.J.; Hoover, W.; Wick, M.R. 1995: CD31 immunoreactivity in mesenchymal neoplasms of the skin and subcutis: Report of 145 cases and review of putative immunohistologic markers of endothelial differentiation. Journal of Cutaneous Pathology 22(3): 215-222
Aubert, V.D.; Béné, M.C.; Leclère, J.; Faure, G.C. 1995: CD31, CD62E, and CD62P identify a specific pattern of endothelial activation in Graves' disease. Clinical Immunology and Immunopathology 76(2): 170-179
Poggi, A.; Panzeri, M.C.; Moretta, L.; Zocchi, M.R. 1996: CD31-triggered rearrangement of the actin cytoskeleton in human natural killer cells. European Journal of Immunology 26(4): 817-824
Charpin, C.; Garcia, S.; Bouvier, C.; Martini, F.; Andrac, L.; Bonnier, P.; Lavaut, M.N.; Allasia, C. 1997: CD31/PECAM automated and quantitative immunocytochemical assays in breast carcinomas: correlation with patient follow-up. American Journal of Clinical Pathology 107(5): 534-541
Zocchi, M.R.; Ferrero, E.; Leone, B.E.; Rovere, P.; Bianchi, E.; Toninelli, E.; Pardi, R. 1996: CD31/PECAM-1-driven chemokine-independent transmigration of human T lymphocytes. European Journal of Immunology 26(4): 759-767
Hara, J.; Hosoi, G.; Okamura, T.; Osugi, Y.; Ishihara, S.; Yumura-Yagi, K.; Kawa-Ha, K.; Tawa, A. 1995: CD33+ B-cell precursor acute lymphoblastic leukemia in children: a distinct subgroup of B-cell precursor acute lymphoblastic leukemia. International Journal of Hematology 61(2): 77-84
Hirayama, Y.; Kohgo, Y.; Kanisawa, Y.; Fujii, S.; Ikeda, K.; Matsunaga, T.; Ito, Y.; Sakamaki, S.; Niitsu, Y. 1993: CD33, CD4-double positive blastic transformation in a patient with chronic myelogenous leukemia. International Journal of Hematology 57(3): 265-268
Goldblum, J.R. 1995: CD34 positivity in fibrosarcomas which arise in dermatofibrosarcoma protuberans. Archives of Pathology and Laboratory Medicine 119(3): 238-241
Nadali, G.; de Wynter, E.A.; Testa, N.G. 1995: CD34 cell separation: From basic research to clinical applications. International Journal of Clinical and Laboratory Research 25(3): 121-127
Contino, R.; Cassano, N.; Rossini, M.; D'argento, V.; Filotico, R.; Labriola, A.; Vena, G.A. 1997: CD34 expression and chronic idiopathic urticaria. International Journal of Immunopathology and Pharmacology 10(1): 63-64
Krause, D.S.; Mucenski, M.L.; Lawler, A.M.; May, W.S. 1998: CD34 expression by embryonic hematopoietic and endothelial cells does not require c-Myb. Experimental Hematology 26(11): 1086-1092
van de Rijn, M.; Hendrickson, M.R.; Rouse, R.V. 1994: CD34 expression by gastrointestinal tract stromal tumors. Human Pathology 25(8): 766-771
Hasegawa, T.; Yang, P.; Kagawa, N.; Hirose, T.; Sano, T. 1997: CD34 expression by inflammatory fibroid polyps of the stomach. Modern Pathology: An Official Journal of the United States and Canadian Academy of Pathology Inc 10(5): 451-456
Ciolli, S.; Leoni, F.; Caporale, R.; Pascarella, A.; Salti, F.; Rossi-Ferrini, P. 1993: CD34 expression fails to predict the outcome in adult acute myeloid leukemia. Haematologica 78(3): 151-155
Maeda, T.; Adachi, E.; Kajiyama, K.; Takenaka, K.; Honda, H.; Sugimachi, K.; Tsuneyoshi, M. 1995: CD34 expression in endothelial cells of small hepatocellular carcinoma: Its correlation with tumour progression and angiographic findings. Journal of Gastroenterology and Hepatology 10(6): 650-654
Thomas, X.; Archimbaud, E.; Charrin, C.; Magaud, J.P.; Fiere, D. 1995: CD34 expression is associated with major adverse prognostic factors in adult acute lymphoblastic leukemia. Leukemia 9(2): 249-253
Delia, D.; Lampugnani, M.G.; Resnati, M.; Dejana, E.; Aiello, A.; Fontanella, E.; Soligo, D.; Pierotti, M.A.; Greaves, M.F. 1993: CD34 expression is regulated reciprocally with adhesion molecules in vascular endothelial cells in vitro. Blood 81(4): 1001-1008
Wood, H.B.; May, G.; Healy, L.; Enver, T.; Morriss-Kay, G.M. 1997: CD34 expression patterns during early mouse development are related to modes of blood vessel formation and reveal additional sites of hematopoiesis. Blood 90(6): 2300-2311
Monihan, J.M.; Carr, N.J.; Sobin, L.H. 1994: CD34 immunoexpression in stromal tumours of the gastrointestinal tract and in mesenteric fibromatoses. Histopathology 25(5): 469-473
Bettencourt, M.C.; Bauer, J.J.; Sesterhenn, I.A.; Connelly, R.R.; Moul, J.W. 1998: CD34 immunohistochemical assessment of angiogenesis as a prognostic marker for prostate cancer recurrence after radical prostatectomy. Journal of Urology 160(2): 459-465
Soligo, D.A.; Oriani, A.; Annaloro, C.; Cortelezzi, A.; Calori, R.; Pozzoli, E.; Nosella, D.; Orazi, A.; Deliliers, G.L. 1994: CD34 immunohistochemistry of bone marrow biopsies: Prognostic significance in primary myelodysplastic syndromes. American Journal of Hematology 46(1): 9-17
Prieto, V.G.; Reed, J.A.; Shea, C.R. 1994: CD34 immunoreactivity distinguishes between scar tissue and residual tumor in re-excisional specimens of dermatofibrosarcoma protuberans. Journal of Cutaneous Pathology 21(4): 324-329
Chaubal, A.; Paetau, A.; Zoltick, P.; Miettinen, M. 1994: CD34 immunoreactivity in nervous system tumors. Acta Neuropathologica 88(5): 454-458
Orazi, A.; Neiman, R.S.; Cualing, H.; Heerema, N.A.; John, K. 1994: CD34 immunostaining of bone marrow biopsy specimens is a reliable way to classify the phases of chronic myeloid leukemia. American Journal of Clinical Pathology 101(4): 426-428
Laughlin, M.J.; Christiansen, N.P.; Herzig, G.P.; Blumenson, L.; Bonney, D.; Stewart, C.C. 1996: CD34 progenitor cell subset analyses in normal human bone marrow and marrow harvested after intermediate-dose chemotherapy. Cytometry 26(4): 235-242
Fruehauf, S.; Haas, R.; Zeller, W.J.; Hunstein, W. 1994: CD34 selection for purging in multiple myeloma and analysis of CD34+ B cell precursors. Stem Cells 12(1): 95-102
Willems, P.; Croockewit, A.; Raymakers, R.; Holdrinet, R.; Van Der Bosch, G.; Huys, E.; Mensink, E. 1996: CD34 selections from myeloma peripheral blood cell autografts contain residual tumour cells due to impurity, not to CD34+ myeloma cells. British Journal of Haematology 93(3): 613-622
Kirchmann, T.T.; Prieto, V.G.; Smoller, B.R. 1994: CD34 staining pattern distinguishes basal cell carcinoma from trichoepithelioma. Archives of Dermatology 130(5): 589-592
Mavroudis, D.; Read, E.; Cottler-Fox, M.; Couriel, D.; Molldrem, J.; Carter, C.; Yu, M.; Dunbar, C.; Barrett, J. 1996: CD34+ cell dose predicts survival, posttransplant morbidity, and rate of hematologic recovery after allogeneic marrow transplants for hematologic malignancies. Blood 88(8): 3223-3229
Warren, M.K.; Rose, W.L.; Beall, L.D.; Cone, J. 1995: CD34+ cell expansion and expression of lineage markers during liquid culture of human progenitor cells. Stem Cells 13(2): 167-174
Kanold, J.; Berger, M.; Rapatel, C.; de Lumley, L.; Lutz, P.; Plantaz, D.; Vannier, J.P.; Bergeron, C.; Mechinaud, F.; Favrot, M. 1995: CD34+ cell immunoselection from G-CSF-alone-primed peripheral blood in children with low body mass. British Journal of Haematology 91(2): 431-433
Silvestri, F.; Banavali, S.; Savignano, C.; Preisler, H.D.; Baccarani, M. 1993: CD34+ cell selection: focus on immunomagnetic beads and chymopapain. International Journal of Artificial Organs 16 Suppl. 5: 96-101
Szczepek, A.J.; Bergsagel, P.L.; Axelsson, L.; Brown, C.B.; Belch, A.R.; Pilarski, L.M. 1997: CD34+ cells in the blood of patients with multiple myeloma express CD19 and IgH mRNA and have patient-specific IgH VDJ gene rearrangements. Blood 89(5): 1824-1833
Benedetti, F. 1996: CD34+ cells: biological aspects. Tumori 82(2 Suppl): S3-S13
Fennie, C.; Cheng, J.; Dowbenko, D.; Young, P.; Lasky, L.A. 1995: CD34+ endothelial cell lines derived from murine yolk sac induce the proliferation and differentiation of yolk sac CD34+ hematopoietic progenitors. Blood 86(12): 4454-4467
Caux, C.; Massacrier, C.; Vanbervliet, B.; Dubois, B.; Durand, I.; Cella, M.; Lanzavecchia, A.; Banchereau, J. 1997: CD34+ hematopoietic progenitors from human cord blood differentiate along two independent dendritic cell pathways in response to granulocyte-macrophage colony-stimulating factor plus tumor necrosis factor alpha: II. Functional analysis. Blood 90(4): 1458-1470
Wickenhauser, C.; Thiele, J.; Drebber, U.; Kvasnicka, H.M.; Thiel, A.; Schmitz, B.; Hansmann, M.L.; Fischer, R. 1995: CD34+ human hemopoietic progenitor cells of the bone marrow differ from those of the peripheral blood: an immunocytochemical and morphometric study. Acta Haematologica 93(2-4): 83-90
Kawashima, I.; Zanjani, E.D.; Almaida-Porada, G.; Flake, A.W.; Zeng, H.; Ogawa, M. 1996: CD34+ human marrow cells that express low levels of Kit protein are enriched for long-term marrow-engrafting cells. Blood 87(10): 4136-4142
Winslow, J.M.; Liesveld, J.L.; Ryan, D.H.; Dipersio, J.F.; Abboud, C.N. 1994: CD34+ progenitor cell isolation from blood and marrow: a comparison of techniques for small-scale selection. Bone Marrow Transplantation 14(2): 265-271
Yasui, M.; Park, Y.D.; Okamura, T.; Chayama, K.; Yoshimoto, T.; Inoue, M.; Yagi, K.; Kawa, K. 1998: CD34+ progenitor cell transplantation from two HLA-mismatched healthy fathers to two infants with severe aplastic anemia. International Journal of Hematology 67(1): 15-22
Neal, T.F.; Holland, H.K.; Baum, C.M.; Villinger, F.; Ansari, A.A.; Saral, R.; Wingard, J.R.; Fleming, W.H. 1995: CD34+ progenitor cells from asymptomatic patients are not a major reservoir for human immunodeficiency virus-1. Blood 86(5): 1749-1756
Collins, R.H. 1994: CD34+ selected cells in clinical transplantation. Stem Cells 12(6): 577-585
Aiba, S.; Tabata, N.; Ohtani, H.; Tagami, H. 1994: CD34+ spindle-shaped cells selectively disappear from the skin lesion of scleroderma. Archives of Dermatology 130(5): 593-597
Johnsen, H.E.; Rasmussen, T.; Knudsen, L.M. 1998: CD34+ subset and tumor cell quantitation by flow cytometry--step toward quality assessment of autografts in B cell malignancies. Vox Sanguinis 74(Suppl): 477-482
Lu, L.; Ge, Y.; Li, Z.H.; Freie, B.; Clapp, D.W.; Broxmeyer, H.E. 1995: CD34 stem/progenitor cells purified from cryopreserved normal cord blood can be transduced with high efficiency by a retroviral vector and expanded ex vivo with stable integration and expression of Fanconi anemia complementation C gene. Cell Transplantation 4(5): 493-503
Verfaillie, C.M.; Miller, J.S. 1994: CD34+/CD33- cells reselected from macrophage inflammatory protein 1 alpha+interleukin-3--supplemented "stroma-noncontact" cultures are highly enriched for long-term bone marrow culture initiating cells. Blood 84(5): 1442-1449
Res, P.; Martínez-Cáceres, E.; Cristina Jaleco, A.; Staal, F.; Noteboom, E.; Weijer, K.; Spits, H. 1996: CD34+CD38dim cells in the human thymus can differentiate into T, natural killer, and dendritic cells but are distinct from pluripotent stem cells. Blood 87(12): 5196-5206
Huss, R.; Guenther, W.; Schumm, M.; Ottinger, H.; Grosse Wilde, H.; Kolb, H.J. 1997: CD34-Negative hematopoietic stem cells isolated from human peripheral blood cells as ultimate precursors of hematopoietic progenitors. Infusionstherapie und Transfusionmedizin 24(6): 404-409
Suzuki, A.; Andrew, D.P.; Gonzalo, J.A.; Fukumoto, M.; Spellberg, J.; Hashiyama, M.; Takimoto, H.; Gerwin, N.; Webb, I.; Molineux, G.; Amakawa, R.; Tada, Y.; Wakeham, A.; Brown, J.; McNiece, I.; Ley, K.; Butcher, E.C.; Suda, T.; Gutierrez-Ramos, J.C.; Mak, T.W. 1996: CD34-deficient mice have reduced eosinophil accumulation after allergen exposure and show a novel crossreactive 90-kD protein. Blood 87(9): 3550-3562
Schmitt, C.; Ktorza, S.; Sarun, S.; Blanc, C.; De Jong, R.; Debre, P. 1993: CD34-expressing human thymocyte precursors proliferate in response to interleukin-7 but have lost myeloid differentiation potential. Blood 82(12): 3675-3685
Komeno, T.; Ninomiya, H.; Itoh, T.; Hasegawa, Y.; Kobayashi, T.; Mori, N.; Nagasawa, T.; Abe, T. 1995: CD34-positive blastoma in a patient with idiopathic myelofibrosis. Internal Medicine 34(10): 1035-1037
Silvestri, F.; Banavali, S.; Yin, M.; Gopal, V.; Savignano, C.; Baccarani, M.; Preisler, H.D. 1992: CD34-positive cell selection by immunomagnetic beads and chymopapain. Haematologica 77(4): 307-310
Alcorn, M.J.; Holyoake, T.L.; Richmond, L.; Pearson, C.; Farrell, E.; Kyle, B.; Dunlop, D.J.; Fitzsimons, E.; Steward, W.P.; Pragnell, I.B.; Franklin, I.M. 1996: CD34-positive cells isolated from cryopreserved peripheral-blood progenitor cells can be expanded ex vivo and used for transplantation with little or no toxicity. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 14(6): 1839-1847
Ktorza, S.; Sarun, S.; Rieux-Laucat, F.; de Villartay, J.P.; Debré, P.; Schmitt, C. 1995: CD34-positive early human thymocytes: T cell receptor and cytokine receptor gene expression. European Journal of Immunology 25(9): 2471-2478
Pursley, H.G.; Williford, P.M.; Groben, P.A.; White, W.L. 1998: CD34-positive eruptive fibromas. Journal of Cutaneous Pathology 25(2): 122-125
Hillyer, C.D.; Lackeyi, D.A.I.; Hart, K.K.; Stempora, L.L.; Bray, R.A.; Bender, J.G.; Donnenberg, A.D. 1993: CD34-positive progenitors and colony-forming units-granulocyte macrophage are recruited during large-volume leukapheresis and concentrated by counterflow centrifugal elutriation. Transfusion 33(4): 316-321
Shea, C.R.; Salob, S.; Reed, J.A.; Lugo, J.; McNutt, N.S. 1996: CD34-reactive fibrous papule of the nose. Journal of the American Academy of Dermatology 35(2 Pt 2): 342-345
Krause, D.S.; Fackler, M.J.; Civin, C.I.; May, W.S. 1996: CD34: structure, biology, and clinical utility. Blood 87(1): 1-13
Gomez, R.S.; Pelka, M.; Johannessen, A.C.; Hornstein, O.P.; von den Driesch, P. 1997: CD36 (OKM5) antigen expression on human mucosal epithelia is associated with keratinization type. Journal of Dermatology 24(7): 435-440
Okamoto, F.; Tanaka, T.; Sohmiya, K.; Kawamura, K. 1998: CD36 abnormality and impaired myocardial long-chain fatty acid uptake in patients with hypertrophic cardiomyopathy. Japanese Circulation Journal 62(7): 499-504
Borzini, P.; Riva, M.; Nembri, P.; Rossi, E.; Pagliaro, P.; Vergani, P.; Greppi, P.; Tantardini, P. 1997: CD36 autoantibodies and thrombotic diathesis, thrombocytopenia and repeated early fetal losses. Vox Sanguinis 73(1): 46-48
Sparrow, J.R.; Ryeom, S.W.; Abumrad, N.A.; Ibrahimi, A.; Silverstein, R.L. 1997: CD36 expression is altered in retinal pigment epithelial cells of the RCS rat. Experimental Eye Research 64(1): 45-56
Thorne, R.F.; Meldrum, C.J.; Harris, S.J.; Dorahy, D.J.; Shafren, D.R.; Berndt, M.C.; Burns, G.F.; Gibson, P.G. 1997: CD36 forms covalently associated dimers and multimers in platelets and transfected COS-7 cells. Biochemical and Biophysical Research Communications 240(3): 812-818
Ren, Y.; Silverstein, R.L.; Allen, J.; Savill, J. 1995: CD36 gene transfer confers capacity for phagocytosis of cells undergoing apoptosis. Journal of Experimental Medicine 181(5): 1857-1862
Huh, H.Y.; Lo, S.K.; Yesner, L.M.; Silverstein, R.L. 1995: CD36 induction on human monocytes upon adhesion to tumor necrosis factor-activated endothelial cells. Journal of Biological Chemistry 270(11): 6267-6271
Endemann, G.; Stanton, L.W.; Madden, K.S.; Bryant, C.M.; White, R.T.; Protter, A.A. 1993: CD36 is a receptor for oxidized low density lipoprotein. Journal of Biological Chemistry 268(16): 11811-11816
Tao, N.; Wagner, S.J.; Lublin, D.M. 1996: CD36 is palmitoylated on both N- and C-terminal cytoplasmic tails. Journal of Biological Chemistry 271(37): 22315-22320
Magnetto, S.; Bruno-Bossio, G.; Voland, C.; Lecerf, J.; Lawler, J.; Delmas, P.; Silverstein, R.; Clezardin, P. 1998: CD36 mediates binding of soluble thrombospondin-1 but not cell adhesion and haptotaxis on immobilized thrombospondin-1. Cell Biochemistry and Function 16(3): 211-221
Dawson, D.W.; Pearce, S.F.; Zhong, R.; Silverstein, R.L.; Frazier, W.A.; Bouck, N.P. 1997: CD36 mediates the In vitro inhibitory effects of thrombospondin-1 on endothelial cells. Journal of Cell Biology 138(3): 707-717
Ryeom, S.W.; Sparrow, J.R.; Silverstein, R.L. 1996: CD36 participates in the phagocytosis of rod outer segments by retinal pigment epithelium. Journal of Cell Science 109: 387-395
Rouabhia, M.; Jobin, N.; Doucet, R.; Bergeron, J.; Auger, F.A. 1994: CD36(+)-dendritic epidermal cells: a putative actor in the cutaneous immune system. Cell Transplantation 3(6): 529-536
Browne, P.V.; Hebbel, R.P. 1996: CD36-positive stress reticulocytosis in sickle cell anemia. Journal of Laboratory and Clinical Medicine 127(4): 340-347
De Flora, A.; Guida, L.; Franco, L.; Zocchi, E.; Bruzzone, S.; Benatti, U.; Damonte, G.; Lee, H.C. 1997: CD38 and ADP-ribosyl cyclase catalyze the synthesis of a dimeric ADP-ribose that potentiates the calcium-mobilizing activity of cyclic ADP-ribose. Journal of Biological Chemistry 272(20): 12945-12951
Zupo, S.; Isnardi, L.; Megna, M.; Massara, R.; Malavasi, F.; Dono, M.; Cosulich, E.; Ferrarini, M. 1996: CD38 expression distinguishes two groups of B-cell chronic lymphocytic leukemias with different responses to anti-IgM antibodies and propensity to apoptosis. Blood 88(4): 1365-1374
Perfetto, S.P.; Malone, J.D.; Hawkes, C.; Mccrary, G.; August, B.; Zhou, S.; Garner, R.; Dolan, M.J.; Brown, A.E. 1998: CD38 expression on cryopreserved CD8+ T cells predicts HIV disease progression. Cytometry 33(2): 133-137
Morra, M.; Zubiaur, M.; Terhorst, C.; Sancho, J.; Malavasi, F. 1998: CD38 is functionally dependent on the TCR/CD3 complex in human T cells. FASEB Journal 12(7): 581-592
Ausiello, C.M.; Urbani, F.; la Sala, A.; Funaro, A.; Malavasi, F. 1995: CD38 ligation induces discrete cytokine mRNA expression in human cultured lymphocytes. European Journal of Immunology 25(5): 1477-1480
Kikuchi, Y.; Yasue, T.; Miyake, K.; Kimoto, M.; Takatsu, K. 1995: CD38 ligation induces tyrosine phosphorylation of Bruton tyrosine kinase and enhanced expression of interleukin 5-receptor alpha chain: synergistic effects with interleukin 5. Proceedings of the National Academy of Sciences of the United States of America 92(25): 11814-11818
Silvennoinen, O.; Nishigaki, H.; Kitanaka, A.; Kumagai, M.; Ito, C.; Malavasi, F.; Lin, Q.; Conley, M.E.; Campana, D. 1996: CD38 signal transduction in human B cell precursors. Rapid induction of tyrosine phosphorylation, activation of syk tyrosine kinase, and phosphorylation of phospholipase C-gamma and phosphatidylinositol 3-kinase. Journal of Immunology 156(1): 100-107
Zupo, S.; Rugari, E.; Dono, M.; Taborelli, G.; Malavasi, F.; Ferrarini, M. 1994: CD38 signaling by agonistic monoclonal antibody prevents apoptosis of human germinal center B cells. European Journal of Immunology 24(5): 1218-1222
Liu, J.H.; Zhang, Q.; Shi, Y.F.; Zeng, X.S.; Wang, X.H.; Li, J.; Chen, Z.; Shen, D.C. 1993: CD38- and Leu6-positive cells in dermal lesions of mycosis fungoides. Chinese Medical Journal 106(5): 370-371
Kitanaka, A.; Ito, C.; Nishigaki, H.; Campana, D. 1996: CD38-mediated growth suppression of B-cell progenitors requires activation of phosphatidylinositol 3-kinase and involves its association with the protein product of the c-cbl proto-oncogene. Blood 88(2): 590-598
Grimaldi, J.C.; Balasubramanian, S.; Kabra, N.H.; Shanafelt, A.; Bazan, J.F.; Zurawski, G.; Howard, M.C. 1995: CD38-mediated ribosylation of proteins. Journal of Immunology 155(2): 811-817
Wang, T.F.; Guidotti, G. 1996: CD39 is an ecto-(Ca2+,Mg2+)-apyrase. Journal of Biological Chemistry 271(17): 9898-9901
Gemignani, M.; Maiman, M.; Fruchter, R.G.; Arrastia, C.D.; Gibbon, D.; Ellison, T. 1995: CD4 lymphocytes in women with invasive and preinvasive cervical neoplasia. Gynecologic Oncology 59(3): 364-369
Theodore, A.C.; Kornfeld, H.; Wallace, R.P.; Cruikshank, W.W. 1994: CD4 modulation of noninfected human T lymphocytes by HIV-1 envelope glycoprotein gp120: contribution to the immunosuppression seen in HIV-1 infection by induction of CD4 and CD3 unresponsiveness. Journal of Acquired Immune Deficiency Syndromes 7(9): 899-907
Root-Bernstein, R.S.; Dewitt, S.H. 1994: CD4 similarity to proteins of infectious agents in AIDS and their role in autoimmunity. Medical Hypotheses 43(6): 361-371
European Collaborative Study Group 1994: CD4 T cell count as predictor of Pneumocystis carinii pneumonia in children born to mothers infected with HIV. British Medical Journal 308(6926): 437-440
Flynn, S.; Toellner, K.M.; Raykundalia, C.; Goodall, M.; Lane, P. 1998: CD4 T cell cytokine differentiation: the B cell activation molecule, OX40 ligand, instructs CD4 T cells to express interleukin 4 and upregulates expression of the chemokine receptor, Blr-1. Journal of Experimental Medicine 188(2): 297-304
Swain, S.L. 1995: CD4 T cell development and cytokine polarization: an overview. Journal of Leukocyte Biology 57(5): 795-798
Klein, L.; Klein, T.; Rüther, U.; Kyewski, B. 1998: CD4 T cell tolerance to human C-reactive protein, an inducible serum protein, is mediated by medullary thymic epithelium. Journal of Experimental Medicine 188(1): 5-16
Khazaei, H.A.; Lunardi, C.; So, A.K. 1995: CD4 T cells in the rheumatoid joint are oligoclonally activated and change during the course of disease. Annals of the Rheumatic Diseases 54(4): 314-317
Martinotti, A.; Stoppacciaro, A.; Vagliani, M.; Melani, C.; Spreafico, F.; Wysocka, M.; Parmiani, G.; Trinchieri, G.; Colombo, M.P. 1995: CD4 T cells inhibit in vivo the CD8-mediated immune response against murine colon carcinoma cells transduced with interleukin-12 genes. European Journal of Immunology 25(1): 137-146
Hosmalin, A.; Autran, B.; McIlroy, D.; Grassi, F.; Samri, A.; Debré, P. 1998: CD4 T helper lymphocytes and antigen presenting cells in the physiopathology of AIDS. Memorias do Instituto Oswaldo Cruz 93(3): 405-406
Keiper, M.D.; Beumont, M.; Elshami, A.; Langlotz, C.P.; Miller, W.T. 1995: CD4 T lymphocyte count and the radiographic presentation of pulmonary tuberculosis. A study of the relationship between these factors in patients with human immunodeficiency virus infection. Chest 107(1): 74-80
Visser, J.; Blauw, B.; Hinloopen, B.; Brommer, E.; de Kloet, E.R.; Kluft, C.; Nagelkerken, L. 1998: CD4 T lymphocytes from patients with chronic fatigue syndrome have decreased interferon-gamma production and increased sensitivity to dexamethasone. Journal of Infectious Diseases 177(2): 451-454
Mujtaba, M.G.; Soos, J.M.; Johnson, H.M. 1997: CD4 T suppressor cells mediate interferon tau protection against experimental allergic encephalomyelitis. Journal of Neuroimmunology 75(1-2): 35-42
Corrigan, C.J.; Haczku, A.; Gemou-Engesaeth, V.; Doi, S.; Kikuchi, Y.; Takatsu, K.; Durham, S.R.; Kay, A.B. 1993: CD4 T-lymphocyte activation in asthma is accompanied by increased serum concentrations of interleukin-5. Effect of glucocorticoid therapy. American Review of Respiratory Disease 147(3): 540-547
Doi, S.; Murayama, N.; Inoue, T.; Takamatsu, I.; Kameda, M.; Omoto, Y.; Toyoshima, K. 1996: CD4 T-lymphocyte activation is associated with peak expiratory flow variability in childhood asthma. Journal of Allergy and Clinical Immunology 97(4): 955-962
Nicholson, J.K.; Jones, B.M.; Hubbard, M. 1993: CD4 T-lymphocyte determinations on whole blood specimens using a single-tube three-color assay. Cytometry 14(6): 685-689
Gao, Q.; Chen, N.; Field, E.H. 1995: CD4 Th2 cells do not functionally suppress CTL generation in neonatal tolerant mice. Transplantation 60(11): 1260-1268
Leitenberg, D.; Constant, S.; Lu, D.D.; Smith, B.R.; Bottomly, K. 1995: CD4 and CD45 regulate qualitatively distinct patterns of calcium mobilization in individual CD4+ T cells. European Journal of Immunology 25(9): 2445-2451
Nah, E.H.; King, D.E.; Craig, F.E. 1997: CD4 and CD8 antigen coexpression: a flow cytometric study of peripheral blood, bone marrow, body fluid, and solid lymphoreticular specimens. Archives of Pathology and Laboratory Medicine 121(4): 381-384
Scanlan, J.M.; Vitaliano, P.P.; Ochs, H.; Savage, M.V.; Borson, S. 1998: CD4 and CD8 counts are associated with interactions of gender and psychosocial stress. Psychosomatic Medicine 60(5): 644-653
Ismaili, J.; Antica, M.; Wu, L. 1996: CD4 and CD8 expression and T cell antigen receptor gene rearrangement in early intrathymic precursor cells. European Journal of Immunology 26(4): 731-737
Winkel, K.; Sotzik, F.; Vremec, D.; Cameron, P.U.; Shortman, K. 1994: CD4 and CD8 expression by human and mouse thymic dendritic cells. Immunology Letters 40(2): 93-99
Leskinen, R. 1993: CD4 and CD8 expression of large granular lymphocytes after bone marrow transplantation and its effect on lymphocyte CD4/CD8 ratio. Apmis: Acta Pathologica Microbiologica et Immunologica Scandinavica 101(2): 149-153
Murayama, Y.; Amano, A.; Mukai, R.; Shibata, H.; Matsunaga, S.; Takahashi, H.; Yoshikawa, Y.; Hayami, M.; Noguchi, A. 1997: CD4 and CD8 expressions in African green monkey helper T lymphocytes: implication for resistance to SIV infection. International Immunology 9(6): 843-851
Sabino, K.C.C.; De Oliveira, A.M.; Coelho, M.G.P.; Freitas, C.S.; Dalmau, S.R. 1996: CD4 and CD8 labelling for the evaluation of early apoptosis in human blood lymphocytes. Medical Science Research 24(7): 487-489
Vrethem, M.; Dahle, C.; Ekerfelt, C.; Forsberg, P.; Danielsson, O.; Ernerudh, J. 1998: CD4 and CD8 lymphocyte subsets in cerebrospinal fluid and peripheral blood from patients with multiple sclerosis, meningitis and normal controls. Acta Neurologica Scandinavica 97(4): 215-220
Barclay, A.N.; Brady, R.L.; Davis, S.J.; Lange, G. 1993: CD4 and the immunoglobulin superfamily. Philosophical Transactions of the Royal Society of London. Series B Biological Sciences 342(1299): 7-12
Post, F.A.; Wood, R.; Maartens, G. 1996: CD4 and total lymphocyte counts as predictors of HIV disease progression. Qjm: Monthly Journal of the Association of Physicians 89(7): 505-508
Stronkhorst, A.; Radema, S.; Yong, S.L.; Bijl, H.; ten Berge, I.J.; Tytgat, G.N.; van Deventer, S.J. 1997: CD4 antibody treatment in patients with active Crohn's disease: a phase 1 dose finding study. Gut 40(3): 320-327
Hampl, J.; Chien, Y.H.; Davis, M.M. 1997: CD4 augments the response of a T cell to agonist but not to antagonist ligands. Immunity 7(3): 379-385
Hughes, M.D.; Daniels, M.J.; Fischl, M.A.; Kim, S.; Schooley, R.T. 1998: CD4 cell count as a surrogate endpoint in HIV clinical trials: a meta-analysis of studies of the AIDS Clinical Trials Group. Aids 12(14): 1823-1832
Jones, B.E.; Oo, M.M.; Taikwel, E.K.; Qian, D.; Kumar, A.; Maslow, E.R.; Barnes, P.F. 1997: CD4 cell counts in human immunodeficiency virus-negative patients with tuberculosis. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 24(5): 988-991
Brady, H.J.; Pennington, D.J.; Miles, C.G.; Dzierzak, E.A. 1993: CD4 cell surface downregulation in HIV-1 Nef transgenic mice is a consequence of intracellular sequestration. EMBO Journal 12(13): 4923-4932
Szabò, G.; Pine, P.S.; Weaver, J.L.; Rao, P.E.; Aszalos, A. 1992: CD4 changes conformation upon ligand binding. Journal of Immunology 149(11): 3596-3604
Tamma, S.M.; Chirmule, N.; Yagura, H.; Oyaizu, N.; Kalyanaraman, V.; Pahwa, S. 1997: CD4 cross-linking (CD4XL) induces RAS activation and tumor necrosis factor-alpha secretion in CD4+ T cells. Blood 90(4): 1588-1593
Weemaes, C.M.; Preijers, F.; de Vaan, G.A.; Bakkeren, J.A.; Klasen, I.S.; Haraldsson, A. 1996: CD4 deficiency in myelodysplastic syndrome with monosomy 7. European Journal of Pediatrics 155(2): 96-98
Moir, S.; Boissinot, M.; Tremblay, M.; Poulin, L. 1997: CD4 deletion mutants evaluated for human immunodeficiency virus type 1 infectivity in a highly efficient system of expression and detection based on LTR-dependent reporter gene activation. Journal of Virological Methods 65(2): 209-217
Feito, M.J.; Ballester, S.; Díez-Orejas, R.; Ojeda, G.; Criado, G.; Portolés, P.; Rojo, J.M. 1997: CD4 dependence of activation threshold and TCR signalling in mouse T lymphocytes. Scandinavian Journal of Immunology 45(2): 166-174
Yasukawa, M.; Inoue, Y.; Sada, E.; Yakushijin, Y.; Furukawa, M.; Fujita, S. 1995: CD4 down-modulation by ganglioside and phorbol ester inhibits human herpesvirus 7 infection. Journal of General Virology 76: 2381-2385
Chen, B.K.; Gandhi, R.T.; Baltimore, D. 1996: CD4 down-modulation during infection of human T cells with human immunodeficiency virus type 1 involves independent activities of vpu, env, and nef. Journal of Virology 70(9): 6044-6053
Mariani, R.; Skowronski, J. 1993: CD4 down-regulation by nef alleles isolated from human immunodeficiency virus type 1-infected individuals. Proceedings of the National Academy of Sciences of the United States of America 90(12): 5549-5553
Gibellini, D.; Zauli, G.; Re, M.C.; Furlini, G.; Lolli, S.; Borgatti, P.; Capitani, S.; La Placa, M. 1994: CD4 engagement by HIV-1 in TF-1 hematopoietic progenitor cells increases protein kinase C activity and reduces intracellular Ca2+ levels. New Microbiologica 17(2): 85-92
Wang, Z.Q.; Dudhane, A.; Orlikowsky, T.; Clarke, K.; Li, X.; Darzynkiewicz, Z.; Hoffmann, M.K. 1994: CD4 engagement induces Fas antigen-dependent apoptosis of T cells in vivo. European Journal of Immunology 24(7): 1549-1552
Reil, H.; Höxter, M.; Moosmayer, D.; Pauli, G.; Hauser, H. 1994: CD4 expressing human 293 cells as a tool for studies in HIV-1 replication: the efficiency of translational frameshifting is not altered by HIV-1 infection. Virology 205(1): 371-375
Cleveland, R.P.; Liu, Y.C. 1996: CD4 Expression by erythroid precursor cells in human bone marrow. Blood 87(6): 2275-2282
Omri, B.; Crisanti, P.; Alliot, F.; Marty, M.C.; Rutin, J.; Levallois, C.; Privat, A.; Pessac, B. 1994: CD4 expression in neurons of the central nervous system. International Immunology 6(3): 377-385
Wallace, V.A.; Rahemtulla, A.; Timms, E.; Penninger, J.; Mak, T.W. 1992: CD4 expression is differentially required for deletion of MLS-1a-reactive T cells. Journal of Experimental Medicine 176(5): 1459-1463
Ando, Y.; Wajjwalku, W.; Kishihara, K.; Arai, T.; Niimi, N.; Hiromatsu, K.; Morishima, T.; Yoshikai, Y. 1996: CD4 expression is important but not essential for infection with exogenous mouse mammary tumor virus. Immunobiology 195(3): 376-384
Patterson, S.; Gross, J.; English, N.; Stackpoole, A.; Bedford, P.; Knight, S.C. 1995: CD4 expression on dendritic cells and their infection by human immunodeficiency virus. Journal of General Virology 76: 1155-1163
Killeen, N.; Davis, C.B.; Chu, K.; Crooks, M.E.; Sawada, S.; Scarborough, J.D.; Boyd, K.A.; Stuart, S.G.; Xu, H.; Littman, D.R. 1993: CD4 function in thymocyte differentiation and T cell activation. Philosophical Transactions of the Royal Society of London. Series B Biological Sciences 342(1299): 25-34
Lusso, P.; Secchiero, P.; Crowley, R.W.; Garzino-Demo, A.; Berneman, Z.N.; Gallo, R.C. 1994: CD4 is a critical component of the receptor for human herpesvirus 7: interference with human immunodeficiency virus. Proceedings of the National Academy of Sciences of the United States of America 91(9): 3872-3876
Wineman, J.P.; Gilmore, G.L.; Gritzmacher, C.; Torbett, B.E.; Müller-Sieburg, C.E. 1992: CD4 is expressed on murine pluripotent hematopoietic stem cells. Blood 80(7): 1717-1724
Arasteh, K.; L'Age, M.; Futh, U.; Grosse, G.; Staib, F. 1995: CD4 lymphocyte count in HIV-positive persons exposed to Cryptococcus neoformans. Zentralblatt für Bakteriologie: International Journal of Medical Microbiology 283(1): 127-135
Cordiali Fei, P.; Solmone, M.; Vanacore, P.; Giglio, A.; Bonifati, C.; Carducci, M.; Mussi, A.; Chiarotti, F.; Ameglio, F. 1995: CD4 Lymphocyte enumeration: comparison between flow cytometry and enzyme immunoassay. Cytometry 22(1): 70-74
Des Jarlais, D.C.; Friedman, S.R.; Marmor, M.; Mildvan, D.; Yancovitz, S.; Sotheran, J.L.; Wenston, J.; Beatrice, S. 1993: CD4 lymphocytopenia among injecting drug users in new York City. Journal of Acquired Immune Deficiency Syndromes 6(7): 820-822
Ducloux, D.; Carron, P.L.; Rebibou, J.M.; Aubin, F.; Fournier, V.; Bresson-Vautrin, C.; Blanc, D.; Humbert, P.; Chalopin, J.M. 1998: CD4 lymphocytopenia as a risk factor for skin cancers in renal transplant recipients. Transplantation 65(9): 1270-1272
Kumlin, U.; Elmqvist, L.G.; Granlund, M.; Olsen, B.; Tärnvik, A. 1997: CD4 lymphopenia in a patient with cryptococcal osteomyelitis. Scandinavian Journal of Infectious Diseases 29(2): 205-206
Kupiec-Weglinski, J.W.; Wasowska, B.; Papp, I.; Schmidbauer, G.; Sayegh, M.H.; Baldwin, W.M.; Wieder, K.J.; Hancock, W.W. 1993: CD4 mAb therapy modulates alloantibody production and intracardiac graft deposition in association with selective inhibition of Th1 lymphokines. Journal of Immunology 151(9): 5053-5061
Fournel, S.; Vincent, C.; Assossou, O.; Gorman, S.D.; Robinet, E.; Phillips, J.M.; Flacher, M.; Cordier, G.; Waldmann, H.; Revillard, J.P. 1996: CD4 mAbs prevent progression of alloactivated CD4+ T cells into the S phase of the cell cycle without interfering with early activation signals. Transplantation 62(8): 1136-1143
Zhang, R.D.; Henderson, E.E. 1994: CD4 mRNA expression in CD19-positive B cells and its suppression by the Epstein-Barr virus. Virology 198(2): 709-713
Carrière, D.; Vendrell, J.; Berthier, A.; Atoui, N.; Salhi, S.L.; Reynes, J.; Gros, P.; Fontaine, C.; Jansen, A.; Huguet, M.; Ait-Cheik, L.; Pau, B. 1996: CD4 masking during human immunodeficiency virus type 1 infection, quantified on peripheral blood lymphocytes, is a potential marker of disease progression. Journal of Infectious Diseases 173(3): 565-573
Miller, R.A.; Chrisp, C.; Galecki, A. 1997: CD4 memory T cell levels predict life span in genetically heterogeneous mice. FASEB Journal 11(10): 775-783
Broder, C.C.; Berger, E.A. 1993: CD4 molecules with a diversity of mutations encompassing the CDR3 region efficiently support human immunodeficiency virus type 1 envelope glycoprotein-mediated cell fusion. Journal of Virology 67(2): 913-926
Nachbaur, D.; Niederwieser, D.; Aichinger, G.; Aulitzky, W.; Tilg, H.; Eibl, B.; König, P.; Gattringer, C.; Majdic, O.; Stockinger, H.; Margreiter, R.; Oberhuber, G.; Födinger, A.M.; Schwaighofer, H.; Huber, C. 1996: CD4 monoclonal antibody VIT4 in human alloimmune response in vitro and in vivo. Immunobiology 195(1): 33-46
Robinet, E.; Stamm, C.; Nicolas, J.F.; Faure, M.; Mercatello, A.; Coronel, B.; Wijdenes, J.; Bienvenu, J.; Revillard, J.P.; Claudy, A. 1997: CD4 monoclonal antibody administration in atopic dermatitis. Journal of the American Academy of Dermatology 36(4): 582-588
Attias, M.R.; Kong, L.; Tortolero, M.; Maccarone, B.G.; Nakabayashi, T.; Talal, N.; Dang, H. 1998: CD4 mononuclear cell infiltrates and Fas/Fas ligand positive mammary gland cells in breast tissue from a patient with Sjögren's syndrome. Journal of Rheumatology 25(6): 1226-1231
Rahemtulla, A.; Shahinian, A.; Kundig, T.; Zinkernagel, R.; Mak, T.W. 1993: CD4 negative mice as a model for immunodeficiency. Philosophical Transactions of the Royal Society of London. Series B Biological Sciences 342(1299): 57-58
Tornatore, K.M.; Reed, K.; Venuto, R.C. 1993: CD4 positive/CD8-positive lymphocyte patterns in renal transplant recipients receiving chronic methylprednisolone. Journal of Medicine 24(2-3): 98-112
Larson, R.S.; McCurley, T.L. 1995: CD4 predicts nonlymphocytic lineage in acute leukemia. Insights from analysis of 125 cases using two-color flow cytometry. American Journal of Clinical Pathology 104(2): 204-211
Flamand, L.; Romerio, F.; Reitz, M.S.; Gallo, R.C. 1998: CD4 promoter transactivation by human herpesvirus 6. Journal of Virology 72(11): 8797-8805
Algeciras, A.; Dockrell, D.H.; Lynch, D.H.; Paya, C.V. 1998: CD4 regulates susceptibility to Fas ligand- and tumor necrosis factor-mediated apoptosis. Journal of Experimental Medicine 187(5): 711-720
Field, E.H.; Gao, Q. 1998: CD4 regulatory cells in immune tolerance. Journal of Laboratory and Clinical Medicine 132(2): 91-96
Crockard, A.D.; Treacy, M.T.; Droogan, A.G.; Hawkins, S.A. 1996: CD4 subsets (CD45RA/RO) exhibit differences in proliferative responses, IL-2 and gamma-interferon production during intravenous methylprednisolone treatment of multiple sclerosis. Journal of Neurology 243(6): 475-481
Kashem, A.; Yamauchi, F.; Yano, N.; Miyazaki, M.; Endoh, M.; Nomoto, Y.; Sakai, H. 1992: CD4 subsets in IgA nephropathy. Tokai Journal of Experimental and Clinical Medicine 17(5-6): 173-177
Anonymous 1997: CD4 surveillance in Scotland: perspectives on severe HIV-related immunodeficiency. CD4 Collaborative Group. AIDS 11(12): 1509-1517
Pilling, D.; Akbar, A.N.; Bacon, P.A.; Salmon, M. 1996: CD4+ CD45RA+ T cells from adults respond to recall antigens after CD28 ligation. International Immunology 8(11): 1737-1742
Schmidt, D.; Goronzy, J.J.; Weyand, C.M. 1996: CD4+ CD7- CD28- T cells are expanded in rheumatoid arthritis and are characterized by autoreactivity. Journal of Clinical Investigation 97(9): 2027-2037
Suzushima, H.; Asou, N.; Eto, K.; Nishimura, S.; Okubo, T.; Fujimoto, T.; Yamasaki, H.; Osato, M.; Takeya, M.; Takatsuki, K. 1994: CD4+ CD8+ granular lymphocytic leukemia arising in a patient with acute myeloblastic leukemia. Leukemia 8(11): 1884-1889
Martin, D.J.; Sim, J.G.; Sole, G.J.; Rymer, L.; Shalekoff, S.; van Niekerk, A.B.; Becker, P.; Weilbach, C.N.; Iwanik, J.; Keddy, K. 1995: CD4+ lymphocyte count in African patients co-infected with HIV and tuberculosis. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology: Official Publication of the International Retrovirology Association 8(4): 386-391
Yoneda, T.; Ellner, J.J. 1998: CD4(+) T cell and natural killer cell-dependent killing of Mycobacterium tuberculosis by human monocytes. American Journal of Respiratory and Critical Care Medicine 158(2): 395-403
Ehlers, S.; Mielke, M.E.; Hahn, H. 1994: CD4+ T cell associated cytokine gene expression during experimental infection with Listeria monocytogenes: the mRNA phenotype of granuloma formation. International Immunology 6(11): 1727-1737
al-Janadi, N.; al-Dalaan, A.; al-Balla, S.; Raziuddin, S. 1996: CD4+ T cell inducible immunoregulatory cytokine response in rheumatoid arthritis. Journal of Rheumatology 23(5): 809-814
Loudovaris, T.; Mandel, T.E.; Charlton, B. 1996: CD4+ T cell mediated destruction of xenografts within cell-impermeable membranes in the absence of CD8+ T cells and B cells. Transplantation 61(12): 1678-1684
Leon, M.P.; Spickett, G.; Jones, D.E.; Bassendine, M.F. 1995: CD4+ T cell subsets defined by isoforms of CD45 in primary biliary cirrhosis. Clinical and Experimental Immunology 99(2): 233-239
Adler, A.J.; Marsh, D.W.; Yochum, G.S.; Guzzo, J.L.; Nigam, A.; Nelson, W.G.; Pardoll, D.M. 1998: CD4+ T cell tolerance to parenchymal self-antigens requires presentation by bone marrow-derived antigen-presenting cells. Journal of Experimental Medicine 187(10): 1555-1564
Kudeken, N.; Kawakami, K.; Saito, A. 1997: CD4+ T cell-mediated fatal hyperinflammatory reactions in mice infected with Penicillium marneffei. Clinical and Experimental Immunology 107(3): 468-473
Jankovic, D.; Cheever, A.W.; Kullberg, M.C.; Wynn, T.A.; Yap, G.; Caspar, P.; Lewis, F.A.; Clynes, R.; Ravetch, J.V.; Sher, A. 1998: CD4+ T cell-mediated granulomatous pathology in schistosomiasis is downregulated by a B cell-dependent mechanism requiring Fc receptor signaling. Journal of Experimental Medicine 187(4): 619-629
Hetzel, C.; Lamb, J.R. 1994: CD4+ T cell-targeted immunomodulation and the therapy of allergic disease. Clinical Immunology and Immunopathology 73(1): 1-10
Sawada, T.; Wu, Y.; Sachs, D.H.; Iacomini, J. 1997: CD4+ T cells are able to reject class I disparate allografts. Transplantation 64(2): 335-340
Finke, D.; Liebert, U.G. 1994: CD4+ T cells are essential in overcoming experimental murine measles encephalitis. Immunology 83(2): 184-189
Matloubian, M.; Concepcion, R.J.; Ahmed, R. 1994: CD4+ T cells are required to sustain CD8+ cytotoxic T-cell responses during chronic viral infection. Journal of Virology 68(12): 8056-8063
González, M.; Schurmans, S.; Ramos, A.; Merino, R.; Lambert, P.H.; Merino, J. 1995: CD4+ T cells determine the ability of spleen cells from F1 hybrid mice to induce neonatal tolerance to alloantigens and autoimmunity in parental mice. European Journal of Immunology 25(6): 1760-1764
Palmen, M.J.; Wijburg, O.L.; Kunst, I.H.; Kroes, H.; van Rees, E.P. 1998: CD4+ T cells from 2,4,6-trinitrobenzene sulfonic acid (TNBS)-induced colitis rodents migrate to the recipient's colon upon transfer; down-regulation by CD8+ T cells. Clinical and Experimental Immunology 112(2): 216-225
Kadowaki, K.M.; Matsuno, H.; Tsuji, H.; Tunru, I. 1994: CD4+ T cells from collagen-induced arthritic mice are essential to transfer arthritis into severe combined immunodeficient mice. Clinical and Experimental Immunology 97(2): 212-218
Zimecki, M.; Kapp, J.A.; Wieczorek, Z. 1995: CD4+ T cells from mice primed for humoral immunity to sheep erythrocytes (SRBC) specifically inhibit cell-mediated immunity and vice versa. Archivum Immunologiae et Therapiae Experimentalis 43(5-6): 259-264
Kobayashi, H.; Kokubo, T.; Sato, K.; Kimura, S.; Asano, K.; Takahashi, H.; Iizuka, H.; Miyokawa, N.; Katagiri, M. 1998: CD4+ T cells from peripheral blood of a melanoma patient recognize peptides derived from nonmutated tyrosinase. Cancer Research 58(2): 296-301
Wilson, A.D.; Redchenko, I.; Williams, N.A.; Morgan, A.J. 1998: CD4+ T cells inhibit growth of Epstein-Barr virus-transformed B cells through CD95-CD95 ligand-mediated apoptosis. International Immunology 10(8): 1149-1157
McKay, D.M.; Benjamin, M.A.; Lu, J. 1998: CD4+ T cells mediate superantigen-induced abnormalities in murine jejunal ion transport. American Journal of Physiology 275(1): G29-G38
Westermann, J.; Geismar, U.; Sponholz, A.; Bode, U.; Sparshott, S.M.; Bell, E.B. 1997: CD4+ T cells of both the naive and the memory phenotype enter rat lymph nodes and Peyer's patches via high endothelial venules: within the tissue their migratory behavior differs. European Journal of Immunology 27(12): 3174-3181
Su, H.; Caldwell, H.D. 1995: CD4+ T cells play a significant role in adoptive immunity to Chlamydia trachomatis infection of the mouse genital tract. Infection and Immunity 63(9): 3302-3308
Wang, J.K.; Zhu, B.; Ju, S.T.; Tschopp, J.; Marshak-Rothstein, A. 1997: CD4+ T cells reactivated with superantigen are both more sensitive to FasL-mediated killing and express a higher level of FasL. Cellular Immunology 179(2): 153-164
Cong, Y.; Brandwein, S.L.; McCabe, R.P.; Lazenby, A.; Birkenmeier, E.H.; Sundberg, J.P.; Elson, C.O. 1998: CD4+ T cells reactive to enteric bacterial antigens in spontaneously colitic C3H/HeJBir mice: increased T helper cell type 1 response and ability to transfer disease. Journal of Experimental Medicine 187(6): 855-864
Reisser, D.; Martin, F. 1994: CD4+ T cells recovered from a mixed immune lymphocyte-tumor cell culture induce thymidine incorporation by naive rat lymphocytes in response to tumor cells. International Journal of Cancer 57(2): 254-258
Okazaki, T.; Ozaki, S.; Nakao, K. 1994: CD4+ T cells require adhesion via LFA-1/ICAM-1 to induce target apoptosis in TNF-independent pathway. Cellular Immunology 156(1): 135-145
Blazar, B.R.; Taylor, P.A.; Noelle, R.J.; Vallera, D.A. 1998: CD4(+) T cells tolerized ex vivo to host alloantigen by anti-CD40 ligand (CD40L:CD154) antibody lose their graft-versus-host disease lethality capacity but retain nominal antigen responses. Journal of Clinical Investigation 102(3): 473-482
Molberg, O.; Nilsen, E.M.; Sollid, L.M.; Scott, H.; Brandtzaeg, P.; Thorsby, E.; Lundin, K.E. 1998: CD4+ T cells with specific reactivity against astrovirus isolated from normal human small intestine. Gastroenterology 114(1): 115-122
De Silva, H.D.; Van Driel, I.R.; La Gruta, N.; Toh, B.H.; Gleeson, P.A. 1998: CD4+ T cells, but not CD8+ T cells, are required for the development of experimental autoimmune gastritis. Immunology 93(3): 405-408
Wecker, H.; Winn, H.J.; Auchincloss, H., J. 1994: CD4+ T cells, without CD8+ or B lymphocytes, can reject xenogeneic skin grafts. Xenotransplantation 1(1): 8-16
Saravolatz, L.; Neaton, J.D.; Sacks, L.; Deyton, L.; Rhame, F.; Sherer, R. 1996: CD4+ T lymphocyte counts and patterns of mortality among patients infected with human immunodeficiency virus who were enrolled in community programs for clinical research on AIDS. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 22(3): 513-520
D'Souza, N.B.; Mandujano, F.J.; Nelson, S.; Summer, W.R.; Shellito, J.E. 1994: CD4+ T lymphocyte depletion attenuates lipopolysaccharide-induced tumor necrosis factor secretion by alveolar macrophages in the mouse. Lymphokine and Cytokine Research 13(6): 359-366
Patel, A.; Halliday, G.M.; Barnetson, R.S. 1995: CD4+ T lymphocyte infiltration correlates with regression of a UV-induced squamous cell carcinoma. Journal of Dermatological Science 9(1): 12-19
Chen, X.; Gavett, S.H.; Wills-Karp, M. 1995: CD4+ T lymphocyte modulation of ozone-induced murine pulmonary inflammation. American Journal of Respiratory Cell and Molecular Biology 12(4): 396-403
Dadmarz, R.; Sgagias, M.K.; Rosenberg, S.A.; Schwartzentruber, D.J. 1995: CD4+ T lymphocytes infiltrating human breast cancer recognise autologous tumor in an MHC-class-II restricted fashion. Cancer Immunology Immunotherapy: Cii 40(1): 1-9
Claesson, M.H.; Rudolphi, A.; Kofoed, S.; Poulsen, S.S.; Reimann, J. 1996: CD4+ T lymphocytes injected into severe combined immunodeficient (SCID) mice lead to an inflammatory and lethal bowel disease. Clinical and Experimental Immunology 104(3): 491-500
Lobato, M.N.; Spira, T.J.; Rogers, M.F. 1995: CD4+ T lymphocytopenia in children: lack of evidence for a new acquired immunodeficiency syndrome agent. Pediatric Infectious Disease Journal 14(6): 527-535
Taylor, J.M.; Sy, J.P.; Visscher, B.; Giorgi, J.V. 1995: CD4+ T-cell number at the time of acquired immunodeficiency syndrome. American Journal of Epidemiology 141(7): 645-651
Qin, H.; Chen, W.; Takahashi, M. 1996: CD4+ T-cell immunity and Ab responses to mutant ras protein in pancreas and colon cancer patients. Zhonghua Zhong Liu Za Zhi 18(3): 173-176
Qin, H.; Chen, W.; Takahashi, M.; Disis, M.L.; Byrd, D.R.; McCahill, L.; Bertram, K.A.; Fenton, R.G.; Peace, D.J.; Cheever, M.A. 1995: CD4+ T-cell immunity to mutated ras protein in pancreatic and colon cancer patients. Cancer Research 55(14): 2984-2987
Schattner, E.J.; Mascarenhas, J.; Bishop, J.; Yoo, D.H.; Chadburn, A.; Crow, M.K.; Friedman, S.M. 1996: CD4+ T-cell induction of Fas-mediated apoptosis in Burkitt's lymphoma B cells. Blood 88(4): 1375-1382
Takahashi, I.; Kiyono, H.; Hamada, S. 1997: CD4+ T-cell population mediates development of inflammatory bowel disease in T-cell receptor alpha chain-deficient mice. Gastroenterology 112(6): 1876-1886
Mitra, D.K.; Mehra, N.K.; Maiti, T.K.; Banerjee, A.; Taneja, V.; Rajalingam, R.; Ahuja, R.K.; Bhattacharya, B.C. 1995: CD4+ T-cell responses to recombinant hsp65 and hsp18 of M. leprae and their trypsin-digested fragments in leprosy: diversity in HLA-DR restriction. International Journal of Leprosy and other Mycobacterial Diseases: Official Organ of the International Leprosy Association 63(4): 518-528
Rosner, E.; Willis, V.; Lambert, R.; Latzanich, G.; Ponsell, P. 1997: CD4+ T-cell testing practices as implications for training. Cytometry 30(4): 181-185
Kawakami, A.; Matsuoka, N.; Tsuboi, M.; Urayama, S.; Nakashima, T.; Kawabe, Y.; Koji, T.; Aoyagi, T.; Maeda, K.; Eguchi, K. 1998: CD4+ T-cell-mediated cytotoxicity against staphylococcal enterotoxin B-pulsed synovial cells. Immunology 95(1): 38-46
Cohen, P.A.; Cohen, P.J.; Rosenberg, S.A.; Mulé, J.J. 1994: CD4+ T-cells from mice immunized to syngeneic sarcomas recognize distinct, non-shared tumor antigens. Cancer Research 54(4): 1055-1058
Anglaret, X.; Diagbouga, S.; Mortier, E.; Meda, N.; Vergé-Valette, V.; Sylla-Koko, F.; Cousens, S.; Laruche, G.; Ledru, E.; Bonard, D.; Dabis, F.; Van de Perre, P. 1997: CD4+ T-lymphocyte counts in HIV infection: are European standards applicable to African patients?. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology: Official Publication of the International Retrovirology Association 14(4): 361-367
Ratto, S.; Sitz, K.V.; Scherer, A.M.; Loomis, L.D.; Cox, J.H.; Redfield, R.R.; Birx, D.L. 1996: CD4+ T-lymphocyte lines developed from HIV-1-seropositive patients recognize different epitopes within the V3 loop. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology: Official Publication of the International Retrovirology Association 11(2): 128-136
Guarner, J.; Montoya, P.; del Rio, C.; Hernandez-Tepichin, G. 1997: CD4+ T-lymphocyte variations in patients with advanced human immunodeficiency virus infection and counts below 100 cells per microliter. Cytometry 30(4): 178-180
Zwacka, R.M.; Zhang, Y.; Halldorson, J.; Schlossberg, H.; Dudus, L.; Engelhardt, J.F. 1997: CD4(+) T-lymphocytes mediate ischemia/reperfusion-induced inflammatory responses in mouse liver. Journal of Clinical Investigation 100(2): 279-289
Azuma, E.; Nagai, M.; Qi, J.; Umemoto, M.; Hirayama, M.; Kumamoto, T.; Hiratake, S.; Komada, Y.; Sakurai, M. 1998: CD4+ T-lymphocytopenia in long-term survivors following intensive chemotherapy in childhood cancers. Medical and Pediatric Oncology 30(1): 40-45,.
Calderón, E.; Sánchez, B.; Medrano, F.J.; Stiefel, P.; Leal, M. 1995: CD4+ T-lymphocytopenia in the elderly. European Journal of Clinical Microbiology and Infectious Diseases: Official Publication of the European Society of Clinical Microbiology 14(1): 75-77
Imro, M.A.; Castagneto, C.; Bosco, O.; Modena, P.; Lanza, L.; Puppo, F.; Filaci, G.; Indiveri, F.; Scudeletti, M. 1995: CD4+ Th0 cell clones, isolated from a metastatic lymph node of a melanoma patient, possess cytolytic function. Cancer Immunology Immunotherapy: Cii 41(4): 210-216
Raziuddin, S.; el-Awad, M.E.; Telmesani, A.W.; Bilal, N.E.; al-Janadi, M. 1995: CD4+ Th2 cell response cytokine production in bacterial meningitis. Journal of Clinical Immunology 15(6): 338-348
Grunewald, J.; Andersson, R.; Rydberg, L.; Gigliotti, D.; Schaufelberger, C.; Hansson, G.K.; Wigzell, H. 1994: CD4+ and CD8+ T cell expansions using selected TCR V and J gene segments at the onset of giant cell arteritis. Arthritis and Rheumatism 37(8): 1221-1227
Sutherland, R.M.; Chua, M.M.; Lavi, E.; Weiss, S.R.; Paterson, Y. 1997: CD4+ and CD8+ T cells are not major effectors of mouse hepatitis virus A59-induced demyelinating disease. Journal of Neurovirology 3(3): 225-228
Blazar, B.R.; Taylor, P.A.; Vallera, D.A. 1997: CD4+ and CD8+ T cells each can utilize a perforin-dependent pathway to mediate lethal graft-versus-host disease in major histocompatibility complex-disparate recipients. Transplantation 64(4): 571-576
Murray, P.D.; Pavelko, K.D.; Leibowitz, J.; Lin, X.; Rodriguez, M. 1998: CD4(+) and CD8(+) T cells make discrete contributions to demyelination and neurologic disease in a viral model of multiple sclerosis. Journal of Virology 72(9): 7320-7329
Acosta, A.G.; Ortiz, J.; Barragan, L.; Torres, S.; Santos, J.I. 1994: CD4+ and CD8+ T lymphocyte subsets in colostrum and peripheral blood from Mexican women. Inmunologia 13(4): 118-121
Conlan, J.W.; Sjöstedt, A.; North, R.J. 1994: CD4+ and CD8+ T-cell-dependent and -independent host defense mechanisms can operate to control and resolve primary and secondary Francisella tularensis LVS infection in mice. Infection and Immunity 62(12): 5603-5607
Chipeta, J.; Komada, Y.; Zhang, X.L.; Deguchi, T.; Sugiyama, K.; Azuma, E.; Sakurai, M. 1998: CD4+ and CD8+ cell cytokine profiles in neonates, older children, and adults: increasing T helper type 1 and T cytotoxic type 1 cell populations with age. Cellular Immunology 183(2): 149-156
Brenner, J.; Paz, R.; Moss, J.S.; Shemesh, M.; Moalem, U.; Shore, L.S.; Meirom, R. 1998: CD4+ and CD8+ cells, IL-6 and TNFalpha activities in bovine peripheral blood during oestrus. Israel Journal of Veterinary Medicine 53(2): 51-58
Naumov, Y.N.; Naumova, E.N.; Gorski, J. 1996: CD4+ and CD8+ circulating alpha/beta T-cell repertoires are equally complex and are characterized by different levels of steady-state TCR expression. Human Immunology 48(1-2): 52-62
Caruso, A.; Canaris, A.D.; Licenziati, S.; Cantalamessa, A.; Folghera, S.; Lonati, M.A.; de Panfilis, G.; Garotta, G.; Turano, A. 1995: CD4+ and CD8+ lymphocytes of patients with AIDS synthesize increased amounts of interferon-gamma. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology: Official Publication of the International Retrovirology Association 10(4): 462-470
Gorla, R.; Airò, P.; Malagoli, A.; Carella, G.; Prati, E.; Brugnoni, D.; Franceschini, F.; Cattaneo, R. 1994: CD4+ and CD8+ subsets: Naive and memory cells in the peripheral blood of patients with systemic sclerosis. Clinical Rheumatology 13(1): 83-87
Akhtar, I.; Gold, J.P.; Pan, L.Y.; Ferrara, J.L.; Yang, X.D.; Kim, J.I.; Tan, K.N. 1995: CD4+ beta islet cell-reactive T cell clones that suppress autoimmune diabetes in nonobese diabetic mice. Journal of Experimental Medicine 182(1): 87-97
Ferbas, J.J.; Toso, J.F.; Logar, A.J.; Navratil, J.S.; Rinaldo, C.R. 1994: CD4+ blood dendritic cells are potent producers of IFN-alpha in response to in vitro HIV-1 infection. Journal of Immunology 152(9): 4649-4662
Nardelli, B.; Gonzalez, C.J.; Schechter, M.; Valentine, F.T. 1995: CD4+ blood lymphocytes are rapidly killed in vitro by contact with autologous human immunodeficiency virus-infected cells. Proceedings of the National Academy of Sciences of the United States of America 92(16): 7312-7316
Garside, P.; Steel, M.; Liew, F.Y.; Mowat, A.M. 1995: CD4+ but not CD8+ T cells are required for the induction of oral tolerance. International Immunology 7(3): 501-504
Krieger, N.R.; Yin, D.P.; Fathman, C.G. 1996: CD4+ but not CD8+ cells are essential for allorejection. Journal of Experimental Medicine 184(5): 2013-2018
Gulwani-Akolkar, B.; Akolkar, P.N.; Minassian, A.; McKinley, M.; Fisher, S.; Silver, J. 1996: CD4+ cell oligoclonality in Crohn's disease: Evidence for an antigen-specific response. Human Immunology 48(1-2): 114-124
Gil, T.; Castilla, J.A.; Hortas, M.L.; Molina, J.; Redondo, M.; Samaniego, F.; Garrido, F.; Vergara, F.; Herruzo, A. 1995: CD4+ cells in human ejaculates. Human Reproduction 10(11): 2923-2927
Moore, R.L.; Fox, B.S. 1994: CD4+ class I-restricted T cells specific for HIV gp160 315-329. Cellular Immunology 154(1): 43-53
Sabin, C.; Pasi, J.; Phillips, A.; Elford, J.; Janossy, G.; Lee, C. 1994: CD4+ counts before and after switching to monoclonal high-purity factor VIIi concentrate in HIV-infected haemophilic patients. Thrombosis and Haemostasis 72(2): 214-217
Pithie, A.D.; Lammas, D.A.; Fazal, N.; Rahelu, M.; Bartlett, R.; Gaston, J.S.; Kumararatne, D.S. 1995: CD4+ cytolytic T cells can destroy autologous and MHC-matched macrophages but fail to kill intracellular Mycobacterium bovis-BCG. Fems Immunology and Medical Microbiology 11(2): 145-154
Serody, J.S.; Poston, R.M.; Weinstock, D.; Kurlander, R.J.; Frelinger, J.A. 1996: CD4+ cytolytic effectors are inefficient in the clearance of Listeria monocytogenes. Immunology 88(4): 544-550
Wang, Z.E.; Reiner, S.L.; Zheng, S.; Dalton, D.K.; Locksley, R.M. 1994: CD4+ effector cells default to the Th2 pathway in interferon gamma-deficient mice infected with Leishmania major. Journal of Experimental Medicine 179(4): 1367-1371
Nakao, M.; Sata, M.; Saitsu, H.; Yutani, S.; Kawamoto, M.; Kojiro, M.; Itoh, K. 1997: CD4+ hepatic cancer-specific cytotoxic T lymphocytes in patients with hepatocellular carcinoma. Cellular Immunology 177(2): 176-181
Watanabe, M.; Takaishi, H.; Hosoda, Y.; Ezaki, T.; Yajima, T.; Inoue, N.; Ueno, Y.; Iwao, Y.; Ishii, H.; Ishikawa, H. 1995: CD4+ intestinal mucosal lymphocytes in the pathogenesis of Crohn's disease. Journal of Gastroenterology 30(Suppl 8): 73-75
Graham, N.M.; Piantadosi, S.; Park, L.P.; Phair, J.P.; Rinaldo, C.R.; Fahey, J.L. 1993: CD4+ lymphocyte response to zidovudine as a predictor of AIDS-free time and survival time. Journal of Acquired Immune Deficiency Syndromes 6(11): 1258-1266
Serrat, C.; Gómez, G.; García de Olalla, P.; Caylà, J.A. 1998: CD4+ lymphocytes and tuberculin skin test as survival predictors in pulmonary tuberculosis HIV-infected patients. International Journal of Epidemiology 27(4): 703-712
Driscoll, P.V.; Naclerio, R.M.; Baroody, F.M. 1996: CD4+ lymphocytes are increased in the sinus mucosa of children with chronic sinusitis. Archives of Otolaryngology--Head and Neck Surgery 122(10): 1071-1076
Cayota, A.; Vuillier, F.; Gonzalez, G.; Dighiero, G. 1996: CD4+ lymphocytes from HIV-infected patients display impaired CD45-associated tyrosine phosphatase activity which is enhanced by anti-oxidants. Clinical and Experimental Immunology 104(1): 11-17
Rich, K.C.; Siegel, J.N.; Jennings, C.; Rydman, R.J.; Landay, A.L. 1995: CD4+ lymphocytes in perinatal human immunodeficiency virus (HIV) infection: evidence for pregnancy-induced immune depression in uninfected and HIV-infected women. Journal of Infectious Diseases 172(5): 1221-1227
Hancock, W.W.; Adams, D.H.; Wyner, L.R.; Sayegh, M.H.; Karnovsky, M.J. 1994: CD4+ mononuclear cells induce cytokine expression, vascular smooth muscle cell proliferation, and arterial occlusion after endothelial injury. American Journal of Pathology 145(5): 1008-1014
Sawyer, R.G.; Adams, R.B.; May, A.K.; Rosenlof, L.K.; Pruett, T.L. 1995: CD4+ t cells mediate preexposure-induced increases in murine intraabdominal abscess formation. Clinical Immunology and Immunopathology 77(1): 82-88
Marotta, G.; Bucalossi, A.; Galieni, P.; Bigazzi, C.; Nuti, S.; Valenzin, P.E.; Bocchia, M.; Lauria, F. 1998: CD4+/CD45RA+ 'naive' T cells and immunological response to influenza virus vaccine in B-cell chronic lymphocytic leukaemia patients. Acta Haematologica 99(1): 18-21
Greenleaf, J.E.; Jackson, C.G.; Lawless, D.; Greenleaf, J.E. 1995: CD4+/CD8+ T-lymphocyte ratio: effects of rehydration before exercise in dehydrated men. Medicine and Science in Sports and Exercise 27(2): 194-199
Pham, B.N.; Martinot-Peignoux, M.; Mosnier, J.F.; Njapoum, C.; Marcellin, P.; Bougy, F.; Degott, C.; Erlinger, S.; Cohen, J.H.; Degos, F. 1995: CD4+/CD8+ ratio of liver-derived lymphocytes is related to viraemia and not to hepatitis C virus genotypes in chronic hepatitis C. Clinical and Experimental Immunology 102(2): 320-327
Thornton, A.M.; Shevach, E.M. 1998: CD4+CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. Journal of Experimental Medicine 188(2): 287-296
Andersson, E.; Ohlin, M.; Borrebaeck, C.A.; Carlsson, R. 1995: CD4+CD57+ T cells derived from peripheral blood do not support immunoglobulin production by B cells. Cellular Immunology 163(2): 245-253
Reinhold, U.; Abken, H. 1997: CD4+ CD7- T cells: a separate subpopulation of memory T cells?. Journal of Clinical Immunology 17(4): 265-271
Tamauchi, H.; Sasahara, T.; Habu, S. 1993: CD4+CD8+ cells lacking self-Mls reactive T cells are induced in mesenteric lymph nodes of Salmonella enteritidis-infected mice. Immunology Letters 37(2-3): 123-130
Blair, P.J.; Bultman, S.J.; Haas, J.C.; Rouse, B.T.; Wilkinson, J.E.; Godfrey, V.L. 1994: CD4+CD8- T cells are the effector cells in disease pathogenesis in the scurfy (sf) mouse. Journal of Immunology 153(8): 3764-3774
Seddon, B.; Saoudi, A.; Nicholson, M.; Mason, D. 1996: CD4+CD8- thymocytes that express L-selectin protect rats from diabetes upon adoptive transfer. European Journal of Immunology 26(11): 2702-2708
Matsuda, S.; Yamane, T.; Hamaji, M. 1998: CD4- and TCRalphabeta-positive T lymphocytes predominantly infiltrated into well-moderately differentiated colon adenocarcinoma tissues. Japanese Journal of Clinical Oncology 28(2): 97-103
Kobayashi, M.; Herndon, D.N.; Pollard, R.B.; Suzuki, F. 1995: CD4+ contrasuppressor T cells improve the resistance of thermally injured mice infected with HSV. Journal of Leukocyte Biology 58(2): 159-167
Mattei, M.; Bach, S.; Di Cesare, S.; Fraziano, M.; Placido, R.; Poccia, F.; Sammarco, I.; Moras, A.M.; Bardone, M.R.; Colizzi, V. 1994: CD4-8- T-cells increase in MRI/lpr mice treated with thymic factors. International Journal of Immunopharmacology 16(8): 651-658
Schneider, M.K.; Grönvik, K.O. 1998: CD4-CD8-C.B-17 SCID thymocytes enter the CD4+CD8+ stage in the presence of neonatally grafted T cells. Scandinavian Journal of Immunology 47(5): 466-474
Berkower, I.; Mostowski, H.; Bull, T.E.; Murphy, D. 1996: CD4-IgG binding threshold for inactivation of human immunodeficiency virus type 1. Journal of Infectious Diseases 173(4): 863-869
Chandler, G.; Elcock, C.; Depledge, P.; Wrigley, S.; Mous, J.; Malkovsky, M.; Moore, M.; Gammon, G. 1993: CD4-binding compounds: an assay to detect new classes of immunopharmacological agents. International Journal of Immunopharmacology 15(3): 361-369
Von Herrath, M.G.; Yokoyama, M.; Dockter, J.; Oldstone, M.B.; Whitton, J.L. 1996: CD4-deficient mice have reduced levels of memory cytotoxic T lymphocytes after immunization and show diminished resistance to subsequent virus challenge. Journal of Virology 70(2): 1072-1079
Criado, G.; Feito, M.J.; Rojo, J.M. 1996: CD4-dependent and -independent association of protein tyrosine kinases to the T cell receptor/CD3 complex of CD4+ mouse T lymphocytes. European Journal of Immunology 26(6): 1228-1234
Meshcheryakova, D.; Andreev, S.; Tarasova, S.; Sidorova, M.; Vafina, M.; Kornilaeva, G.; Karamov, E.; Khaitov, R. 1993: CD4-derived peptide and sulfated polysaccharides have similar mechanisms of anti-HIV activity based on electrostatic interactions with positively charged gp120 fragments. Molecular Immunology 30(11): 993-1001
Deckert, P.M.; Ballmaier, M.; Lang, S.; Deicher, H.; Schedel, I. 1996: CD4-imitating human antibodies in HIV infection and anti-idiotypic vaccination. Journal of Immunology 156(2): 826-833
Hesselgesser, J.; Halks-Miller, M.; DelVecchio, V.; Peiper, S.C.; Hoxie, J.; Kolson, D.L.; Taub, D.; Horuk, R. 1997: CD4-independent association between HIV-1 gp120 and CXCR4: functional chemokine receptors are expressed in human neurons. Current Biology: Cb 7(2): 112-121
Montefiori, D.C.; Zhou, J.; Shaff, D.I. 1992: CD4-independent binding of HIV-1 to the B lymphocyte receptor CR2 (CD21) in the presence of complement and antibody. Clinical and Experimental Immunology 90(3): 383-389
Dyall, R.; Vasović, L.V.; Molano, A.; Nikolić-Zugić, J. 1995: CD4-independent in vivo priming of murine CTL by optimal MHC class I-restricted peptides derived from intracellular pathogens. International Immunology 7(8): 1205-1212
Potempa, S.; Picard, L.; Reeves, J.D.; Wilkinson, D.; Weiss, R.A.; Talbot, S.J. 1997: CD4-independent infection by human immunodeficiency virus type 2 strain ROD/B: the role of the N-terminal domain of CXCR-4 in fusion and entry. Journal of Virology 71(6): 4419-4424
Chehimi, J.; Prakash, K.; Shanmugam, V.; Collman, R.; Jackson, S.J.; Bandyopadhyay, S.; Starr, S.E. 1993: CD4-independent infection of human peripheral blood dendritic cells with isolates of human immunodeficiency virus type 1. Journal of General Virology 74: 1277-1285
Miller, S.B.; Tse, H.; Rosenspire, A.J.; King, S.R. 1992: CD4-independent inhibition of lymphocyte proliferation mediated by HIV-1 envelope glycoproteins. Virology 191(2): 973-977
Sullivan, N.; Sun, Y.; Sattentau, Q.; Thali, M.; Wu, D.; Denisova, G.; Gershoni, J.; Robinson, J.; Moore, J.; Sodroski, J. 1998: CD4-Induced conformational changes in the human immunodeficiency virus type 1 gp120 glycoprotein: consequences for virus entry and neutralization. Journal of Virology 72(6): 4694-4703
Lucas, B.; Marodon, G.; Penit, C. 1996: CD4low TCRint thymocytes do not belong to the CD8 lineage maturation pathway. Journal of Immunology 156(5): 1743-1747
Bergamo, P.; Balestrieri, M.; Cammarota, G.; Guardiola, J.; Abrescia, P. 1997: CD4-mediated anchoring of the seminal antigen gp17 onto the spermatozoon surface. Human Immunology 58(1): 30-41,.
Zerbib, A.C.; Reske-Kunz, A.B.; Lock, P.; Sékaly, R.P. 1994: CD4-mediated enhancement or inhibition of T cell activation does not require the CD4:p56lck association. Journal of Experimental Medicine 179(6): 1973-1983
Lasarte, J.J.; Sarobe, P.; Golvano, J.; Prieto, I.; Civeira, M.P.; Gullón, A.; Sarin, P.S.; Prieto, J.; Borrás-Cuesta, F. 1994: CD4-modified synthetic peptides containing phenylalanine inhibit HIV-1 infection in vitro. Journal of Acquired Immune Deficiency Syndromes 7(2): 129-134
Yoshimoto, T.; Paul, W.E. 1994: CD4pos, NK1.1pos T cells promptly produce interleukin 4 in response to in vivo challenge with anti-CD3. Journal of Experimental Medicine 179(4): 1285-1295
Menage, P.; Thibault, G.; Barthelemy, C.; Lelord, G.; Bardos, P. 1992: CD4-positive CD45RA-positive T lymphocyte deficiency in autistic children: Effect of a pyridoxine-magnesium treatment. Brain Dysfunction 5(5-6): 326-333
Koeppen, H.K.; Singh, S.; Stauss, H.J.; Park, B.H.; Rowley, D.A.; Schreiber, H. 1993: CD4-positive and B lymphocytes in transplantation immunity. I. Promotion of tumor allograft rejection through elimination of CD4-positive lymphocytes. Transplantation 55(6): 1349-1355
Bishop, D.K.; Chan, S.; Li, W.; Ensley, R.D.; Xu, S.; Eichwald, E.J. 1993: CD4-positive helper T lymphocytes mediate mouse cardiac allograft rejection independent of donor alloantigen specific cytotoxic T lymphocytes. Transplantation 56(4): 892-897
Scheglovitova, O.; Capobianchi, M.R.; Antonelli, G.; Guanmu, D.; Dianzani, F. 1993: CD4-positive lymphoid cells rescue HIV-1 replication from abortively infected human primary endothelial cells. Archives of Virology 132(3-4): 267-280
Yin, D.; Fathman, C.G. 1995: CD4-positive suppressor cells block allotransplant rejection. Journal of Immunology 154(12): 6339-6345
Charlton, B.; Meltzer, J.; Fathman, C.G. 1994: CD4-positive/heat-stable antigen-positive thymocytes cause graft-versus-host disease across non-major histocompatibility complex incompatibilities. European Journal of Immunology 24(7): 1706-1709
Lenert, P.; Lenert, G.; Senécal, J.L. 1996: CD4-reactive antibodies in systemic lupus erythematosus. Human Immunology 49(1): 38-48
Huard, B.; Prigent, P.; Tournier, M.; Bruniquel, D.; Triebel, F. 1995: CD4/major histocompatibility complex class Ii interaction analyzed with CD4- and lymphocyte activation gene-3 (LAG-3)-Ig fusion proteins. European Journal of Immunology 25(9): 2718-2721
Fries, K.M.; Sempowski, G.D.; Gaspari, A.A.; Blieden, T.; Looney, R.J.; Phipps, R.P. 1995: CD40 Expression by human fibroblasts. Clinical Immunology and Immunopathology 77(1): 42-51
Urashima, M.; Chauhan, D.; Uchiyama, H.; Freeman, G.J.; Anderson, K.C. 1995: CD40 ligand triggered interleukin-6 secretion in multiple myeloma. Blood 85(7): 1903-1912
Schattner, E.J.; Elkon, K.B.; Yoo, D.H.; Tumang, J.; Krammer, P.H.; Crow, M.K.; Friedman, S.M. 1995: CD40 ligation induces Apo-1/Fas expression on human B lymphocytes and facilitates apoptosis through the Apo-1/Fas pathway. Journal of Experimental Medicine 182(5): 1557-1565
Sempowski, G.D.; Chess, P.R.; Moretti, A.J.; Padilla, J.; Phipps, R.P.; Blieden, T.M. 1997: CD40 mediated activation of gingival and periodontal ligament fibroblasts. Journal of Periodontology 68(3): 284-292
Ishida, T.; Kobayashi, N.; Tojo, T.; Ishida, S.; Yamamoto, T.; Inoue, J. 1995: CD40 signaling-mediated induction of Bcl-XL, Cdk4, and Cdk6. Implication of their cooperation in selective B cell growth. Journal of Immunology 155(12): 5527-5535
Galibert, L.; Burdin, N.; de Saint-Vis, B.; Garrone, P.; Van Kooten, C.; Banchereau, J.; Rousset, F. 1996: CD40 and B cell antigen receptor dual triggering of resting B lymphocytes turns on a partial germinal center phenotype. Journal of Experimental Medicine 183(1): 77-85